id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,tiktoken_without_attributes_markdown_token_num,chunk_num_tokens,output,is_chunked
562,9836,3496170,P3a latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"[1671, 44]","intervention:mean:177.0684375standard_deviation:31.134675group_size:18comparator:mean:202.29203standard_deviation:29.8086176385group_size
---
outcome:
---
",True
213,2913,5459456,lateral bending for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,5.8,0.5,5.9,0.7,-0.1554,0.2508,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","Comparator: ACVC – artificial cervical vertebra and intervertebral complex (ACVC)Comparator: ACCF – artificial cervical corpectomy and fusion (with titanium and plate fixation)C2-C4 segmentsMeanStandard DeviationGroupSizeComparisonInterventionInterventionGroupSizeMe
---
intervention: {
""mean"": 5.8, ""standard_deviation"": 0.5, ""group\_size"": 9}comparator: {
""mean"": 5.6, ""standard\_deviation"": 0.8, ""group\_size"": 9}
---
intervention: { mean: 6.7, standard_deviation: 1.1, group_size: 9 } comparator: { mean: 6.5, standard_deviation: 0.8, group_size: 9 }
---
intervention: mean: 0.69 mean_with_sd: 0.20 group_size: 7 comparator: mean: 0.34 mean_with_sd: 0.12 group_size: 8
---
intervention: mean:10.0standard_deviation:4.0group_size:20comparator: mean:6.0standard_deviation:4.0group_size:20outcome: Not provided
---
",True
82,3745,3546023,CD4+/CD8+ ratio,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,1.19,0.43,1.03,0.53,0.3277,0.0687,,,,,Values are for week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","{ intervention: mean: 1.7870; group_size: 9: comparator: mean: 1.4398; group_size: 9.}
---
intervention: mean: 0.1416785443521standard_deviation: 0.08671841337722group_size: 7
---
intervention: mean: - group_size: 58 comparator: mean: - group_size: 56 outcome: CD4+/CD8+ ratio - Table  [1](#) shows the baseline levels of CD4+/CD8+ ratio in smokers and nonsmokers.
---
{ interventioncomparator: [ { mean: 0.97 standard_deviation: 0.44 group_size: 56 comparator: [ { mean: 1.18 standard_deviation: 0.38 group_size: 58 ] }] }
---
intervention: mean:2.101813standard_deviation:0.4784679group_size:60comparator: mean:1.983428standard_deviation:0.4315428group_size:60
---
intervention: mean: 0.1175827483467202 standarddeviation: 0.1068333701197525 group_size: 19 comparator: mean: 0.104587063
---
intervention: mean: 0intervention: standard_deviation: 0intervention: group_size: 19[7,11]
---
intervention:
---
intervention: mean: 200.000 standard_deviation: 0.000 group_size: 28 comparator: mean:14.4562500 standard_deviation: 2.09511621136 group_size: 7
---
intervention: mean: -0.02446504882493828 standard_deviation: 0.08873063448681464 group_size: 719 comparator: mean: -0.02617
---
",True
92,10164,4173437,Postoperatively hematocrit,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,[],intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER,False
366,12887,5976949,leptin/adiponectin ratio (LAR),"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,0.97,1.31,0.72,0.46,0.2624,0.0908,,,,,found in table,TRUE,4402,2905,TEST,2274,"[1558, 1103]","Yes, correct. Since the unit conversion was not provided in the original table, we assume that the original table is in the imperial unit system (pounds, feet, days, etc.) and the BMI values were converted to the metric system (only the unit of kg/m2 is needed).
---
{ % Intervention % comparator % outcome % intervention % mean % standard_deviation % group_size % comparator % mean % standard_deviation % group_size % } 0.9721.700LARGDM1- tight glycaemic targets, fasting blood glucose < 
---
",True
165,615,5062234,The 24 h morphine requirement,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,34.57,14.64,32.76,14.34,0.1225,0.0954,,,,,,TRUE,1345,1148,TEST,971,[],"intervention: mean: ""34.57"" standard_deviation: ""14.64"" group_size: ""42"" comparator: mean: ""32.76"" standard_deviation: ""14.34"" group_size: ""42""",False
322,4726,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1650, 1319, 1031]","intervention:
---
The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:
---
comparator: mean: 2.95 standard_deviation: 0.59 group_size: 11intervention_group_1: mean: 2.82 standard_deviation: 0.57 group_size: 10intervention_group_2: mean: 2.
---
",True
574,8565,2952311,Verbal rating scale pain intensity,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1591],"intervention: mean: 0.0000000000000001 standard_deviation: 1.17 group_size: 33 comparator: mean: 0.0000000000000005 standard_deviation: 
---
",True
663,13295,4987981,percentage of patients achieving 75 % reduction in PASI and ESI scores,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","intervention: mean: 0.4814; standard_deviation: 0.232; group_size: 18 comparator: mean: 0.2058; standard_deviation: 0.171; group_size: 21
---
intervention: mean: 0.8 standard_deviation: 0.2 group_size: 29
---
intervention:
---
I: metformin OR pioglitazone (8.8, 6.2)[I: pioglitazone(14.4, 4.45)[C: placebo
---
intervention: mean: 0.55636987 standard_deviation: 0.22657096 group_size: 51 comparator: mean: 0.24549024 standard_deviation: 0.22238077
---
",True
271,2991,3214395,laryngoscopy failure,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 48",group 3 involved bispectral index (BIS) of 38,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],intervention: mean: 60 standard_deviation: 0 group_size: 25,False
11,9681,2363753,Glomerular filtration rate fall,Amifostine,Control,continuous,,20,,20,10,,37,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],intervention: mean: 105 standard_deviation: 21.5 group_size: 40 comparator: mean: 107 standard_deviation: 20.5 group_size: 40,False
480,4801,5515881,VO2peak,demanding balance training program,relaxation group,continuous,,,,,32.07,6.52,31.947,7.89,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1670, 1268]","intervention: mean: 32.07 standard\_deviation: 6.52 group\_size: 40 comparator: mean: 31.95 standard\_deviation: 7.89 group\_size: 40
---
intervention:
---
",True
293,6104,4215531,MCCB performance : Verbal Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.1,10,47.3,10.4,-0.0192,0.1053,,,,,used post values and Treatment as Usual as Baseline,TRUE,7352,5561,TEST,4156,"[1672, 1641, 963]","intervention:mean:72.54standard_deviation:9.10group_size:60comparator:mean:47.17standard_deviation:7.57group_size:109
---
intervention: mean:30.8920 standard_deviation:6.6262 group_size:38113 comparator: mean:30.5916 standard_deviation:6.9636 group_size:38113
---
intervention:mean: -8.8standard_deviation: : 13.0group_size: 20comparator:mean: -5.5standard_deviation: -20.0group_size: 30
---
",True
471,4803,5515881,spatial score,demanding balance training program,relaxation group,continuous,,,,,0.443,0.75,0.04,0.91,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1670, 1268]","intervention: mean: [number] standard_deviation: [number] group_size: [number] comparator: mean: [number] standard_deviation: [number] group_size: [number] outcome: comparator: [number]
---
intervention: balance training program1 : 19 : 65comparator: relaxation training program1: 71 : 84outcome: spatial score5 : 0.31 3 : 0.16
---
",True
544,7792,3508963,Pain score after 5 minutes,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,3.18,2.27,4.45,2.16,-0.5713783,0.01734682,,,,,,TRUE,3561,2387,TEST,1552,"[1557, 216]","intervention:
intervention_group: Lidocaine Injection
---
intervention: mean:9.92947135867392standard_deviation:2.200729522664328group_size:120comparator: mean:8.90784183135216
---
",True
274,6419,3654355,Body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-17.5,6.1,-0.5,2.8,-3.1892,0.0933,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: mean: −17.0 standard_deviation: 9.5 group_size: 71comparator: x
---
intervention:
mean: 128.90000000000105663694927399967comparator:
---
intervention: { mean: 17.50000 standard_deviation: 16.58727 group_size: 71 comparator: { mean: 2.42857 standard_deviation: 22.01724 group_size: 65
---
intervention: mean: −1.4375 standard_deviation: 9.12 group_size: 25 comparator: mean: 2.5 standard_deviation: 11.36 group_size: 25
---
intervention:
mean: 102.645333333333334555555555555666666666666666677777777777742.23
---
",True
577,8567,2952311,Salivary alpha-amylase,Acupressure at distal points,Acupressure at local points,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1591],"intervention: mean: 36.800 standard_deviation: 27.900 group_size: 11 comparator: mean: 37.100 standard_deviation: 10.500 group_size: 11 outcome: [] intervention: mean: 3
---
",True
310,7833,4541185,onset of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,9.83,1.12,10.85,0.79,-1.0388,0.0757,,,,,found in abstract,TRUE,1359,1043,TEST,907,[],intervention: mean: 5.86 standard_deviation: 1.66 group_size: 30,False
406,2803,5781260,Movement induced pain (VAS),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 1227]","> interventions: [{""group_size"": 40, ""intervention"": {""mean"": 42.65, ""standard_deviation"": 11.33, ""name"": ""placebo""}},""group_size"": 40, ""intervention"": {""mean"": 45.3
---
intervention: mean:49.30standard_deviation:21.73group_size:26comparator: mean:66.08standard_deviation:25.56group_size:25
---
",True
316,9843,4928400,Postoperative pain,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.3,1,3.6,1.2,0.619,0.1,,,,,,TRUE,4037,2288,TEST,1670,[1630],"intervention:
mean: 6.4000000000000001
---
",True
635,12290,5777645,Mean BMI change,to peer-led structured patient education,conventional care alone,continuous,,,,,-1.65,2.5,0.05,3.2,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"[1055, 1401, 1282, 724]","intervention: {mean: -1.65, standard_deviation:2.5,group_size: 76}comparator: {mean: 0.05, standard_deviation:3.2,group_size: 75}outcome:
---
intervention:mean: -2.3standard_deviation: 5.1group_size: 65comparator:mean: 0.5standard_deviation: 6.1group_size: 64
---
The response data (in YAML) is as follows: intervention:mean: -5.40standard_deviation: 7.564group_size: 424comparator:mean: -0.74standard_deviation: 3.972group_size: 206
---
intervention: mean: 0.650 standard_deviation: 0.029 group_size: 0 comparator: mean: 0.610 standard_deviation: 0.029 group_size: 0
---
",True
334,5081,5617873,Inappropriate speech,Aripiprazole,Placbeo,continuous,,45,,47,-2.2,0.4,-1.5,0.4,-1.7354,0.0599,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"[1552, 722, 1531, 1010]","intervention: mean: 1\.005 standard_deviation: 0\.994 group_size: 19 comparator: mean: 0\.971 standard_deviation: 0\.982 group_size: 19
---
intervention: mean: 2.60 standard_deviation: 1.15 group_size: 166
comparator: mean: 2.00 standard_deviation: 1.14 group_size: 165
---
intervention:mean: −7.5standard_ deviation: 1.4group_size: 47comparator:mean: −11.4standard_ deviation:1.3group_size: 45
---
Intervention:placeboComparator:aripiprazoleOutcome:Inappropriate speechIntervention: {mean: 9.62}Comparator: {mean: 7.79}
---
",True
22,3245,2972614,Shoulder Pain and Disability Index score,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,48.13,22.1,40.99,20.98,0.325,0.0798,,,,,,TRUE,7041,2968,TEST,1931,"[838, 1256]","intervention: mean: 5.56 standard_deviation: 1.36 group_size: 30 comparator: mean: 5.36 standard_deviation: 1.64 group_size: 22
---
intervention: mean: 36.392standard_deviation: 20.531group_size: 8comparator: mean: 36.425standard_deviation: 21.149group_size: 12
---
",True
392,1120,3577738,efficiency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[1637],"intervention: mean: 6.5 standard_deviation: 1.6 group_size: 458 comparator: mean: 8.0 standard_deviation: 1.9 group_size: 458
---
",True
44,6986,3169777,Plasma endothelin-1 concentrations,macitentan dose of 600 mg,placebo,continuous,,6,,14,,,,,cannot calculate,cannot calculate,,,,,The mean and SD are in bar chart (figure),FALSE,5143,4376,TEST,3326,"[1586, 1671, 396]","intervention: macitentan dose of 600 mg
---
intervention:
mean: 2.85247212976829747522631935264929471420125934096353763132827266
---
intervention: mean: 0.0023 standard_deviation: 0.00103 group_size: 14 comparator: mean: 0.0011 standard_deviation: 0.0003 group_size: 14
---
",True
99,929,4183415,patient adherence,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,"Data found in Table 6. Used same values as ""completed treatment",TRUE,10420,7106,TEST,5310,"[1557, 954, 1029, 882, 888, 842]","intervention: mean: 68.7 standard_deviation: 9.42 group_size: 444 comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
intervention: mean: 0.50 standard_deviation: 0.50 group_size: 378
---
intervention: mean: 0.93 standard_deviation: 0.23 group_size: 453 comparator: mean: 0.90 standard_deviation: 0.13 group_size: 453
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
intervention:mean: 2.71standard_deviation: 2.83group_size: 71comparator:mean: 1.14standard_deviation: 1.06group_size: 76
---
intervention:mean:0.96standard_deviation:0.13group_size:37comparator:mean:0.96standard_deviation:0.13group_size:40
---
",True
168,2797,5079604,incremental area under the curve for insulin (AUCi),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[739, 1755, 1654, 706]","intervention: 22.9215 10.686 group_size: 28 comparator: −17.4822 −13.497 group_size: 27 For the numerical data presented, the outcome measure chosen (SI) from the trial article is not listed as
---
intervention: {  ""group_size"": 50,  ""mean"": 2975,  ""standard_deviation"": 216}
---
intervention: mean: 0.40 standard_deviation: 0.25 group_size: 16comparator: mean: 0.98 standard_deviation: 0.33 group_size: 14
---
What is the number of subjects who relapsed with and without significant changes in insulin sensitivity (Si)?
---
",True
320,4724,5539943,"sustain talk"" (ST)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1650, 1319, 1031]","intervention: 0.317 0.107 71 comparator: 0.232 0.193 42
---
intervention:
---
intervention: mean: ""38"" standard_deviation: ""20"" group_size: ""72""
---
",True
438,3261,3475525,Scores on sodium quiz,MTL group,choices group,continuous,,98,,98,93.5,16.4,47.1,21.1,2.44594908,0.03567007,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention:
mean: NANA (mean of sodium quiz scores for the MTL group was not presented in the article)
---
intervention:
---
intervention:
mean: 23.963616884718213280959259148316375305100255100100281.597036344
---
Here is your response: intervention:mean: 11.03standard_deviation: 2.67*1group_size:10comparator:mean: 7.50standard_deviation: 2.50*1group_size:10
---
",True
554,9720,3648394,pNN50,10-week yoga program,Control,continuous,,18,,19,20.7,25.3,19.4,18.4,0.05775336,0.10823221,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"[1586, 970, 1651, 518]","intervention: mean: 7.464 standard_deviation: 0.598 group_size: 18 comparator: mean: 8.039 standard_deviation: 0.433 group_size: 19
---
intervention:
---
intervention: mean: 27.7 number_format: 0, digits: 0 standard_deviation: 20.7 number_format: 0, digits: 0 group_size: NUMBER comparator: mean: x number_format: 0, digits: 0 standard_
---
intervention:
mean: 45.7
standard_deviation: 47.59
group_size: 11
---
",True
327,5374,5559992,Anxiety,Buprenophine 96 mg,No treatment,continuous,,5,,5,0,0,23.8,13.82,-2.1985,0.6417,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],"intervention:
mean: NANA",False
111,9522,4319071,High-energy snack intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.5,2.76,2.84,2.71,-0.1242,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[975, 2176, 811, 1363, 1589, 1399, 1753, 1361]","control:
---
intervention: groups_comprised_of: - group_size: 123 standard_deviation: 9 mean: 3.380294 comparator: groups_comprised_of: - group_size: 124–128 standard_deviation: 9–1
---
intervention:mean:8.95standard_deviation:8.09group_size:902
---
intervention: mean: 0.22 standard_deviation: 2.24 group_size: 124 comparator: mean: 1.91 standard_deviation: 1.13 group_size: 123
---
intervention: {mean: 0.81,standard_ deviation: 0.41,group_ size: 99}comparator: {mean: 0.89,standard_deviation: 0.40,group_size: 96}
---
intervention: mean: 3.03 standard_deviation: 4.06 group_size: 1506 comparator: mean: 3.07 standard_deviation: 4.06 group_size: 470
---
intervention: {mean: 1.234}standard_deviation: 2.345group_size: 808comparator: {mean: 2.345}standard_deviation: 2.345group_size: 808
---
intervention: mean: -0.29 standard_deviation: 6.65 group_size: 128 comparator: mean: -0.05 standard_deviation: 6.57 group_size: 128
---
",True
613,11584,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean:0.15 standard_deviation:0.09 group_size:699comparator: mean:0.16 standard_deviation:0.09 group_size:694
---
intervention:
---
intervention:
mean: 0.24124188588923155556296134348564426865549392832816014252562296
---
",True
589,11583,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","{ ""intervention"": { ""mean"": 0.560, ""standard_deviation"": 0.231, ""group_size"": 891 }, ""comparator"": { ""mean"": 2.796, ""standard_deviation"": 0.932, ""group_
---
90 mg once daily:
---
The given data contains an empty circular graph with information regarding the number of patients in three treatment groups.
---
",True
216,2915,5459456,new bone formation around the screws and bone-implant contact (BIC) in both sections,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating,ACVC,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"".
---
intervention:
mean: 0.4228571428571429
standard_deviation: 0.0469009140750715713442246340779665157
---
The following output is in YAML format and contains the requested numerical information: intervention: mean: 0.4148 standard_deviation: 0.1257 group_size: 16comparator: mean: 0.2291 standard_deviation: 0.0395
---
Comparator: ACVCTotal group size: 17Mean: 27.15Percentile: 45.00Standard deviation: 33.08Group size for post hoc analysis: 6Mean for post hoc analysis: 45.17Percentile for post h
---
intervention: mean: 0.0778459 standard_deviation: 0.116247 group_size: 226 comparator: mean: 0.0635899 standard_deviation: 0.0797785 group_size:
---
",True
243,8057,5534041,composite z-scores in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.13,0.82,-0.25,0.71,0.4783,0.1714,,,,,,TRUE,6951,5679,TEST,4357,"[926, 1571, 1677, 482]","The extracted values from the given trial article into YAML format are provided in the Table 10. Only the field ""group_size"" was added to the table.
---
intervention:
mean: 10.5569093417211467241650624539695241563887726065345031406605681
---
intervention: mean: 0.09 standard_deviation: 0.87 group_size: 14 comparator: [mean: -0.25, standard_deviation: 0.74] group_size 14
---
intervention: mean: 1.259 standard_deviation: 1.167 group_size: 9 comparator: mean: 2.03 standard_deviation: 1.263 group_size: 12
---
",True
650,13097,5976307,awake time,etomidate,propofol based on midazolam,continuous,,62,,62,15.08,10.06,17.07,11.83,-0.1801099,0.03238887,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[1636],"intervention: {mean: 0.14, standard_deviation: 0.06, group_size: 1136}
---
",True
597,11583,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention:
---
intervention:
---
To answer this question, we need to analyze the text carefully and extract the required information. The information is presented in two parts:
---
",True
306,7831,4541185,duration of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,703.83,42.9,556.38,37.96,3.5929,0.1742,,,,,found in text,TRUE,1359,1043,TEST,907,[],intervention: mean: 703.83 standard_deviation: 42.90 group_size: 30comparator: mean: 556.38 standard_deviation: 37.96 group_size: 30,False
351,4494,5874317,Knee flexion (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,99.8,10.2,86.8,2.9,1.6509,0.2979,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[716, 3252, 976]","The response is as follows: Comparator: Unilateral training Outcome: 1RM Knee Flexion (kg) Intervention: Bilateral training Pre_test: Mean Standard _ deviation Group _size Pre_test: Mean Standard _ deviation Group _size Comparator: 72.724.6
---
* Intervention: Bilateral training, Comparator: Unilateral training, Outcome: Knee flexion (1-rep Max)intervention:mean: 207.9y standard_deviation: 30.2x group_size: 9comparator:mean: 207.9
---
The YAML response is the following. No numerical information of pre measurements could be found:
---
",True
419,3262,3475525,intent of purchase,MTL+caloric intake group,choices group,continuous,,90,,98,3.6,1.5,4.1,1.7,-0.3098034,0.02157045,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","{% set ""intervention"" = [""MTL+caloric intake group""] %} {% set ""comparator"" = [""choices group""] %} {% set ""intervention_size"" = [""MTL+caloric intake group"": 246, ""choices group"": 244]
---
intervention:
mean: 85.63
standard_deviation: 7.136788772134111
---
intervention:mean:4.1standard_deviation:1.5group_size:49comparator:mean:4.1standard_deviation:1.7group_size:97
---
{% if variable.name == ""calories"" %}intervention:mean:9320.300standard_deviation:11696.829group_size:123intervention:mean:3828.347standard_deviation:7019.
---
",True
346,10233,5686687,Need for dipyrone,Resveratrol,Placebo,continuous,,22,,22,1944,1793,625,250,1.0119,0.1025,,,,,found in table,TRUE,7451,3515,TEST,2366,"[1235, 1108]","intervention: mean: 25 standard_deviation: 2 group_size: 20 comparator: mean: 20 standard_deviation: 3 group_size: 22
---
{% for field_name, field_value in intervention_data[0].items() %} {% assign variable_name = field_name %} {% assign variable_value = field_value %} {% if variable_name != ""group_size"" %} interventions: {% if (variable_name ==
---
",True
282,6422,3654355,baseline skeletal muscle mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,38.4,7.9,37.9,7.4,0.0641,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","Note: The information in the table is based on our own interpretation of the provided information. If there is a different interpretation, please reach out to us.
---
intervention: mean: −5.8 standard_deviation: 1.8 group_size: 71comparator: mean: −0.2 standard_deviation: 1.0 group_size: 33
---
intervention:mean: NUMBERstandard_deviation: NUMBERgroup_size: NUMBERcomparator:mean: NUMBERstandard_deviation: NUMBERgroup_size: NUMBER
---
intervention:
---
intervention: {mean: 37.6, standard_deviation: 4.61, group_size: 50}comparator: {mean: 37.2, standard_deviation: 5.65, group_size: 50}
---
",True
634,12289,5777645,HbA1c levels,to peer-led structured patient education,conventional care alone,continuous,,70,,70,1.05,2,0.15,1.7,0.48225433,0.02940203,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"[1055, 1401, 1282, 724]","intervention: mean: -1.05 standard_deviation: 2.0 group_size: 151
---
intervention: mean: -1.05 standard_deviation: 2.0 group_size: 70 comparator: mean: -0.15 standard_deviation: 1.7 group_size: 70
---
There seem to be two datasets in this trial article – one for ""Baseline Characteristics"" and one for ""Outcomes"". For ""Baseline Characteristics"", the requested fields were extracted, but we did not extract any information for ""Outcomes"" because the values and corresponding 95% confidence intervals and p values need to be extracted first
---
intervention: mean: -0.70standard_deviation: 0.96group_size: 70comparator: mean: -0.50standard_deviation: 1.26group_size: 70
---
",True
620,11603,1863515,absolute neutrophil count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,5639,,6150,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"[1630, 1586]","intervention: mean: −485.68 standard_deviation: 757.14 group_size: 667 comparator: mean: 147.01 standard_deviation: 596.68 group_size: 769
---
<pre><code>intervention: mean: 5000.00 standard_deviation: 0.00 group_size: 4267 comparator: mean: 2938.10 standard_deviation: 38.70 group_size: 5236
---
",True
288,6102,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,treatment as usual (TAU),continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,"[1672, 1641, 963]","intervention:
---
intervention:
number: '20'standard_deviation: '10.28'group_size: '50'
---
intervention: mean: 3.38289811404264 standard_deviation: 1.89111573392932 group_size: 19 comparator: mean: 3.282898105140
---
",True
223,2914,5459456,Rotation stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.02,0,1.62,0.47,-4.5509,0.8972,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention:
mean: 19.123333333333335
standard_deviation: 9.193642032839487
---
intervention: mean: 6.98 standard_deviation: 1.05 group_size: 56 ------------ comparator: mean: 6.20 standard_deviation: 1.19 group_size: 56
---
group_size: 115group_size: 99intervention: Rotation stiffnessStandard deviation: 0.32Intervention: 0.40standard_deviation: 0.29Intervention: Artificial cervical vertebra with an HA biocoatingOutcome: Rot
---
intervention: mean: 0.69 standard_deviation: 0.20 group_size: 18 comparator: mean: NUMBER standard_deviation: NUMBER group_size: 18
---
This is a reminder that I am an AI language model, and my understanding of a study like this is through the information provided in the input. My response is also based on that same information. I do not have access to any additional context or background information about the study beyond what was provided. I apologize if my response appears to be unclear
---
",True
160,7711,5056957,BMI z-score at 12months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,0.61,1.8,0.66,1.69,-0.0285,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1657, 626, 2074, 1039]","intervention: mean: -0.08 standard_deviation: 0.22 group_size: 589 comparator: mean: -0.09 standard_deviation: 0.26 group_size: 332
---
intervention:mean: 20.14standard_
---
intervention: mean: 0.19 standard_deviation: 1.10 group_size: 506 comparison: mean: 0.19 standard_deviation: 1.12 group_size: 528
---
Based on the given trial article, what is the table of mean outcome and standard deviation in YAML format for the following Intervention, Comparator, and Outcome?Intervention: Behavioral therapyComparator: ControlOutcome: Weight status (BMI*z-score)Both groups received a year-long health and behavior
---
",True
472,5710,3343759,improvment in ANELT by day 21,higher level of education (>12 years),<12 years of education,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Median is reported. Group sizes are only available in methods section.,FALSE,3838,2633,TEST,2065,"[1467, 589]","intervention:
mean: 2.71
---
Sliding semilunar valve (SSV) repair with or without annuloplasty is indicated for the patients with symptomatic, nonrheumatic, and primary organic mitral regurgitation, SSV prolapse accounts for approximately 10–30% of primary mitral regurgitation, with
---
",True
418,3262,3475525,intent of purchase,MTL group,choices group,continuous,,98,,98,3.8,1.4,4.1,1.7,-0.1919025,0.02050211,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","comparison_group:
name: 'Choices'
group_size_intervention: 80
group_size_comparator: 80
---
intervention: mean: 193.94 standard_deviation: 86.17 group_size: 96 comparator: mean: 238.46 standard_deviation: 104.30 group_size: 96 group-size-total: 192
---
intervention: { 'mean': 4.1, 'standard_deviation': 1.5, 'group_size': 98 }comparator: { 'mean': 4.1, 'standard_deviation': 1.7, 'group_size': [99, 99, 99
---
intervention: mean: 0.1990 standard_deviation: 0.1286 group_size: 209 comparator: mean: 0.1682 standard_deviation: 0.1352 group_size: 193
---
",True
618,11603,1863515,haemoglobin level at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,10.7,,11.2,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"[1630, 1586]","intervention:mean: 10.28standard_deviation: 0.78group_size: 667comparator:mean: 10.39standard_deviation: 0.90group_size: 667
---
intervention:
mean: 9.5401748036285579SD: 0.82063811733756576group_size: 721comparator:
---
",True
514,6551,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 1200 mg,Control,continuous,,,,,-34.5,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,"[1205, 1677, 1566, 907]","intervention: mean: −28.7 standard_deviation: 30.6 group_size: 121 comparator: mean: −23.3 standard_deviation: 33.2 group_size: 121
---
intervention:
mean: 81.8858
---
intervention: { ""mean"": 57.3, ""standard_deviation"": 33.0, ""group_size"": 125 }
---
intervention: mean: −24.1341192 standard_deviation: 0.05304295 group_size: 283 comparator: mean: −29.1862386standard_deviation: 0.0587784
---
",True
141,1272,4880652,the modified Aldrete scores at 60 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,[],intervention: mean:15.35standard_deviation:2.84group_size:76comparator:mean:16.53standard_deviation:2.41group_size:70,False
78,3740,3546023,tocopherol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.11,3.89,11.39,3.06,0.7671,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: mean:3.9396 standard_deviation:1.5769 group_size:34 comparison: mean:0 standard_deviation:0 group_size:33
---
intervention: mean: 200x10^3µg/L
---
intervention: mean: 0.1 group_size: 104 standard_deviation: 0.0852
---
intervention: mean: 1.34 standard_deviation: 0.24 group_size: 26 comparator: mean: 1.19 standard_deviation: 0.24 group_size: 26
---
intervention:
---
intervention: mean: 0.33776 standard_deviation: 0.11444 group_size: 64
---
This table specifies the means and standard deviations of the outcome for each group (smokers, nonsmokers). There is no data on Palmvitee intake in this table.
---
intervention: mean: 2.99556 standard_deviation: 0.934573 group_size: 40comparator: mean: 2.43819 standard_deviation: 0.917213 group_size: 40
---
intervention: mean: [220.044] standard_deviation: [63.1576] group_size: [18] comparator: mean: [77.1111] standard_deviation: [104.5823] group_size: [1
---
intervention:mean: x.x × 10−4standard_deviation: x.x × 10−4group_size: 6
---
",True
436,3261,3475525,Scores on sodium quiz,MTL group,No label group,continuous,,98,,99,93.5,16.4,42.6,20.7,2.71359845,0.03899447,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean:0.69 standard_deviation:0.09 group_size:251 comparator: mean:0.63 standard_deviation:0.09 group_size:249
---
MTL:
---
intervention: {} mean: NANA standard_deviation: NANA group_size: 98 comparator: {} mean: NANA standard_deviation: NANA group_size: 99
---
The YAML format for the information regarding Outcome and standard deviation are not available in the text, but from the table mentioned in the instruction, the Mean for sodium quiz for MTL group is 5.75 and standard deviation is 1.93. There are no details of the total size of each group
---
",True
102,1886,4188762,heart rate,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[1441],"intervention:
---
",True
276,6421,3654355,Visceral fat,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-82.3,31.6,4.3,22.7,-2.6604,0.0784,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: mean: −86.6 standard_deviation: 51.6 group_size: 71 comparator: mean: −52.4 standard_deviation: 14.7 group_size: 33
---
intervention:
---
Sure, I can help you with that! Which table would you like me to extract the data from? Please provide me with the name of the table and its row and column numbers.
---
intervention: mean: 23.32000 standard_deviation: 14.14969group_size: 241
comparator: mean: 34.4416696 standard_deviation: 9.1789894group_size
---
outcome_x_baseline: standard_deviation: x mean:x group_size:x outcome_x_baseline: standard_deviation: x mean:x group_size:x
---
",True
159,7710,5056957,BMI reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,21.07,6.39,21.27,5.9,-0.0323,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1657, 626, 2074, 1039]","intervention: mean: 0.75 standard_deviation: 0.01 group_size: 1150
---
intervention:
mean: 25.4479394583218837373291914574356859776611046982344463830129147
---
{ ""intervention"": {'mean': 23.95, 'standard_deviation': 4.07, ""group_size"": 7}, ""usual PE and sport programmes"": {'mean': 23.87, 'standard_deviation': 3.87, ""group_size
---
Achievements: {% set output = ""MULTIPLE"" %}
---
",True
388,1119,3577738,focused on the social presence elements in terms of duration,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[1637],"# [YAML format for Table with mean and standard deviation of the outcome 'focused on the social presence elements in terms of duration (in seconds)'. In addition to the Table (Fig. 3) a table including standard deviations is created using the data reported in the text. [(91) (91
---
",True
446,4002,4879328,waist circumference,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.32,0.3,3.54,-0.3450435,0.01866038,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[989, 1648, 1674, 1355, 1003]","intervention:mean: xstandard_deviation: xgroup_size: 114comparator:mean: xstandard_deviation: xgroup_size: 114OUTCOME (Waist circumference):mean: 101.82standard_deviation: 10.97group
---
intervention:mean: 82.8standard_deviation: 19.4group_size: 114comparator:mean: 83.6standard_deviation: 18.7group_size: 114
---
intervention: mean:4.40(cm) standard_deviation:2.20(cm) group_size:78(participants) comparator: mean:4.59(cm) standard_deviation:2.36(cm) group_size:72(participants)
---
intervention: mean: −1.34 standard_deviation: 2.31 group: 103 comparator: mean: −0.32 standard_deviation: 1.47 group_size: 103
---
{% set interval = ""post"" %} [{% assign value = ""intervention"" set = 104 %} {% assign value = ""comparator"" set = 114 %} {% assign value = ""mean"" set = ""-1.18"" %} {% assign value = ""standard
---
",True
211,2913,5459456,inflexion-extension for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.1,1.4,0.2,0,0.25,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","- intervention: ACVC-HA 10.74127,139.653673group_size: 5comparator: CTR 8.478293,144.7396group_size: 6outcome: inflexion-extension
---
intervention:
mean: 3.9993498890091554
---
intervention:mean{5.6, 6.8}standard_deviation{2.4, 2.1}group_size{18, 20}comparator:mean{5.7, 6.6}standard_deviation{2.4, 2.1}group_size{
---
intervention: {
""group\_size"": { ""intervention"": 2, ""control"": 2 }, ""mean"": { ""intervention"": ""6.2±0.9"", ""control"": ""6.9±0.8"" }, ""standard\_deviation"": { ""intervention"": ""0.9"", ""
---
intervention:mean: −4.74standard_deviation: 5.03group_size: 26comparator:mean: −12.07standard_deviation: 9.48group_size: 28
---
",True
579,8566,2952311,State-Trait Anxiety Inventory-I,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1591],"intervention: mean: 43.20 standard_deviation: 6.80 group_size: 110 comparator: mean: 40.18 standard_deviation: 10.98 group_size: 110
---
",True
278,6422,3654355,Baseline body mass index,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,42.8,4.6,42.8,6.3,0,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: mean: 30.100 standard_deviation: 5.166 group_size: 99comparator: mean: 30.009 standard_deviation: 5.223 group_size: 82
---
intervention: mean: 42.8 standard_deviation: 4.6 group_size: 71
---
intervention:
mean:27.03standard_deviation:3.95group_size:117comparator:mean: NaNstandard_deviation: NaNGroup size: 71
---
intervention: {mean: 33.06, standard_deviation: 3.62, group_size: 34}
---
intervention:
---
",True
665,13296,4987981,FPG,pioglitazone,placebo,continuous,,16,,23,103.4,28.9,97.6,20.8,0.23275367,0.1066728,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","intervention: mean: 125.10 standard_deviation: 35.60 group_size: 23 comparator: mean: 100.80 standard_deviation: 32.00 group_size: 16
---
intervention: mean: 103.4 standard_deviation: 28.9 group_size: 251 comparator: mean: 97.6 standard_deviation: 20.8 group_size: 127
---
intervention:
mean: 118.8624926
---
intervention: mean: 20.5 standard_deviation:17.4 group_size:21comparator: mean:6.9standard_deviation:14.6group_size:21
---
intervention: mean: 2.191 standard_deviation: 0.376 group_size: 66 comparator: mean: 1.797 standard_deviation: 0.272 group_size: 65
---
",True
163,7713,5056957,BMI z-score at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,0.69,1.81,0.71,1.63,-0.0115,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1657, 626, 2074, 1039]","intervention: mean: 0.0947 standard_deviation: 0.1824 group_size: 1051 comparator: mean: 0.0970 standard_deviation: 0.1811 group_size: 1051
---
intervention: mean: −0.08 standard_deviation: 0.22 group_size: NUMBER comparator: mean: −0.13 standard_deviation: 0.22 group_size: NUMBER
---
intervention:
---
intervention: mean: 0.69 standard_deviation: 0.08 group_size: 570comparator: mean: 0.66 standard_deviation: 0.06 group_size: 425
---
",True
172,2790,5079604,Hyperglycemia relapse-free survival,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[739, 1755, 1654, 706]","intervention: mean: 480 days standard_deviation: 162.63 days group_size: 17 comparator: mean: 305 days standard_deviation: 106.29 days group_size: 15
---
intervention:
mean: 0.5180376524613479standard_deviation: 0.15560959235648222group_size: 20comparator:mean: 0.119878
---
intervention: ∣ ∣−∣ ∣--∣ ∣−∣. ∣ ∣comparator: ∣ −. ∣−. ∣ *.
---
intervention: mean: 0.4827954861257standard_deviation: 0.20839775546103group_size: 308comparator: mean: 0.305555555555
---
",True
430,3261,3475525,Scores on the saturated fat quiz,MTL group,choices group,continuous,,98,,98,90.7,20.4,35.7,15.9,2.99563986,0.04330066,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 60.152 standard_d
---
Choices group:
---
intervention:
---
intervention:mean: 8.3000000000standard_deviation: 2.938952565375861group_size: 36comparator:mean: 4.3000000000standard_deviation:
---
",True
185,4338,5122613,Colonic transit time,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,39.7,22.3,48,25,-0.3459,0.0712,,,,,,TRUE,6184,3742,TEST,2832,"[1633, 1102]","intervention: mean:59.36; standard_deviation:23.91; group_size:N = 29 groups; comparator: mean:48.47; standard_deviation:24.12; group_size:N = 29 groups
---
intervention:mean: 8.29standard_deviation: 7.16group_size: 59comparator:mean: 6.98standard_deviation: 3.86group_size: 12
---
",True
364,12885,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)","GDM2 (less tight glycaemic targets, <5.3_mmol/L and <_7.8_mmol/L)",continuous,,20,,21,23.1,25.6,21.5,25.8,0.061,0.0977,,,,,found in table,TRUE,4402,2905,TEST,2274,"[1558, 1103]","# YAML is not a widely used or recommended data format. The data obtained from your question seems not to be clear based on the given table in the given research article. Therefore, I could not produce required output from the provided information.
---
intervention:
---
",True
662,13294,4987981,"Psoriasis Area and Severity Index (PASI), Erythema, Scaling and Induration (ESI) and Physician global assessment (PGA) scores",metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","intervention:
---
intervention:
---
intervention:
---
intervention: ‐ mean: 0.006 standard_deviation: 0.005 group_size: 15 ‐ mean: 0.119 standard_deviation: 0.028 group_size: 15 ‐ mean: 0.147 standard_
---
{ ""Intervention"": { ""mean"": 5.2, ""standard_deviation"": 2.11, ""group_size"": 20 }, ""Comparator"": { ""mean"": 10, ""standard_deviation"": 4.29, ""group_size"": 20 } }
---
",True
325,5372,5559992,Anxiety,Buprenophine 32 mg,No treatment,continuous,,5,,5,1,2.23,11,8.63,-1.4322,0.5026,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],intervention: mean: 6.8 x standard_deviation: 5.91 x group_size: 5 x comparator: mean: x standard_deviation: x group_size: 14,False
302,3878,4357072,improvement in symptom scores,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,0.2,0.4,0.8,0.6,-1.1448,0.1552,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],intervention: mean:7.5 standard_deviation:4.5 group_size:15,False
300,5599,4355974,School days missed for asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"[1518, 1642, 573]","intervention: mean: 11.0 standard_deviation: 3.9 group_size: 37 comparator: mean: 16.2 standard_deviation: 5.0 group_size: 28 school_days_missed: NUMBER
---
intervention:mean: 0.2standard_deviation: 0.2group_size: 28comparator:mean: 0.4standard_deviation: 0.2group_size: 14
---
intervention: mean: 3.74 standard_deviation: 6.98 group_size: 194 comparator: mean: 5.04 standard_deviation: 6.45 group_size: 68
---
",True
485,5714,3343759,communication ability,very early speech and language therapy (SLT),control,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome.,FALSE,3838,2633,TEST,2065,"[1467, 589]","Yes, please find the requested YAML format below:intervention: {: mean: 1.3: standard_deviation: 2.1: group_size: 123}comparator: {: mean: 1.2: standard_deviation: 2.1: group_size: 
---
intervention:
---
",True
669,13296,4987981,triglycerides levels,pioglitazone,placebo,continuous,,16,,23,200.1,55.9,181.8,61.3,0.30295813,0.10715497,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","intervention: pioglitazonemean: -8.1830standard_deviation: [8.1678]group_size: 16comparator: pioglitazonemean: -8.6607standard_deviation: [7.9224]group_size:
---
intervention: mean: 194.3 standard_deviation: 63.1 group_size: 20 comparator: mean: 144.3 standard_deviation: 25.3 group_size: 20
---
intervention:
---
intervention: {mean: 44.3standard_deviation: 45.4group_size: Placebo21}comparator: {mean: 53.3standard_deviation: 36.9group_size: Pioglitazone16}
---
intervention: mean: 93 standard_deviation: 28 group_size: 108 comparator: mean: 91 standard_deviation: 35 group_size: 117
---
",True
433,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.6,15.5,47.2,19.6,2.54502741,0.03834748,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 73.30 standard_deviation: 6.90 group_size: 96 comparator: mean: 67.80 standard_deviation: 10.30 group_size: 96 outcome: sugarsquiz Results Table:
---
The standardized mean difference was .45, calculated as:0.084456−0.0844320.0791972
---
intervention: mean: 0.73 standard_deviation: 0.10 group_size: 98 comparator: mean: 0.67 standard_deviation: 0.10 group_size: 99
---
intervention: mean: 10.2 standard_deviation: 1.1 group_size: 73 comparator: mean: 10.5 standard_deviation: 1.5 group_size: 68
---
",True
26,3244,2972614,Motion range - Shoulder abduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,166.66,21.38,172.72,16.67,-0.3054,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"[838, 1256]","outcome: ""Motion Range - Shoulder Abduction""
---
intervention: mean: 168 standard_deviation: 22.65 group_size: 29 comparator: mean: 174.31 standard_deviation: 14.98 group_size: 25
---
",True
21,3243,2972614,Severity of pain,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,3.76,1.45,4.63,2.1,-0.4889,0.0811,,,,,,TRUE,7041,2968,TEST,1931,"[838, 1256]","intervention: mean: x standard_deviation: x group_size: 30 comparator: mean: x standard_deviation: x group_size: 22
---
intervention: 
mean: 8.20 
standard_deviation: 2.66 
group_size: 9 
---
",True
417,3262,3475525,intent of purchase,MTL+caloric intake group,No label group,continuous,,90,,99,3.6,1.4,4.1,1.5,-0.3426709,0.02152276,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","# The YAML response Intervention Comparator Outcome interventionmean123.5standard_deviation42.5group_size115comparatormean95.0standard_deviation42.0group_size115
---
intervention:
---
intervention:
---
The YAML format response is:intervention:mean: 0.129standard_deviation: 0.046group_size: 24comparator:mean: 0.198standard_deviation: 0.054group_size: 24
---
",True
385,1118,3577738,website use in terms of the number of pages visited,website with social presence elements.,website without social presence elements.,continuous,,,,,7.5,4,8,3.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,[1637],"intervention: mean: 7.35 standard_deviation: 1.69 group_size: 458 comparator: mean: 7.88 standard_deviation: 2.59 group_size: 413
---
",True
204,5497,5380326,Th1/Th2 cytokines,Vitamin D supplementation,Control,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome numerical values in the RCT. Cannot clearly identify the actual metric or measure for the given outcome.,FALSE,10658,5810,TEST,4260,"[618, 1669, 1370, 1494]","intervention: mean: 24.24 standard_deviation: 5.14 group_size: 80 comparator: mean: 24.24 standard_deviation: 4.86 group_size: 80 Outcome: Intervention: mean: 10.97 standard
---
intervention: mean:23.5162group_size:40comparator: mean:26.1538group_size:40
---
intervention: mean: 0.0mean_standard_deviation: 0.0group_size: 40comparator: mean: 0.0mean_standard_deviation: 0.0group_size: 40outcome:th1th2intervention: mean: 0.0mean
---
intervention: mean: -1.09 standard_deviation: 33.37 group_size: 26 comparator: mean: 25.05 standard_deviation: 33.37 group_size: 26
---
",True
164,617,5062234,The visual analog scale scores at rest and on coughing,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,,,,,cannot calculate,cannot calculate,,,,,Data found in table in graphic format.,FALSE,1345,1148,TEST,971,[],intervention: mean: 33.07 standard_deviation: 12.68 group_size: 42 comparator: mean: 38.52 standard_deviation: 12.68 group_size: 42,False
513,6549,4033571,Overall seizure median percent reduction,Extended-release oxcarbazepine 1200 mg,Control,continuous,,109,,117,-38.3,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,"[1205, 1677, 1566, 907]","The YAML format should be placed in quotes since the data is in a string format. Note that ""median"" needs to be changed to ""mean"" to reflect the YAML format. The YAML format should include fields ""mean"", ""standard_deviation"", and ""group_size"" for ""Intervention"" only
---
intervention: [{""mean"": ""−7.0"", ""standard_deviation"": ""21.8"", ""group_size"": ""17""}]comparator: [{""mean"": ""-7.1"", ""standard_deviation"": ""28.1"", ""group_size"": ""79""}]
---
intervention: mean: x standard_deviation: 21.07 group_size: 48 comparator: mean: x standard_deviation: -67.47 group_size: 48
---
intervention: {- mean: 15.-38%- standard_deviation: 23.5%- group_size: 191}
---
",True
298,5597,4355974,Days limited activity from asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-1.8,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"[1518, 1642, 573]","As shown above, based on the given table #1, the table of mean outcome and standard deviation for the following Intervention, Comparator,
---
intervention:mean: 0.6standard_deviation: 0.2group_size: 28comparator:mean: 2.0standard_deviation: 1.9group_size: 14
---
intervention: mean: 83standard_deviation: 73.1group_size: 64comparator: mean: 87standard_deviation: 97.6group_size: 64
---
",True
564,9838,3496170,N1 latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"[1671, 44]","intervention: {'mean': 'NANANANANA', 'standard_deviation': 'NANANANANA', 'group_size': 'NANANANANA'}comparator: {'mean': 'NANANANANA', 'standard_deviation': 'NANANANANA', 'group
---
intervention:
---
",True
67,3041,3321528,wrist flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1398, 1531]","Here are the YAML files for the table of outcome information based on the intervention and comparator mentioned: electrical muscle stimulation (EMS) vs. control. Outcome: wrist flexion. The results were extracted at day 15 from the respective table or figure of the manuscript. Since no numerical information for pre- and post-
---
intervention:mean:5standard_deviation:1standard_dev_unit:nmeasurable_scoreapplicable_to_intervention:truecomparator:mean:4standard_deviation:2standard_dev_unit:nmeasurable_scoreapplicable_to_comparator:true
---
",True
144,1272,4880652,"diastolic blood pressure at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 4's graphics.,FALSE,1406,1149,TEST,966,[],intervention: mean: 54.3710 standard_deviation: 16.1130 group_size: 76 comparator: mean: 54.2008 standard_deviation: 13.7764 group_size: 70,False
676,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider-school intervention,control,continuous,,14,,12,56.4,33,64.2,28,-0.2451619,0.15591776,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[946, 1631, 54, 2187, 1659, 153, 2173, 1311]","intervention: mean: 14% standard_deviation: 28% group_size: 12 comparator: mean: 36% standard_deviation: 44% group_size: 12
---
intervention: standard_deviation: 0.075group_size: 1850comparator: standard_deviation: 0.075group_size: 1850
---
intervention: mean: 0.287377standard_deviation: 0.123979group_size: 16549680comparator: mean: 0.287377standard_deviation: 0.123979group_
---
{intervention: {mean: 0.484, standard_deviation: 0.257, group_size: 277}, comparator: {mean: 0.178, standard_deviation: 0.139, group_size: 1251}}
---
intervention: mean: 2.3 (.3) standard_deviation: NUMBER group_size: NUMBER comparator: mean: 4.7 (.5) standard_deviation: NUMBER group_size: NUMBER
---
provider-school interventioncomparator: mean: 0.181standard_ deviation: 0.053group_size: 1202provider-school interventioncomparator: mean: 0.194standard_deviation: 0.052group_size: 1202
---
intervention: mean: 0.043333 standard_deviation: 0.11758 group_size: 392 comparator: mean: 0.14522 standard_deviation: 0.0577 group_size: 1246
---
intervention: mean: 0.5715standard_deviation: 0.5500group_size: 649comparator: mean: 0.4448standard_deviation: 0.5447group_size: 606
---
",True
462,4431,5726464,Lipid profile: total cholesterol,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","intervention: mean: -0.10 standard_deviation: 26.7 group_size: 79 comparator: mean: 0.17 standard_deviation: 29.9 group_size: 86
---
intervention:
---
outcome: lipid_profile/total_cholesterol lipid_profile/low_density_lipoprotein_cholesterol lipid_profile/high_density_lipoprotein_cholesterol lipid_profile/triglycerides lipid_profile/cholesterol
---
",True
323,4726,5539943,Motivational Interviewing (MI) knowledge,MI training (MI-AU),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1650, 1319, 1031]","intervention: {""mean"": 0.22, ""standard_deviation"": 0.13, ""group_size"": 190}
---
intervention: mean:57.210standard_deviation:25.998group_size:50comparator: mean:48.211standard_deviation:25.812group_size:50
---
intervention: mean: 3.49 standard_deviation: 0.77 group_size: 83 comparator: mean: 2.69 standard_deviation: 0.77 group_size: 83
---
",True
656,13176,5773985,subjective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,3,1.08,2.92,1.03,0.07461636,0.08005568,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"[1592, 407]","intervention: 
intervention: 0.5% bupivacaine with 1:200000 epinephrine in group I 
---
intervention:
mean: 67.0000000000000340000000000000000000112mean_unit: μg/Kg/hourstandard_deviation: 53.000
---
",True
167,2797,5079604,Disposition index (DI),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[739, 1755, 1654, 706]","intervention: mean: 0.4657917374115793 standard_deviation: 0.1483180785920284 group_size: 20 comparator: mean: -0.18952702
---
intervention:
mean: 28.5428542854285428542854285428542854285428542854285428542854285
---
intervention:
---
intervention: mean: 480.000 standard_deviation: 0.000 group_size: 25 comparator: mean: 305.000 standard_deviation: 0.000 group_size: 27
---
",True
273,2991,3214395,awakening,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 50",group 3 involved bispectral index (BIS) of 40,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],{,False
528,6919,4411165,diastolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"[1632, 485]","intervention: mean:0.00standard_deviation:2.60group_size:10comparator: mean:1.60standard_deviation:1.20group_size:10
---
intervention:
---
",True
610,11584,115849,Swollen joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","{intervention: {mean: 5.87, standard_deviation: 2.80, group_size: 789}comparator: {mean: 6.00, standard_deviation: 2.75, group_size: 891}
---
{ ""intervention"" : { ""mean"" : 3.42, ""standard_deviation"" : 0.95, ""group_size"": 390 }, ""comparator"" : { ""mean"" : 1.43, ""standard_deviation"" : 1.05, ""
---
intervention: mean: 18.24 standard_deviation: 7.14 group_size: 32 comparator: mean: 15.93 standard_deviation: 4.38 group_size: 33
---
",True
356,4710,5884950,objective-SCORAD score,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,"[752, 1661, 1538, 1630, 267]","intervention: mean: 2.33 standard_deviation: 1.3 group_size: 19
---
intervention:
---
intervention: mean: 82 95% CI: [76, 90] standard_deviation: 16 [16, 22] group_size: 459 comparator: mean_control: 73 95% CI: [62, 83
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
intervention: mean: 15.66 standard_deviation: 19.47 group_size: 54 comparator: mean: 17.18 standard_deviation: 22.44 group_size: 57
---
",True
404,2805,5781260,Glutathione peroxidase (GPxP),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 1227]","intervention:
mean: 41.0625
---
intervention: mean: 0.008 standard_deviation: 0.003 group_size: 23comparator: mean: 0.010 standard_deviation: 0.001 group_size: 23
---
",True
390,950,3278655,subsidence,The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,-0.38,0.37,-0.04,0.11,-1.1288,0.1068,,,,,Used numerical values for Superior/inferior translation (SD). Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,"[1649, 1417]","The YAML format should include the following fields for the Outcome “subsidence”:
---
intervention:
---
",True
522,6698,5154016,Total drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,248.5,18.8,318.5,26.7,-2.9921679,0.14127557,,,,,,TRUE,3046,2156,TEST,1642,"[1448, 465]","intervention: mean: 180mlstandard_deviation: 76.48group_size: 30comparator: mean: 180mlstandard_deviation: 76.48group_size: 30outcome: total drainage volume
---
We used YAML, a language-independent data serialization format . The YAML formatted data for Intervention, Comparator, and Outcome extracted from the given trial article is as follows:
---
",True
156,13481,5055753,The mean ¬± SD of intraoperatively administered fentany,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,105,30.8,165,34.5,-1.817,0.0706,,,,,,TRUE,3292,2470,TEST,2114,"[1599, 640]","intervention: mean: 105 standard_deviation: 30.8 group_size: 40
---
intervention:
---
",True
464,4431,5726464,Lipid profile: LDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","intervention: mean: 104.90 standard_deviation: 24.40 group_size: 79 comparator: mean: 101.20 standard_deviation: 27.00 group_size: 86
---
intervention: mean: 37.936987759752standard_deviation: 32.32028622353964group_size: 302comparator: mean: 31.7856439473
---
intervention: mean:3.34, standard_deviation:0.62, group_size:1138comparator: mean:3.49, standard_deviation:0.77, group_size:1149
---
",True
444,8802,4467620,differences in the accuracy,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"[1636, 1448]","intervention: mean: 0.1805 standard_deviation: 0.086 group_size: 8 comparator: mean: 0.2387 standard_deviation: 0.122 group_size: 8 outcome: [0.1, 0.2, 
---
intervention:
mean: 0.38
---
",True
573,8561,5541727,lateral tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-3.7,3.4,-0.8,3.5,-0.8015134,0.27647057,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,"[867, 1610, 1671, 76]","The YAML format is presented as follows:
---
{ ""Mean"":3620.81,""Standard Deviation"":1485.25,""Group Size"":159}
---
intervention: mean: 4 mean_sd: [2.91, 2.72] group_size: [48, 45] comparator: mean: 0 mean_sd: [6.29, 9.06] group_size: [48, 45]
---
intervention: {mean: 0.350, standard_deviation: 1.100, group_size: 18}comparator: {mean: 1.200, standard_deviation: 2.320, group_size: 45}
---
",True
571,8559,5541727,SF-36 bodily pain score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[867, 1610, 1671, 76]","intervention: mean: 16.6 standard_deviation: 0.0 group_size: 11 comparator: mean: 6.2 standard_deviation: 0.0 group_size: 6
---
intervention: mean: 6.58 standard_deviation: 2.11 group_size: 11 comparator: mean: 4.95 standard_deviation: 3.68 group_size: 6
---
intervention:mean:25.0standard_deviation:4.3group_size:29comparator:mean:21.0standard_deviation:5.5group_size:38
---
intervention: mean:0.54688 standard_deviation:0.20355 group_size:22comparator: mean:0.47994 standard_deviation:0.18296 group_size:19
---
",True
455,4422,4483334,Amount of calcium and phosphate on enamel surface,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],intervention: mean: 193.05 standard_deviation: 23.82 group_size: 20 comparator: mean: 82.66 standard_deviation: 6.85 group_size: 20,False
79,3740,3546023,tocotrienol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,587.68,87.5,59.49,4.21,8.4162,0.6569,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: mean: 127.0 standard_deviation: 36.3 group_size: 21
---
intervention:
---
The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:
---
What are the fields required in CONSORT? Explain the meaning of each field for CONSORT table. Provide an example of a validly structured CONSORT table.
---
The YAML format for the given table is as follows:
---
{
---
intervention: mean: 0.025 standard_deviation: 0.027 group_size: 21comparator: mean: 0.013 standard_deviation: 0.016 group_size: 17
---
{
---
intervention: mean: 200 group_size: 32comparator: mean: 0 group_size: 2x
---
intervention: mean: x standard_deviation: x group_size: NUMBER
---
",True
363,12884,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,23.1,25.6,98.3,104.6,-0.9238,0.0995,,,,,found in table,TRUE,4402,2905,TEST,2274,"[1558, 1103]","intervention: mean: 98.33 standard_deviation: 20.92 group_size: 25 name: ANGPTL4 expression
---
intervention: mean: 23.1 standard_deviation: 25.6 group_size: 8 comparator: mean: 21.5 standard_deviation: 25.8 group_size: 9
---
",True
129,4927,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,H0 (saline),"H1(haloperidol 1 mg),",continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"[1538, 1161]","H1: {mean: NUMBER, standard_deviation: NUMBER, group_size: NUMBER}
---
The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:
---
",True
181,4339,5122613,Left SCTT,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,10.2,8.6,12.1,9.5,-0.207,0.0706,,,,,Had to do some simple math to get accurate group size.,TRUE,6184,3742,TEST,2832,"[1633, 1102]","intervention: mean: 1.123 standard_deviation: 0.5 group_size: 57comparator: mean: 8.389 standard_deviation: 0.000035 group_size: 57
---
{intervention: {mean: 70.2, standard_deviation: 27.3, group_size: 42}comparator: {mean: 64.3, standard_deviation: 25.1, group_size: 21}}
---
",True
517,6695,5154016,24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,187.9,82,230.8,75,-0.538859,0.06908641,,,,,,TRUE,3046,2156,TEST,1642,"[1448, 465]","intervention: mean: 187.9 standard_deviation: 82 group_size: 30 comparator: mean: 185.2 standard_deviation: 68 group_size: 30
---
intervention: mean: 35.051 standard_deviation: 5.049 group_size: 63comparator: mean: 38.722 standard_deviation: 3.649 group_size: 63
---
",True
242,8056,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6.2,1.8,4.8,0.9,0.9498,0.1855,,,,,,TRUE,6951,5679,TEST,4357,"[926, 1571, 1677, 482]","intervention: mean: 0.13 standard_deviation: 0.82 group_size: 12
---
intervention: mean: 81.18 standard_deviation: 15.26 group_size: 30 comparator: mean: 64.59 standard_deviation: 24.73 group_size: 27 outcome: overall working memory (WM) performance in autism spectrum
---
intervention:
mean:0.21 standard_deviation:0.60 group_size:14 comparator: mean:0.5 standard_deviation:0.79 group_size:14
---
intervention: mean: x.x standard_deviation: x standard_group_size: 12 comparator: mean: x standard_deviation: x standard_group_size: 12
---
",True
569,8557,5541727,Activities of daily living,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[867, 1610, 1671, 76]","{% if defined(post_s1_pwr) and defined(post_s1_cmp) and defined(post_s2_pwr) and defined(post_s2_cmp) %}intervention:mean: post_s1_pwrstandard_deviation: xgroup_size: xcompar
---
comparator: [{'mean': 40.0, 'standard_deviation': 7.0, 'group_size': 4}]intervention: [{'mean': 92.8, 'standard_deviation': 6.4, 'group_size': 11}]
---
{
""intervention"": {
""mean"": 16.9, ""standard_deviation"": 1.73, ""group\_size"": 237, ""baseline"": 19.07, ""follow-up"": 16.97, ""timeframe"": ""6–2
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER outcome: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
",True
458,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],intervention: mean: 0.014199 standard_deviation: 0.002729 group_size: 4 comparator: mean: 0.012975 standard_deviation: 0.002226 group_size: 4,False
72,3042,3321528,the total MRC score of the legs,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1398, 1531]","intervention: mean: 29.00 standard_deviation: 0.5 group_size: 28 comparator: mean: 25.00 standard_deviation: 3.0 group_size: 28
---
intervention: mean: 14 standard_deviation: 1.5 group_size: 28 comparator: mean: 12 standard_deviation: 2 group_size: 28
---
",True
295,6104,4215531,MCCB performance : Social Cognition,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,39.3,11.1,42.8,11.7,-0.3005,0.1065,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1672, 1641, 963]","intervention: mean: X.000 standard_deviation: X.000 group_size: NUMBER
---
intervention: mean: 52.79 standard_direction: 10.62 standard_deviation: group_size: 19 comparator: mean: 49.97 standard_direction: 12.55 standard_deviation: group_size: 24
---
intervention:mean:44.6standard_deviation:12.2group_size:19comparator:mean:38.5standard_deviation:11.5group_size:19
---
",True
23,3247,2972614,Laboratory parameters,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome and also no numerical data for this specific outcome,FALSE,7041,2968,TEST,1931,"[838, 1256]","intervention:mean: 5.19standard_deviation: 0.88group_size: 14comparator:mean: 5.27standard_deviation: 1.16group_size: 14
---
intervention: mean:3.76standard_deviation:1.45group_size:42comparator: mean:4.63standard_deviation:2.10group_size:42
---
",True
413,3262,3475525,Taste perception,MTL+caloric intake group,No label group,continuous,,90,,99,5.4,1.4,5.8,1.4,-0.2845666,0.02142635,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 76.3 standard_deviation: 8.5 group_size: 90comparator: mean: 76.3 standard_deviation: 8.2 group_size: 90
---
intervention: mean: 6.6347 standard_deviation: 1.57639 group_size: 111 comparator: mean: 5.54545 standard_deviation: 1.79969 group_size: 109
---
```yamlIntervention: MTL+caloric intake groupCompartor: No label groupOutcome: Taste perceptionintervention:mean:87.30standard_deviation:81.43group_size:98comparator:mean:xstandard_deviation:xgroup_size:99
---
{ ""intervention"": { ""mean"": 0.56, ""standard_ deviation"": 0.09, ""group_size"": 134}, ""comparator"": { ""mean"": 0.30, ""standard_deviation"": 0.07, ""group_size"": 1
---
",True
682,13506,5777419,attachment gain,antibiotic,placebo,continuous,,16,,15,4.1,1,4.3,1.4,-0.1610069,0.12958478,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[1099, 1320, 1023]","intervention:
mean: 3.981345029987129999999999999999998172961249229612492111492
---
intervention: mean: 4.4 standard_deviation: 1 std group_size: 16comparator: mean: 4.1 standard_deviation: 1.1 std group_size: 15
---
intervention:mean:1.040standard_deviation:0.5group_size:""intervention"" = 36comparator:mean:0.500standard_deviation:0.04group_size:""comparator"" = 16
---
",True
550,9719,3648394,LF:HF component of HRV,10-week yoga program,Control,continuous,,18,,19,0.35,0.43,0.04,0.38,0.74878609,0.1157639,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"[1586, 970, 1651, 518]","intervention: mean: 0.10788 standard_deviation: 0.06966 group_size: 18 comparator: mean: 0.09795 standard_deviation: 0.06884 group_size: 19
---
Comparator:
---
intervention: mean:0.0185standard_deviation:0.0095group_size:21.8447comparator: mean:0.00310standard_deviation:0.00005group_size:9.76187
---
intervention:mean: −0.17325standard_deviation: 0.299994group_size: 22comparator:mean: −0.219581standard_deviation: −0.06920656group_size: 18
---
",True
240,8055,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6,0.9,4.8,0.9,1.2873,0.2012,,,,,,TRUE,6951,5679,TEST,4357,"[926, 1571, 1677, 482]","intervention: mean: 0.11 group_size: 11 standard_deviation: 0.81comparator: mean: -0.25 group_size: 11 standard_deviation: 0.71
---
intervention: mean: 6.2 standard_deviation: 1.8 group_size: 24comparator: mean: 6.0 standard_ deviation: 0.9 group_size: 24
---
intervention: mean: 0.15 standard_deviation: 0.87 group_size: 12comparator: mean: −0.25 standard_deviation: 0.74 group_size: 12
---
intervention: mean: 21.4320055588group_size: 14comparator: mean: 20.972007071541group_size: 15
---
",True
486,6382,3786549,Improvement in Vaginal Maturation Index,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,35.2,21.7,9.9,14.5,1.35893992,0.05594726,,,,,Numerical values based on intention-to-treat,TRUE,9725,6231,TEST,4323,"[1678, 1676, 1258]","intervention:mean: 35.2percent: 100.0standard_deviation: 14.0604group_size: 87comparator:mean: 9.9percent: 100.0standard_deviation: 14.2863group_size
---
intervention: {""mean"": ""4.9"", ""standard_deviation"": ""5.1"", ""group_size"": ""44""}
---
intervention: mean: 0.03 standard_deviation: 0.01 group_size: 87comparator: mean: 0.01 standard_deviation: 0.01 group_size: 87
---
",True
336,5083,5617873,Compulsion scale,Aripiprazole,Placbeo,continuous,,45,,47,-1.3,0.5,-2,0.5,1.3883,0.054,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"[1552, 722, 1531, 1010]","intervention:
mean: -2.83378065793412158186162161599469983759987097898676069539913552
---
The YAML format for the requested comparison included the following fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"":
---
aripiprazole:
---
intervention:
mean: 4.8000000000000004
---
",True
126,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H1(haloperidol 1 mg),continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"[1538, 1161]","intervention: mean: 1.2 standard_deviation: 1.5 group_size: 53 comparator: mean: 1.3 standard_ deviation: 1.5 group_size: 48 YAML: [/EDITOR/YAML,
---
For intervention and comparator, the YAML format is as follows:
---
",True
629,12234,3510731,Median time in seconds (interquartile range) - Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,25,,25.3,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,[],intervention: mean: 25.0 standard_deviation: 37.2 group_size: 249 comparator: mean: 25.3 standard_deviation: 35.8 group_size: 514,False
553,9725,3648394,Quality of life - MCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,10.6,48.5,7.7,-0.1060797,0.1083392,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,"[1586, 970, 1651, 518]","# Total: 37 (intervention group) versus 38 (control group)intervention:mean:28.981standard_deviation:10.629group_size:18comparator:mean:26.710standard_deviation:7.8868group
---
intervention: mean: 48 standard_deviation: 9.5 group_size: 76comparator: mean: 47 standard_deviation: 9.1 group_size: 79
---
comparator:mean:47.5standard_deviation:2.7group_size:42intervention:mean:48.5standard_deviation:3.5group_size:42
---
intervention:
---
",True
136,2448,4574984,postoperative in-hospital stay,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",continuous,,326,,326,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,12997,7944,TEST,5795,"[718, 1310, 1592, 928, 1664, 467]","intervention: mean: 9 standard_deviation: 7 group_size: 326 comparator: mean: 10 standard_deviation: 7 group_size: 326
---
intervention: mean: 2.00 standard_deviation: 1.08 group_size: 64 comparator: mean: 3.33 standard_deviation: 0.58 group_size: 66
---
intervention:
---
intervention:mean: ""20107.2""standard_deviation: ""21475.18""group_size: ""392""comparator:mean: ""20615""standard_deviation: ""22441""group_size: ""428""
---
intervention:
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
",True
646,13025,4675066,The mean language score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,97.2,12.2,97.9,11.5,-0.058139,0.07553046,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"[1501, 1640, 1216]","intervention: 150 μg/d 99.412.259comparator: Placebo97.212.230
---
intervention: mean: 101.7 standard_deviation: 8.2 group_size: 26&comparator: mean: 97.9 standard_deviation: 10.7 group_size: 25
---
The YAML format for the given trial's intervention, comparator, and outcome requested is:
---
",True
402,2804,5781260,Exercise-induced Creatine kinase (CK),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 1227]","> {% for row in data_list %} > > intervention: > > mean:{{row.lemon_verbena}} > > standard_deviation:{{row.lemon_verbena_SD}} > > group_size:{{row.lemon_verbena_group_size}} > >
---
intervention: mean: ****.231standard_deviation: ""0.331""group_size: intervention:10comparator:
---
",True
8,9683,2363753,Days with fever,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],{ intervention: mean: 8 standard_deviation: 3 group_size: 20 comparator: mean: 9 standard_deviation: 3 group_size: 20,False
520,6696,5154016,24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,185.2,68,230.8,75,-0.6287208,0.06996075,,,,,,TRUE,3046,2156,TEST,1642,"[1448, 465]","intervention: mean: ""1943.2"" standard_deviation: ""124.94"" group_size: ""30"" comparator: mean: ""1997.9"" standard_deviation: ""130.13"" group_size: ""30""
---
{""intervention"": {""mean"": ""54.06"", ""standard_deviation"": ""5.56"", ""group_size"": ""121""}},""comparator"": {""mean"": ""47.53"", ""standard_deviation"": ""6.08"", ""group_size"": ""1
---
",True
331,5078,5617873,Parent-rated Aberrant Behavior Checklis improvement,Aripiprazole,Placbeo,continuous,,45,,47,-11.4,1.3,-7.5,1.4,-2.8604,0.088,,,,,"all means and std found in table 2, given as mean change from baseline",TRUE,7551,5383,TEST,4396,"[1552, 722, 1531, 1010]","intervention: group_size: 47mean: 26.15standard_deviation: 6.09comparator: group_size: 45mean: 24.96standard_deviation: 7.57
---
intervention: {% set mean = x %} {% set standard_deviation = x %} {% set group_size = 45 %} comparator: {% set mean = x %} {% set standard_deviation = x %} {% set group_size = 45 %}
---
intervention: mean: 120.34968 standard_deviation: 140.21677 group_size: 45 comparator: mean: 226.94914 standard_deviation: 148.12415 group_size:
---
intervention: mean: 0.98 standard_deviation: 1.41 group_size: 46comparator: mean: 1.38 standard_deviation: 1.37 group_size: 45
---
",True
409,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,TL+SNL group,continuous,,90,,95,73.3,6.9,65.8,7.3,1.05077696,0.02462157,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 73.3 standard_deviation: 6.9 group_size: 97comparator: mean: 65.8 standard_deviation: 7.3 group_size: 99
---
intervention: mean: 95 sd_deviation: 5 group_size: 98 comparator: mean: 90 sd_deviation: 2 group_size: 90
---
intervention: group_size: 92standard_deviation: NUMBERintervention: mean: 58.6intervention: NUMBERcomparator: group_size: 95comparator: standard_deviation: NUMBERcomparator: meancomparator: NUMBER
---
intervention: mean:1.35 standard_deviation: 1.00 group_size: 95 comparator: mean:2.55 standard_deviation: 2.22 group_size: 96
---
",True
143,1272,4880652,"oxygen saturation at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 5's graphics.,FALSE,1406,1149,TEST,966,[],"{ ""intervention"": (""fentanyl"" (1) and ""propofol""), ""standard_deviation"": [1.3], ""group_size"": [76] }, {""intervention"": (""paracetamol"" (1), ""propofol""), ""standard_deviation"": [1.3",False
394,1120,3577738,enjoyment,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[1637],"intervention: mean: 5.55625 standard_deviation: 0.863068 group_size: 458 comparator: mean: 5.09064 standard_deviation: 0.833917 group_size: 458
---
",True
456,4423,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],intervention: mean: 2.35 standard_deviation: 0.93 group_size: 8 comparator: mean: 1.5 standard_deviation: 1.53 group_size: 38,False
296,5595,4355974,Days of wheeze,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-4.2,,cannot calculate,cannot calculate,,,,,standard deviations not given and means are mean change,FALSE,7450,5464,TEST,3820,"[1518, 1642, 573]","intervention: mean: 6.00 standard_deviation: 3.20 group_size: 37 comparator: mean: 4.20 standard_deviation: 5.30 group_size: 21
---
intervention: { 'mean': 2.9, 'standard_deviation': 2.4, 'group_size': 28 }
---
intervention: {mean: 1.318 standard_deviation: 5.268 group_size: 48}
---
",True
420,3401,3877023,quantitative contour sharpness of the Cervicothoracic Spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,0.95,0.24,1.43,0.48,-1.2099846,0.12194464,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","intervention: mean: 35.95 standard_deviation: 3.8 group_size: 48 comparator: mean: 39.07 standard_deviation: 2.67 group_size: 55
---
- intervention: mean: 19.8 standard_deviation: 8.5 group_size: 48 CEREVIPCompar: mean: 31.7 standard_deviation: 21.6 group_size: 55 CEREVIP10.7554/eLife
---
intervention: mean:5.499333333333333 standard_deviation:0.916666666666667 group_size:9 comparator: mean:4.983333333333333
---
intervention:mean:0.8166group_size:n/astandard_deviation:0.2634comparator:mean:N/Agroup_size:n/astandard_deviation:x
---
intervention: mean: 0.8085 standard_deviation: 0.09 group_size: 30 comparator: mean: 1.17456 standard_deviation: 0.133333 group_size: 34
---
",True
545,8460,3263860,HbA1c reduction,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,-0.1,0.6,-0.1,0.6,0,0.02919864,,,,,Mean change,TRUE,3178,2587,TEST,2232,"[1614, 796]","intervention: mean: −0.1 standard_deviation: 0.7 group_size: 146comparator: mean: −0.1 standard_deviation: 0.7 group_size: 146
---
intervention: mean: −0.55 standard_deviation: 0.98 group_size: 51 comparator: mean: −0.21 standard_deviation: 1.05 group_size: 50
---
",True
640,12772,4511433,LDL cholesterol,2.5 mg,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,"[1648, 1677]","Mean: 4.29
---
Note: The data is not normalized by group size. YAML: 2.5 mg: { ""mean"": 7.4, ""standard\_deviation"": 2.5, ""group\_size"": 12 } Comparator: { ""mean"": 7.4, ""standard\_deviation"": 2
---
",True
119,2981,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Mild-cooling,No cooling,continuous,,10,,13,70,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"[1626, 879]","intervention: mean: 0.21432standard_deviation: 7.524641xgroup_size: 32comparator: mean: 0.0787968standard_deviation: 4.67845xgroup_size: 13
---
1999
---
",True
281,6422,3654355,baseline fat-free mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,68.3,13.2,67.1,12.8,0.0911,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: mean: 42.6 standard_deviation: 5.2 group_size: 71 comparator: mean: 42.6 standard_deviation: 5.2 group_size: 33
---
outcome:
name: baselineFat free massintervention: [standard_deviation,group_size,mean]
---
intervention: mean: 100.310 standard_deviation: 14.266 group_size: 33comparator: mean: 98.500standard_deviation: 15.916group_size: 33
---
intervention: mean: 10.11 standard_deviation: 1.39 group_size: 49comparator: mean: 9.55 standard_deviation: 2.29 group_size: 66
---
control: { 34.8: 4.6, 11, 34.9 Mean, standard\_deviation, N
---
",True
217,2912,5459456,surgery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,67,16,65,13,0.1297,0.2505,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention: mean: 68 standard_deviation: 11 group_size: 32 comparator: mean: 68 standard_deviation: 11 group_size: 32
---
Table: 10.1371/journal.pone.0178775.t001
---
intervention:
mean: 36.3898658239182891213138128064832761727286189264669586851523453
---
intervention: {mean: ""16.7"", standard_deviation: ""1.3"", group_size: ""16""}
---
intervention:
* mean: NUMBER
---
",True
586,11522,547916,matrix metalloproteinase-9 (MMP-9),doxycycline (100 mg),placebo,continuous,,10,,4,2.18,1.94,3.26,3.58,-0.4117458,0.35605481,,,,,found in abstract,TRUE,4542,3636,TEST,2822,"[1530, 1517]","To calculate the effect size (Cohen's d, Hedges' g) for the MMP-9 level in AVM tissue from Ex vivo treatment of AVM tissues section, we found the mean and standard deviation (SD) for active and total MMP-9 between groups and converted those to Cohen's d using
---
intervention: mean: 129 standard_deviation: 43.5 group_size: unknowncomparator: mean: unknown standard_deviation: unknown group_size: unknown
---
",True
268,2991,3214395,laryngoscopy duration,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 45",group 3 involved bispectral index (BIS) of 35,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],intervention: mean:2.77standard_deviation:1.4group_size:25comparator: mean:2.53standard_deviation:1.4group_size:25outcome: laryngoscopy duration,False
415,3262,3475525,Taste perception,MTL+caloric intake group,choices group,continuous,,90,,98,5.4,1.4,5.3,1.5,0.06854473,0.02132769,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","choices: mean: 18.60 standard_deviation: 4.58 group_size: 65
---
intervention:
---
Intervention: 6.8 10.1 98 Total size: 90 Choices group 6.4 11.6 98 Total size: 98 MTL+caloric intake: 9.1 15.8 98 Total size: 90
---
intervention: mean: 0.00088437 standard_deviation: 0.002087421 group_size: 36 comparator: mean: -0.00035374868 standard_deviation: 0.0020
---
",True
685,13760,2836833,Fecal fat loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1595, 1207, 1243, 1126, 1526]","intervention:
---
intervention: mean: -0.10 standard_deviation: 7.8 group_size: 34comparator: mean: -2.28 standard_deviation: 17.3 group_size: 34
---
{intervention: {mean: 514.5,standard_deviation: 175.44,group_size: 17comparator: {mean: 492.76,standard_deviation: 189.13,group_size: 17}}
---
intervention: mean: 11.1 standard_deviation: 2.3 group_size: 388 comparator: mean: 8.9 standard_deviation: 2.2 group_size: 384
---
intervention: mean: 1500.00 standard_deviation: 302.49 group_size: 61 comparator: mean: 500.00 standard_deviation: 102.29 group_size: 62
---
",True
244,10306,5571493,Glycemic level,Dw 5% with Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,0.82,0.05,0.92,0.07,-1.5744,0.262,,,,,,TRUE,1507,1019,TEST,928,[],"# Data in YAML format for the 'Glycemic level' outcome for a 4 h infusion of isotonic saline, isotonic glucose, isotonic saline with quinine (0.1% w/w, therapeutic dosage), and isotonic glucose with",False
674,13314,4550271,treatment according to guidelines,provider-school intervention,control,continuous,,14,,12,23.5,26,22.6,23,0.035327,0.1547859,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[946, 1631, 54, 2187, 1659, 153, 2173, 1311]","intervention:mean:0.48standard_deviation:0.20group_size:12comparator:mean:0.42standard_deviation:0.20group_size:12
---
intervention: (1)
---
interventions: provider-school interventioncomparator: controlmeasure: treatment according to guidelinesmeanintervention: -67.300standard_deviationintervention: 31.597group_sizeintervention: 36group_sizecomparator: 36
---
The total number of participants in the Intervention group and Comparator group in this study is different from the number reported in the article. Therefore, the values for group_size shown below are the total number of participants in the article, and are derived from the values for the intervention group and comparator group.
---
intervention:mean:33.3standard_deviation:27.9group_size:7225158comparator:mean:11.8standard_deviation:11.1group_size:7225158
---
provider-school intervention: treatment according to guidelinesgroup_size: 578comparator: treatment according to guidelinesgroup_size: 578intervention: mean: 50.74standard_deviation: 74.331standard_deviation: 1.626comparator: mean
---
intervention:mean: 9.13267standard_deviation: 0.839439878group_size: 85comparator:mean: 10.59051standard_deviation: 3.155092771group_size
---
intervention: standard_deviation: 0.036 group_size: 9466 comparator: standard_deviation: 0.163 group_size: 5656
---
",True
348,10235,5686687,Prolactin levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,"[1235, 1108]","There is not enough information available in the provided clinical trial article to determine the prolactin levels.
---
intervention:mean: 11.1standard_deviation: 4.2group_size: 22comparator:mean: 11.1standard_deviation: 4.2group_size: 22
---
",True
312,7835,4541185,drop in mean arterial pressure,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,91.2,6.62,92.04,7.15,-0.1203,0.0668,,,,,found in table,TRUE,1359,1043,TEST,907,[],intervention: mean2: 9.83 standard_deviation2: 1.12 group_size2: 30 comparator: mean2: 10.85 standard_deviation2: 0.79 group_size2: 30,False
255,10572,5711682,In-stent late lumen loss at 9 months,Genoss drug-eluting stent (DES),Promus Element,continuous,,38,,39,0.11,0.25,0.16,0.43,-0.1361,0.2005,,,,,,TRUE,13148,4660,TEST,2966,"[1669, 1605]","intervention: mean: 0.11 standard_deviation: 0.25 group_size: 38
---
Mean: 0.16 Standard deviation: 0.16 Group size: 18
---
",True
32,5580,3003523,Pain,Certolizumab 400 mg,Control,continuous,,390,,199,53.9,22.2,34,20.1,0.9238,0.0083,,,,,Used values for weeks 52 (final timepoint).,TRUE,12247,10091,TEST,7520,"[1675, 455, 3308, 1649, 1104]","{ ""intervention"": {""mean"": 98, ""standard_deviation"": ""x"", ""group_size"": 165}, ""comparator"": {""mean"": 80, ""standard_deviation"": ""x"", ""group_size"": 162}}
---
{ ""intervention"": {""mean"": ""0"", ""standard_deviation"": ""x"", ""group_size"": ""xx""}, ""comparator"": {""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": ""x""} }
---
intervention:
mean: 37.34standard_deviation: 37.93number_of_cases: 333comparator:
 mean: 34.05standard_deviation: 11.9number_of_cases: 390
---
intervention: mean: 3.7 standard_deviation: 1.5 group_size: 739 comparator: mean: 3.1 standard_deviation: 1.6 group_size: 721
---
intervention: mean:1.870standard_deviation:1.550group_size:341comparator: mean:0.895standard_deviation:0.535group_size:293
---
",True
639,12772,4511433,LDL cholesterol,5 mg elobixibat,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,"[1648, 1677]","5 mg elobixibat: group_size: 12mean: 3.508standard_deviation: 0.502placebo: group_size: 24mean: 4.055standard_deviation: 0.401
---
intervention: mean: 0.0−04 standard_deviation:0.079 group_size: 36comparator: mean: -0.04 standard_deviation: 0.104 group_size: 36
---
",True
35,5579,3003523,Fatigue Assessment Scale improvement,Certolizumab 200 mg,Control,continuous,,393,,199,,,,,cannot calculate,cannot calculate,,,,,Values are in figure.,FALSE,12247,10091,TEST,7520,"[1675, 455, 3308, 1649, 1104]","intervention:mean: 6.4standard_deviation: 2.0group_size: 299comparator:mean: 6.5standard_deviation: 2.1group_size: 274
---
certolizumab_pegol_200_mg_group_1:
---
intervention:
mean: 0.48363761586126993413052883915509192170265342069804984591828529
---
intervention: mean: -6.976 standard_deviation: 11.944 group_size: 249 comparator: mean: 3.75 standard_deviation: 10.648 group_size: 160
---
intervention: mean: -2.5901258604409554 standard_deviation: 9.46106850406861 group_size: 134 comparator: mean: -6.300072488
---
",True
214,2913,5459456,lateral bending for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2,0.4,1.8,0.2,0.5979,0.2612,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention: mean: 32.243standard_deviation: 2.243group_size: 32comparator: mean: N/Astandard_deviation: N/Agroup_size: 32outcome: mean: 18.378standard_deviation: N
---
intervention: 
  mean: ""4.0"" 
  standard_deviation: ""0.6"" 
  group_size: ""16"" 

comparator: 
  mean: ""3.9"" 
  standard_deviation: ""0.6"" 
---
intervention: mean:0.966125standard_deviation:0.1272164group_size:8comparator: mean:0.6078125standard_deviation:0.05042173group_size:8 10.1
---
intervention: mean: 10.5 standard_deviation: 1.5 group_size: 8 comparator: mean: 10.1 standard_deviation: 1.5 group_size: 8
---
intervention: mean: 2.45 standard_deviation: 1.96 group_size: 10 comparator: mean: 2.22 standard_deviation: 2.20 group_size: 10
---
",True
280,6422,3654355,baseline fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,60.5,11,60.4,13.5,0.0084,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention:
---
intervention: {mean: 80.3, standard_deviation: 12.0, group_size: 100}
---
intervention: mean: null standard\_deviation: null group\_size: 156comparator: mean: null standard\_deviation: null group\_size: 156outcome:baseline fat mass:mean: 29.084981standard\_deviation: 5.512
---
intervention: {
""group\_size"": 41,
---
intervention: mean: 27.5 standard_deviation: 3.5 group_size: 49comparator: mean: 27.9 standard_deviation: 3.3 group_size: 20
---
",True
440,8803,4467620,decrease in exercise intensity as time elapsed (at time 10),Hot + Cooling conditions,Hot conditions,continuous,,8,,8,114.6,35.6,123.9,30.2,-0.2663137,0.25221634,,,,,Added the last timepoint to the outcome name. Since there are 10 different time points.,TRUE,7288,4607,TEST,3858,"[1636, 1448]","The YAML response is provided in the format of ""intervention"", ""comparator"", and ""outcome"" fields:
---
interventions: [{""label"": ""Hot + Cooling conditions"", ""mean"": 196.6, ""standard_deviation"": 0.424301, ""group_size"": 72}]outcomes: [{""label"": ""decrease in exercise intensity as time elapsed (at time
---
",True
666,13296,4987981,total cholesterol,metformin,placebo,continuous,,21,,23,206.9,36.2,184.4,37.5,0.59900785,0.0951747,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","Comparator: pioglitazone Outcome: total cholesterol Intervention: metformin Comparator: pioglitazone Outcome: ESI Mean: 3.10 Standard_deviation: 3.02 Group_size: 23 Comparator: pioglitazone Outcome:
---
intervention:
---
intervention: mean: -2.90571753standard_deviation: 0.6989578759group_size: 85comparator: mean: -1.096116667standard_deviation: 0.64648
---
intervention: mean: 2.2standard_deviation: 10.0group_size: 21comparator: mean: 1.4standard_deviation: 6.3group_size: 21
---
intervention:
mean: 95.8
---
",True
487,6383,3786549,Baseline characteristics: menopause,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,13.11,7.02,13,6.94,0.01562115,0.04545593,,,,,,TRUE,9725,6231,TEST,4323,"[1678, 1676, 1258]","intervention: mean: x standard_deviation: x group_size: 100 comparator: mean: x standard_deviation: x group_size: 100
---
intervention: mean: 0 group_size: 8 comparator: mean: 1 standard_deviation: 0 group_size: 8
---
intervention: 
comparator: 
---
",True
443,8801,4467620,accuracy of the cognitive tasks,Exercise - Hot condition,At rest - Hot condition,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"[1636, 1448]","intervention: mean:0.92standard_deviation:0.06group_size:8comparator: mean:0.89standard_deviation:0.05group_size:8
---
intervention: mean: 15.9 standard_deviation: 2.0 group_size: 9 comparator: mean: 7.3 standard_deviation: 0.4 group_size: 9
---
",True
248,10309,5571493,QT interval,Dw 5%+ Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],intervention: mean: x standard_deviation: x group_size: 8 comparator: mean: x standard_deviation: x group_size: 8,False
503,6485,5419060,Phlebotomy questionnaire score: CHC A,Phlebotomy training programme,Control,continuous,,23,,23,96,3.89,63,12.31,3.55292234,0.22416584,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1537, 528, 1598, 748]","Compared to the [control] group, which received no training, the phlebotomy questionnaire score of the intervention group significantly improved for CHC A after the training programme.
---
intervention:mean:22.434standard_deviation:2.406group_size:40comparator:null
---
intervention:
---
The YAML format shall be interpreted with the given ""Intervention"", ""Comparator"", and ""Outcome. Intervention: Phlebotomy training programme Comparator: Control Outcome: Phlebotomy questionnaire score: CHC A Intervention:mean (this is unclear, maybe the percentages given as x.x%
---
",True
686,13761,2836833,Urinary calcium excretion,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1595, 1207, 1243, 1126, 1526]","intervention: mean: 146.4 standard_deviation: 77.9 group_size: 40 comparator: mean: 128.3 standard_deviation: 57.9 group_size: 40
---
intervention: { mean: 1500 standard_deviation: 0 group_size: 15 } comparator: { mean: 500 standard_deviation: 0 group_size: 10 }
---
[{""Intervention"": {""mean"": 0.53, ""standard_deviation"": 0.32, ""group_size"": 14}, ""Comparator"": {""mean"": 0.11, ""standard_deviation"": 0.11, ""group_size"": 12}, ""Out
---
intervention: mean: 1500 mg calcium standard_deviation: x group_size: 75 comparator: mean: 500 mg calcium standard_deviation: x group_size: 38
---
Calcium - Intervention: 1000meq-day-1; Outcome: Fecal Calcium (mg-day- 1); Fields: standard_deviation: 250; mean: 322;
---
",True
466,4433,5726464,Changes in body mass index,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","intervention: Mean -0.1264; Intervention group_size: 79; Standard_deviation: 0.1349; Comparator: Mean -0.1277; Comparator group_size: 86; Standard_deviation: 0.0971
---
intervention: mean: 0.025 group_size: 187 comparator: mean: -0.019 group_size: 128
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
",True
636,12291,5777645,Mean waist circumference,to peer-led structured patient education,conventional care alone,continuous,,,,,-3.34,9.3,2.65,10.3,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"[1055, 1401, 1282, 724]","We did our best to manually summarize the intervention, comparator, and outcome from the full text. We had to resort to a ""natural language processing"" approach, as the paper did not explicitly provide these values. Specifically, for the ""mean waist circumference"" outcome, there were two references to it, one in the abstract and the
---
intervention: > group_size: 76comparator: > group_size: 75outcome: waist circumferencemean: 93.9standard_deviation: 11.9intervention: >mean: xstandard_deviation: xgroup_size: xcomparator: >mean: xstandard
---
intervention: {mean: 0.007925629standard_deviation: 0.004672464group_size: 143}comparator: {mean: 0.009932615standard_deviation: 0.0
---
intervention:
mean: 99.14
---
",True
615,11602,1863515,haemoglobin level between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-0.4,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"[1630, 1586]","{ intervention: { mean: 0.4 { standard_deviation: 0.5 group_size: 667 comparator: { mean: – 0.3 { standard_deviation: 0.4 group_size: 769 } } haemoglobin level: { mean:
---
intervention: mean: 0.79 standard_deviation: 0.20 group_size: 982600comparator: mean: 0.74 standard_deviation: 0.20 group_size: 982
---
",True
600,11583,115849,Tender joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention:
---
naproxen 500 mg twice daily:
intervention:
mean: -0.43
standard_deviation: 0.141583568023789212353809
group_size: 357comparator:
---
{intervention: naproxen 500mg twice daily, comparator: placebo, outcomes: [tender joint count]}
---
",True
29,3244,2972614,Motion range - Shoulder external rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,44.83,5.64,44.09,1.97,0.1626,0.079,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"[838, 1256]","intervention: mean:45.4 standard_deviation:9.2 group_size:30 comparator: mean:42.7 standard_deviation:9.8 group_size:22
---
intervention: mean: 44.83 standard_deviation: 5.67 group_size: 250 comparator: mean: 44.09 standard_deviation: 1.97 group_size: 260
---
",True
104,1885,4188762,mean blood pressure,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[1441],"intervention: {: mean: 0.72:} {: standard_deviation: 0.0987:} {: group_size: 30}
---
",True
142,1272,4880652,systolic pressures at 0 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 3's graphics.,FALSE,1406,1149,TEST,966,[],outcome:,False
332,5079,5617873,Clinician-rated Clinical Global Impression-Improvement scores,Aripiprazole,Placbeo,continuous,,,,,2.4,0.1,3.4,0.1,-9.9164,0.5779,,,,,raw values foun din text,TRUE,7551,5383,TEST,4396,"[1552, 722, 1531, 1010]","{::: metadata}intervention_group: PlacbeoComparsion_group: AripiprazoleComparator_mean: 8.1Comparator_standard_deviation: 2.0Intervention_group_size: 45Intervention_mean: 5.7Intervention_standard_deviation
---
intervention: mean: -3.94 standard_deviation: 4.59 group_size: 32 comparator: mean: x standard_deviation: x group_size: 32
---
aripiprazole: intervention: ""mean"": 4.85, ""standard_deviation"": 0.18, ""group_size"": 47 comparator: ""mean"": 5.00, ""standard_deviation"": 0.18, ""group_size"": 45
---
The YAML structure in this case would be:
---
",True
80,3740,3546023,tocopherol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,14.56,3.06,11.75,2.27,1.029,0.0781,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: mean: 11.52 standard_
---
intervention: mean: 77.9080 standard_deviation: 20.2451 group_size: 56 comparator: mean: 2.8167 standard_deviation: 0.6846 group_size: 56
---
intervention:
mean: 2.52mg/L
---
intervention: mean:60.781383standard_deviation:26.569552group_size:50comparator: mean:123.148233standard_deviation:27.719595group_size:27
---
The following is a YAML text file for the data from the article:
---
{ ""intervention"": {""mean"": ""2.7 x 108 C.O."", ""standard_deviation"": ""2.4 x 108 C.O."", ""group_size"": 20}, ""comparator"": {""mean"": ""1.0 x 108 C.O."", ""
---
intervention: CD4+^CD8+^S1group_size: 39comparator: CD4+^CD8+^S2group_size: 39
---
intervention: mean: 2.186164 standard_deviation: 1.165277 group_size: 784 comparator: mean: 1.140741 standard_deviation: 0.613778 group_size: 35
---
intervention: mean: 200.0000 standard_deviation: 1.0000 group_size: 108 comparator: mean: 11.0000 standard_deviation: 3.3333 group_size: 108
---
A significant positive correlation was observed in smokers when comparing total white blood cells count and total B cells count at 0 week (r=0.57, p<0.05) (Table  [2](#)); also a significant positive correlation was found between TWBC count and total CD4
---
",True
309,7833,4541185,onset of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,4.36,0.81,4.84,0.65,-0.6451,0.0701,,,,,found in abstract,TRUE,1359,1043,TEST,907,[],intervention: mean: 30.1495571 standard_deviation: 9.27238286 group_size: 30comparator: mean: 48.65 standard_deviation: 4.27273618 group_size: ,False
287,6100,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,"[1672, 1641, 963]","intervention: mean: -1.01734n: 19comparator: mean: -0.983915n: 16intervention: mean: -1.06354n: 8comparator: mean: -0.983265n: 
---
intervention: mean:6.397standard_deviation:2.387group_size:27comparator: mean:6.515standard_deviation:2.341group_size:22
---
The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:
---
",True
595,11583,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","{ ""intervention"": {""mean"": ""1.12"", ""standard_deviation"": ""3.12"", ""group_size"": ""90"", ""unit"": ""mg""}, ""comparator"": {""mean"": ""0.38"", ""standard_deviation"": ""-"", ""group_size"": ""-"", ""
---
{% assign group_size_I = ""65"" %} {% assign group_size_C = ""66"" %} {% assign mean_I = ""1.08"" %} {% assign mean_C = ""0.99"" %} {% assign standard_deviation_I =
---
8) etoricoxib 90 mg [placebo] Serum C-reactive protein 
---
",True
345,10232,5686687,Pain,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,given as median and range,FALSE,7451,3515,TEST,2366,"[1235, 1108]","intervention: mean: 5.4 standard_deviation: 2.6 group_size: 22 comparator: mean: 5.7 standard_deviation: 2 group_size: 22
---
intervention: group_size: 22 comparator: group_size: 22 mean: 3.9 standard_deviation: 5.3 mean: 3.2 standard_deviation: 3.5
---
",True
536,7795,3508963,Baseline characteristics - age,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,35.23,12.37,37.71,11.08,-0.2105282,0.016759,,,,,,TRUE,3561,2387,TEST,1552,"[1557, 216]","intervention:
mean: 35.2312.37152
---
intervention:
---
",True
602,11583,115849,Patient global assessment of pain,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","{ ⟪Intervention⟫: [ ⟪naproxen 500 mg twice daily⟫: [ ⟪mean⟫: 2.65, ⟪standard_deviation⟩:1.52, ⟪group
---
comparison: placebo group outcome: Patient global assessment of pain (100 mm VAS): mean: -1.43 standard_deviation: 1.62 group_size: 174 intervention: naproxen 500 mg twice daily outcome: Patient global assessment of pain (10
---
intervention: mean: 1.7 group_size: 145 comparator: mean: 1.7 group_size: 146
---
",True
125,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H0 (saline),continuous,,50,,50,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"[1538, 1161]","intervention: Sedation score in the post-anesthesia care unit (PACU) over 2 h postoperatively comparator: SalineOutcome: The sedation score recorded in PACU over the 2-h post-operative observation periodIntervention: 1 mg haloperidolComparator: 
---
intervention: mean: 10 standard_deviation: 20 group_size: 50 comparator: mean: 10 standard_deviation: 20 group_size: 49 outcome: The sedation score recorded in the postanesthesia care unit (PACU) over the 2
---
",True
171,2793,5079604,The restricted mean time to hyperglycemia relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,480,,305,,cannot calculate,cannot calculate,,,,,SD is not given.,FALSE,12690,6902,TEST,4923,"[739, 1755, 1654, 706]","I cannot find the requested information from the text "" RESEARCH DESIGN AND METHODS This prospective, 4-year, placebo controlled study randomly assigned 48 African American subjects with DKA and severe hyperglycemia to metformin 1,000 mg daily (*n* = 1
---
intervention:
---
intervention: mean: 0 group_size: 28 comparator: mean: 0 group_size: 20
---
intervention: mean: 540.19 standard_deviation: 113.97 group_size: 82 comparator: mean: 305.4 group_size: 94
---
",True
526,6916,4411165,tympanic temperature from Pre to P20 (-0.28 ±0.11°C),"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-0.28,0.11,-0.14,0.05,-1.5691765,0.26155787,,,,,Values on mean change are based on what is reported in abstract.,TRUE,3146,2589,TEST,2336,"[1632, 485]","intervention: mean: -0.28 standard_deviation: 0.11 group_size: 10comparator: mean: -0.14 standard_deviation: 0.05 group_size: 10
---
intervention: mean: -0.28 standard_deviation: 0.11 group_size: 15 comparator: mean: 0.13 standard_deviation: 0.10 group_size: 10
---
",True
169,2792,5079604,hyperglycemia relapse-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[739, 1755, 1654, 706]","intervention: mean: 48.0 standard_deviation: 360.0 group_size: 17 comparator: mean: 305.0 standard_deviation: 360.5 group_size: 15
---
intervention:
---
intervention: {mean: 8.7, standard_deviation: 2.8, group_size: 29}
---
intervention: mean: 480.00 standard_deviation: 0.00 group_size: 122 comparator: mean: 305.00 standard_deviation: 0.00 group_size: 127
---
",True
601,11583,115849,Swollen joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: naproxen 500 mg twice daily mean: 18.08352456 group_size: 245 comparator: placebo mean: 23.07690774 group_size: 223 standard_deviation: 5.
---
{- mean: x - standard_deviation: x - group_size: x}- mean: x - standard_deviation: x - group_size: x
---
{% set data1 = {""intervention"": ""naproxen 500 mg twice daily"", ""standard_deviation"": ""1.879"", ""group_size"": ""N = 173"", ""scores"": 11}, ""comparator"": {""intervention"": ""placebo"",
---
",True
429,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.3,15.1,33.6,16.3,3.71430281,0.0577096,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 73.3 standard_deviation: 6.9 group_size: 96 comparator: mean: 67.8 standard_deviation: 10.3 group_size: 96
---
intervention: mean: 73.543 standard_deviation: 20.3 group_size: 98 comparator: mean: 48.257 standard_deviation: 27.963 group_size: 98
---
intervention:
---
intervention: mean: 0 mean: standard_deviation: 1 standard_deviation: 1 group_size: x
---
",True
582,10219,3504298,Attentional Function,Word-based attentional bias modification,Face-based attentional bias modification,continuous,,16,,16,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"[1656, 1393]","intervention: mean:69.44 standard_deviation:12.95 group_size:132 comparator: mean:77.34 standard_deviation:8.65 group_size:114
---
The following table shows the extracted information from the study.
---
",True
396,1120,3577738,interest,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[1637],"intervention: mean: 5.9 standard_deviation: 1 standard_deviation group_size: 402 comparator: mean :5.6 standard_deviation:1.06 standard_deviation group_size: 402
---
",True
441,8804,4467620,weight reduction,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,68.6,7.7,68.8,7.5,-0.0248738,0.25001933,,,,,The numerical values are from Exercise state.,TRUE,7288,4607,TEST,3858,"[1636, 1448]","intervention: mean: [43.092 ×107] standard_deviation: [8.938×107] group_size: 8
comparator: mean: [40.980×107] standard_deviation: [8.474×10
---
intervention:
mean: ""0.41_0.07""
standard_deviation: ""0.22""
---
",True
397,2240,4678179,progression-free-survival (PFS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,,,,,cannot calculate,cannot calculate,,,,,Median was only given.,FALSE,9517,6474,TEST,5204,"[715, 1652, 1614, 1177]","intervention:mean: 4.0standard_deviation: 1.8group_size: 106comparator:mean: 2.5standard_deviation: 1.5group_size: 106
---
intervention:
---
intervention:
---
intervention:
---
",True
371,228,1475568,Baseline life-quality score,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,"[1439, 1156]","intervention: mean: 26.00 standard_deviation: 10.75 group_size: 64 comparator: mean: 22.50 standard_deviation: 14.50 group_size: 63
---
{% set result = '' %} {% set rowSet = ['''] {% set x = ''%}{% set y = ''%}{% endset %}{% set x = y %} [ '''] %}{% set x = 69.25 %} {% set y = 7.5
---
",True
89,5538,3912320,Correct response rate for 500 Hz frequency,Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],intervention: { mean:0.00008526 standard_deviation:0.0033 group_size:0.040 comparator: { mean:0.00008148 standard_deviation:0.0028 group_size:0.03,False
448,4003,4879328,effects for vigorous activity,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.2,1.56,-0.4,2.48,0.28575833,0.0185746,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[989, 1648, 1674, 1355, 1003]","intervention:mean:0.24standard_deviation: 0.24group_size:113comparator:mean:0.20standard_deviation: 0.24group_size:114
---
Note: The YAML representation shows ""group_size"" only for the ""comparator"" and ""intervention"" group, regardless if ""outcome"" was represented or not. For other fields missing they correspond to the respective field for group_size (.xlsx file).
---
The first column (in blue font) indicates the outcome variable, the second column (in yellow font) indicates the treatment of interest, the third column (in yellow font) indicates the control (which is clearly the other treatment group given the trial design), and the fourth column (in yellow font) indicates the outcomes for the treatment group.
---
intervention: mean: −0.5 group_size: 104 comparator: mean: −0.3 group_size: 114
---
intervention: {: mean: 0.15: standard_deviation: 0.34: group_size: 104}comparator: {: mean: 0: standard_deviation: 0.34: group_size: 114}
---
",True
604,11583,115849,Serum C-reactive protein,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","naproxen 500 mg twice daily: mean: 4.78 standard_deviation: 1.44 group_size: 104 placebo: mean: 4.61 standard_deviation: 1.44 group_size: 147
---
naproxen_500_mg_twice_daily:
---
intervention: mean: 3.15 standard_deviation: 5.81 group_size: 87 comparator: mean: 2.70 standard_deviation: 4.37 group_size: 93
---
",True
521,6697,5154016,Total drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,231.5,18.1,318.5,26.7,-3.7647135,0.18477557,,,,,,TRUE,3046,2156,TEST,1642,"[1448, 465]","intervention: mean: 231.511 standard_deviation: 18.1193 group_size: 3 comparator: mean: 248.463 standard_deviation: 18.752 group_size: 3
---
intervention: mean: 61.84 standard_deviation: 6.60 group_size: 120 comparator: mean: 47.53 standard_deviation: 6.08 group_size: 120
---
",True
395,1120,3577738,active trust,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[1637],"intervention: mean: 5.8 standard_deviation: 3.2 group_size: 134 comparator: mean: 5.3 standard_deviation: 2.7 group_size: 132
---
",True
563,9837,3496170,Self-report questionnaire,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,2318,1990,TEST,1731,"[1671, 44]","intervention: mean:12 (given information in the article)standard_deviation:4.5 (given information in the article)group_size:7comparator:mean:<x>standard_deviation:<x>group_size:<x>outcome:mean:<x>standard_deviation
---
intervention: { ""mean"": 0.0, ""standard_deviation"": 1.0, ""group_size"": 22 }
---
",True
697,5639,5712123,morphine requirements,D/E group,P group,continuous,,30,,30,17.9,3.2,31.9,6.7,-2.6318902,0.12439038,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","For outcome: morphine requirements at 24 h, the group_size in Comparator: P group is 30. However, I cannot confirm whether ""30"" and ""38"" were used to indicate the number of patients or number of arms (total number of patients). Please confirm with the authors of the original article.
---
intervention: mean: 4.404standard_deviation: 1.111group_size: 68comparator: mean: 2.754standard_deviation: 1.351group_size: 68outcome:
---
intervention: mean: 23standard_deviation: 20.9group_size: 30comparator: mean: 21.75standard_deviation: 20.7group_size: 30
---
{intervention: D/E group, mean: 9.8, standard_deviation: 2.3, group_size: 30}
---
",True
350,4493,5874317,Knee extension (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,237.2,51,182.4,8.4,1.4252,0.2786,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[716, 3252, 976]","To my knowledge, the given trial does not report tables on mean and standard deviation of measured outcomes. The results in the text are not presented in a format that allows extracting the numbers in a structured way. Moreover, the given trial is a cross-sectional study, so the measured outcomes are not of any interest here.
---
intervention: mean: 207.9 standard_deviation: 30.2 group_size: 9 comparator: mean: 207.9 standard_deviation: 30.2 group_size: 9
---
intervention: { mean: 81.78868904835193 standard_deviation: 20.271115007774972 group_size: 23 comparator: { mean: 79.489847
---
",True
695,5639,5712123,morphine requirements,E group,P group,continuous,,30,,30,24.6,4.5,31.9,6.7,-1.2625038,0.0799493,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","intervention: mean: 80.60 standard_deviation: 13.37 group_size: 7 3 (48) comparator: mean: 78.83 standard_deviation: 16.78 group_size: 9 9 (48)
---
intervention: mean: −2.8Standard Deviation: 1.4group_size: 12comparator: mean: −1.4standard_deviation: 1.8group_size: 12
---
intervention:
---
intervention: mean: 10.661 standard_deviation: 0.8994 group_size: 41 comparator: mean: 9.2788 standard_deviation: 0.95476 group_size: 41 group_size:10.6
---
",True
197,7734,5380284,Pain scores 48 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
mean: 83.4mean: 0.6standard_deviationgroup_size: 22.3group_size: 37",False
34,5578,3003523,Mental Component Summary improvement,Certolizumab 400 mg,Control,continuous,,390,,199,45.4,11.5,41.1,10.8,0.3811,0.0077,,,,,Used values for MCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"[1675, 455, 3308, 1649, 1104]","intervention:
mean: 6.4000046891257732000000000000000000001238group_size: 39200000000000132
---
intervention: mean: 5.5 standard_deviation: 19.3 group_size: 183 comparator: mean: 2.0 standard_deviation: 18.9 group_size: 180
---
This is an improvement in Mental Component Summary (MCS), a health-related quality of life measure, and the information provided is from the ""Certolizumab group"". The table shows the mean score for MCS (with subcomponents as well as an overall score) at baseline, 12 weeks, 24 weeks and
---
intervention:
mean: 72.89428571428571
---
intervention: mean:0.2932standard_deviation:0.55group_size:116
comparator: mean:0.2291standard_deviation:0.59group_size:169
---
",True
335,5082,5617873,Social withdrawal,Aripiprazole,Placbeo,continuous,,45,,47,-4.7,1.1,-5.2,1,0.4722,0.0447,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"[1552, 722, 1531, 1010]","There are two outcomes specified in the question, Social Anhedonia and Social Withdrawal. Since this is not specified in the question, I am assuming these are the same outcomes. I am also assuming that the outcomes Social Anhedonia and Social Withdrawal should be from the same intervention and comparator. I am choosing to use social withdrawal
---
intervention:
---
intervention: mean: −9.60 standard_deviation: 9.09 group_size: 173a comparator: mean: −5.76 standard_deviation: 8.67 group_size: 168a
---
intervention: mean: 0.570standard_deviation: 0.291group_size: 160comparator: mean: 0.161standard_deviation: 0.128group_size: 80
---
",True
202,5498,5380326,Interferon gamma-induced protein 10,Vitamin D supplementation,Control,continuous,,40,,40,636.47,448.47,748.88,551,-0.2216,0.0503,,,,,,TRUE,10658,5810,TEST,4260,"[618, 1669, 1370, 1494]","intervention:
---
25-hydroxycholecalciferol: 
---
{ ""intervention"": { ""mean"": 41.4, ""standard_deviation"": 7.5, ""group_size"": 40 }, ""comparator"": { ""mean"": 7807.8, ""standard_deviation"": 309.5, ""group_size"": 
---
intervention: mean: 45 standard_deviation: 22.4 group_size: 39 comparator: mean: 56 standard_deviation: 74 group_size: 42
---
",True
399,2242,4678179,Response rates,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,8,,13,,cannot calculate,cannot calculate,,,,,Only difference in response rates as percent is given.,FALSE,9517,6474,TEST,5204,"[715, 1652, 1614, 1177]","The YAML format should include the fields ""mean"" and ""standard_deviation"" for only ""intervention"" and ""comparator"" but not ""outcome""
---
intervention: mean: 0.024225229387758213 standard_deviation: 0.0168221333730251 group_size: 53 comparator: mean: 0.036876
---
The YAML format is required to extract the data from the main text in the ClinicalTrials.gov registration website for a single main outcome (progression-free survival (months)) of our interest in Table 2 for the intervention ""gemcitabine plus vismodegib (GV)"" and a reference comparator
---
intervention:
---
",True
603,11583,115849,Health Assessment Questionnaire disability,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean:3.789 standard_deviation:1.347 group_size:609comparator: mean:4.803 standard_deviation:1.497 group_size:512
---
The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"".
---
intervention: mean: 30.8000 standard_deviation: 49.8264 group_size: 1049comparator: mean: 51.2682 standard_deviation: 69.1059 group_size: 3752
---
",True
360,8712,5971365,Symbol Digit Modalities Test (SDMT) score at week 144 in limited patients,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,287,,277,6.3,12.6,3.1,13.2,0.2478,0.0071,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1626, 724]","{  ""intervention"": { ""mean"": 49.22, ""standard_deviation"": 15.45, ""group_size"": null }, ""comparator"": { ""mean"": 49.2, ""standard_deviation"": 15.85, ""group_size"": null
---
intervention: mean: 54.88 standard_deviation: 8.97 group_size: 62 comparator: mean: 53.64 standard_deviation: 10.20 group_size: 63
---
",True
566,8556,5541727,Knee Injury and Osteoarthritis Outcome Score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[867, 1610, 1671, 76]","intervention: mean:28.87 standard_deviation:0.45 group_size:11 comparator: mean:30.4 standard_deviation:1.43 group_size:7
---
intervention:
mean: -34.721330372706876902826328745794276231262968456110065360197751compar
---
intervention: mean: 0.28 standard_deviation: 2.54 group_size: 6188 comparator: mean: 2.52 standard_deviation: 10.7 group_size: 4218
---
intervention:mean:1.92standard_deviation:0.62group_size:24comparator:mean:0.31standard_deviation:0.62group_size:25
---
",True
693,5636,5712123,postoperative pain at rest,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,2,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","intervention &: &comparator: group_size: 30 group_size: 30intervention: group_size: 30 group_size: 30standard_deviation: 1.44standard_deviation: 1.08standard_deviation: 1.25standard_
---
The YAML format for the provided trials is as follows:
---
As per my knowledge, this study has 2 intervention groups, a placebo group and one outcome. The mean and standard deviation for pain scores at rest for each of the 4 groups is as follows:intervention1: 6.812.9group_size1: 30intervention2: 5.
---
intervention: mean: 1.323standard_deviation: 0.674group_size: 30comparator: mean: 1.21standard_deviation: 0.297group_size: 30
---
",True
557,9830,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Casein shake (Placebo),continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1672, 1417]","intervention: mean: 50 standard_deviation: 25 group_size: 12 comparator: mean: 50 standard_deviation: 25 group_size: 16
---
interventions: ""- intervention: mean: ""X"" standard_deviation: ""X"" group_size: ""X"" ""
---
",True
465,4431,5726464,Lipid profile: Triglycerides,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","intervention: { ""mean"": 99, ""standard_deviation"": 96, ""group_size"": 165 }
---
intervention: mean: 0.27 standard_deviation: 13.5 group_size: 78 comparator: mean: 2.4 standard_deviation: 8.9 group_size: 71
---
intervention: mean: 24.71 standard_deviation: 26.63 group_size: 47 comparator: mean: 21.48 standard_deviation: 27.15 group_size: 47
---
",True
637,12720,4132222,decrease in average lesion,application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,"[1617, 117]","Sure, here's the extract in YAML format: outcome: decree_in_average_lesionIntervention: application_of_a_canola_phenolic_acid_based_cream (CPA)Comparator: placebomean: 1.880581standard_dev
---
intervention:
mean: 7.800000
---
",True
616,11602,1863515,leucocyte count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-423,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"[1630, 1586]","intervention:mean: xstandard_deviation: xgroup_size: xcomparator:mean: xstandard_deviation: xgroup_size: x
---
intervention: mean: 0003250.40 standard_deviation: 0002720.01 group_size: 875 comparator: mean: 0002900.48 standard_deviation: 0002490.0
---
",True
68,3041,3321528,hip flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1398, 1531]","intervention: mean: 0.331standard_deviation: 0.148group_size: 24comparator:mean: 0.079standard_deviation: 0.105group_size: 28
---
intervention: {""mean"": 4, ""standard_deviation"": 1, ""group_size"": 24}
---
",True
576,8563,2952311,State-Trait Anxiety Inventory-I,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1591],"intervention: {: mean: 44.5, : standard_deviation: 8, : group_size: 11}comparator: {: mean: 43.2, : standard_deviation: 6.8, : group_size: 11}
---
",True
157,13482,5055753,Mean ± SD of heart rate,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Info in figure graphics.,FALSE,3292,2470,TEST,2114,"[1599, 640]","intervention: mean: 70.65 standard_deviation: 15 group_size: 40
---
intervention:mean: 76.66514standard_deviation: 7.26264554540896group_size: 60comparator:mean: 82.92857standard_deviation: 12.00091
---
",True
468,4802,5515881,memory score,demanding balance training program,relaxation group,continuous,,,,,9.44,5.48,8,4.16,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1670, 1268]","intervention: standard_deviation: 7.43 group_size: 21 comparator: standard_deviation: 4.25 group_size: 22
---
intervention:
mean: 1.600
---
",True
177,10754,5086025,General mental health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.24,7.41,45.63,6.31,0.6598,0.0811,,,,,,TRUE,29049,17627,TEST,13068,"[739, 1755, 1654, 1640, 1675, 738, 1666, 1032, 3194]","{ intervention:mean: 2.52standard_deviation: 0.681group_size: 21comparator:mean: 2.47standard_deviation: 0.794group_size: 26
---
Table name: Treatment in N-of-1 Trials for General Mental Health
---
intervention: mean: 38.61 standard_deviation: 11.36 group_size: 30comparator: mean: 38.41 standard_deviation: 10.86 group_size: 25
---
intervention:
---
The figure shows the flow of participants through the study. This is the CONSORT diagram for a randomized controlled trial, where it presents the number of participants enrolled, screened, randomized, analyzed, and retained (see Figure 5), as well as the reasons for exclusion at each stage.
---
intervention: mean: 22 standard_deviation: 18.2 group_size: 1517 comparator: mean: 16 standard_deviation: 14.9 group_size: 109
---
intervention:11.841.4547comparator:10.941.6466#Outcome data not found.
---
intervention:
---
intervention: mean: x standard_deviation: x group_size: x comparator: mean: x standard_deviation: x group_size: x outcome: general_mental_health: mean: x standard_deviation: x group_size: x
---
",True
678,13505,5777419,the total cultivable microbiota,antibiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,"[1099, 1320, 1023]","comparison_between_groups:
---
intervention: mean = 0.5, standard_deviation = 1.3, group_size = 16.0 comparator: mean = 0.8, standard_deviation = 1.7, group_size = 15.0 outcome: mean = x, standard_deviation = x,
---
intervention: mean: 37x standard_deviation: x group_size: 16x comparator: mean: 22x standard_deviation: x group_size: 15x outcome: total cultivable microbiota
---
",True
54,5309,3195393,Restraint knowledge,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,6.23,,5.51,,cannot calculate,cannot calculate,,,,,No SD information provided,FALSE,15527,8380,TEST,5589,"[1670, 663, 1648, 1306, 708]","The restraint rate in the intervention site decreased from 13.8% to 13.4%. A total of 642 participants were included in the intervention site ([Table 1(b)](#)) and the mean age was 74.7 years (SD 10.8) with a
---
intervention:mean:5.510standard_deviation:4.339group_size:107comparator:mean:5.092standard_deviation:4.138group_size:108
---
intervention: mean: 1.90 standard_deviation: 0.41 group_size: 11926 comparator: mean: 2.23 standard_deviation: 0.40 group_size: 17970
---
{% if data.group_size.intervention > data.group_size.comparator %}intervention: mean: 43.5019732670202875625 standard_deviation: 6.493974836593
---
intervention: mean: 7.1 standard_deviation: 0.08 group_size: 562 comparator:mean: 0.4 standard_deviation: 0.01 group_size: 310
---
",True
449,4004,4879328,FFBQ Total Index Score,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.07,0.26,0.01,0.33,0.20018961,0.01847923,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[989, 1648, 1674, 1355, 1003]","{ ""intervention"": { ""mean"": 8.2, ""standard_deviation"": 7.7, ""group_size"": 114 }, ""comparator"": { ""mean"": 8.7, ""standard_deviation"": 6.2, ""group_size"": 114 } }
---
intervention: mean:3.3standard_deviation:3.3group_size:114comparator: mean:3.3standard_deviation:3.3group_size:114
---
intervention: mean: -2.13 standard_deviation: 1.08 group_size: 129 comparator: mean: -0.28 standard_deviation: 1.11 group_size: 129
---
intervention: mean: ""0.2"" standard_deviation: ""0.08"" group_size: ""104"" comparator: mean: ""0.02"" standard_deviation: ""0.07"" group_size: ""114""
---
intervention: mean: 1.52 standard_deviation: 0.83 group_size: 104 comparator: mean: 1.45 standard_deviation: 0.61 group_size: 114
---
",True
285,6302,3929816,Pathologic changes in the liver,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,[],intervention: mean:16.4813standard_deviation:5.5908group_size: control_group:5test_group:10comparator: mean:11.5128standard_deviation:3.8003group_size: control_group:5test,False
643,12880,5830087,duration of objective response,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,"[966, 1275, 1632, 1659, 157, 1914, 831, 989]","intervention: mean: 8.36825951 standard_deviation: 4.282741976 group_size: 92comparator: mean: 4.58865675 standard_deviation: 4.5886567
---
intervention {mean: 6.1; standard_deviation: 4.04; group_size: 29}comparator {mean: 4.2; standard_deviation: 4.90; group_size: 29}
---
intervention: mean: 11.64845 standard_deviation: 9.313956 group_size: 41 comparator: mean: 9.612548 standard_deviation: 6.8453356 group_size: 23
---
intervention:
---
intervention: mean: 4.13 standard_deviation: 1.74 group_size: 43599comparator: mean: 4.2 standard_deviation: 1464 group_size: 28966
---
intervention : 7.4 standard_deviation : 5.4 group_size : 47 comparator : 5.8 standard_deviation : 5.4 group_size : 58 
---
intervention: mean: 5.03 standard_deviation: 1.65 group_size: 442]comparator: mean: 4.02 standard_deviation: 1.51 group_size: 434
---
intervention:
mean: 10.5964000000264806291168862456939498000253846191460225750340000
---
",True
672,13313,4550271,Community knowledge,provider-school intervention,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,"[946, 1631, 54, 2187, 1659, 153, 2173, 1311]","intervention: mean: 0.32 standard_deviation: 0.17 group_size: 9899
---
The YAML response is:
---
To: Author of Record<br />Subject: Request for data<div style=""font-family: Arial,sans-serif;""><br /></div>Dear Author,<br />I am a machine learning algorithm created by Satoshi Nakamoto, and I am writing to request the data from your article titled '<
---
intervention:
mean: 4.4459595959596
---
intervention:mean:13.52standard_deviation:2.62group_size:[59,407,30]comparator:mean:10.42standard_deviation:3.25group_size:[57,392,31]
---
intervention:
---
provider_school: 16.232680268026804 (82%) 85% (17%) -27.3%(-44.4, -10.1) provider: 18.23846153846
---
intervention: mean: 0.593751534 standard_deviation: 0.3793740371 group_size: 140277087 comparator: mean: 0.513873321 standard_deviation:
---
",True
592,11583,115849,Swollen joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention:mean:29standard_deviation:15group_size:353comparator:mean:29standard_deviation:15group_size:353
---
comparison: ""Intervention:placebo""
---
I found the following content in the article:""""Table 2 shows the mean, standard deviation (SD), and group size for the primary efficacy variable of swollen joint count (SJC) at each time point. Results showed that both 90-mg and 120-mg doses of etoricox
---
",True
354,4497,5874317,Horizontal countermovement jump,Bilateral training,Unilateral training,continuous,,9,,9,2.34,0.07,2.21,0.15,1.0576,0.2533,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[716, 3252, 976]","{
---
intervention: mean: ""3.58"" standard_deviation: ""0.21"" group_size: ""9"" comparator: mean: ""4.05"" standard_deviation: ""0.36"" group_size: ""9"" outcome: mean: ""xxxx"" standard_deviation:
---
intervention:mean:207.052standard_deviation:52.993group_size:10comparator:mean:148.048standard_deviation:53.188group_size:10
---
",True
598,11583,115849,Patient global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean: 7.1 standard_deviation: 1.4 group_size: NANAcomparator: mean: 6.2 standard_deviation: 1.4 group_size: NANA
---
intervention:
---
The output must be put as plain text-only in RTF. Do NOT produce RTF format that contains other stuff beyond the plain text output. Copy the plain text output. Do NOT copy the YAML output. For RTF output, do not copy by highlighting and pasting using word editor such as Word, which adds hidden special
---
",True
180,10757,5086025,General physical health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.87,11.02,50.46,7.83,0.0422,0.0769,,,,,,TRUE,29049,17627,TEST,13068,"[739, 1755, 1654, 1640, 1675, 738, 1666, 1032, 3194]","The YAML format includes the fields ""mean"" and ""standard_deviation"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:
---
intervention:
---
intervention: mean: 53.200000 standard_deviation: 15.000097 group_size: 108 comparator: mean: 47.900241 standard_deviation: 14.011441 group_size
---
The YAML format of the table is already included in the ""Results - Outcome data"" subsection. The original table presents the posttest data of the two groups under comparison in between subject design (comparison group, intervention group) and, therefore, is in fact a 2a2-Table (2 times 2 tables -
---
outcome: general_physical_health
intervention: """"mean"""": 41.5, ""standard_deviation"""": 10.5, ""group\_size"""": 15
---
intervention:
---
Previous research has also suggested that interventions adapted for the young adults, and delivered via online platforms, may have high participation rates and be feasible and acceptable.
---
intervention: mean: 16.900 standard_deviation: 3.67 group_size: 1956comparator: mean: 15.880 standard_deviation: 3.40 group_size: 1656
---
intervention: mean: 19066.99standard_deviation: 178493.61group_size: 19comparator:mean: 212085.14standard_deviation: 189937.06group_size: 
---
",True
452,4001,4879328,weight loss,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.33,0.3,3.54,-0.3445812,0.01865965,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[989, 1648, 1674, 1355, 1003]","intervention:
---
intervention:
---
intervention: mean:−1.00 standard_deviation:3.72 group_size:13 comparator: mean:−0.25 standard_deviation:3.52 group_size:12
---
intervention: mean: ""−0.89"" standard_deviation: ""1.53"" group_size: ""104"" comparator: mean: ""0.30"" standard_deviation: ""0.95"" group_size: ""114""
---
comparator: mean: 0.00 number; standard_deviation: 3.19 number; group_size: 114 numberintervention: mean: −1.35 number; standard_deviation: 3.82 number; group_size: 104 number
---
",True
161,7712,5056957,Weight reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,61.08,15.15,61.94,14.25,-0.0582,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1657, 626, 2074, 1039]","intervention: mean: 45.476 standard_deviation: 7.743 group_size: 20957 comparator: mean: 45.476 standard_deviation: 8.181 group_size: 19329
---
intervention:mean: 0intervention:standard_deviation: 3.1intervention:group_size: 867comparator:mean: 0comparator:standard_deviation: 3.2comparator:group_size: 856
---
intervention: group_size: 592 comparison_group: group_size: 592 mean: 55.96 standard_deviation: 12.60 mean: 55.22 standard_deviation: 12.51 comparison_group: group_size: 4
---
{ 
""intervention"": { 
""mean"": ""61.08"", 
""standard_deviation"": ""3.12"", 
---
",True
645,13025,4675066,The mean cognitive score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,99.4,12.2,101.7,8.2,-0.2172012,0.07594364,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"[1501, 1640, 1216]","intervention: mean: x standard_deviation: x group_size: 59 comparator: mean: x standard_deviation: x group_size: 30
---
intervention: {% assign first_intervention_group_size = intervention_group|size %} {% assign first_comparator_group_size = comparator_group|size %} {% if intervention_group|size > comparator_group|size %}mean: 0.3934992
---
intervention:
mean: 91.20000000000072
---
",True
286,6303,3929816,Pathologic changes in the kidneys,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,20,,,,cannot calculate,cannot calculate,,,,,Not enough measures given for calculation,FALSE,1047,859,TEST,749,[],"The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:",False
421,3401,3877023,quantitative contour sharpness of the thoracolumbar spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,0.83,0.22,1.32,0.51,-1.2060514,0.07410885,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","intervention:
---
intervention: [{""group_size"": 16}, {""mean"": 48}, {""standard_deviation"": 8.5}]comparator: [{""group_size"": 16}, {""mean"": 55}, {""standard_deviation"": 21.6}]Intervention intervention comparatorOutcome th
---
intervention: mean: 8.8 standard_deviation: 1.2 group_size: 24 comparator: mean: 8.5 standard_deviation: 0.8 group_size: 33
---
intervention: mean: 0.226281298 standard_deviation: 0.057829291736 group_size: 117 comparator: mean: 0.406280773501 standard_deviation: 
---
intervention: mean: 0.8 standard_deviation: 0.2 group_size: 32comparator: mean: 1.1 standard_deviation: 0.2 group_size: 34
---
",True
518,6699,5154016,Second 24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,53.7,3.8,63.5,14.2,-0.9305774,0.07388312,,,,,,TRUE,3046,2156,TEST,1642,"[1448, 465]","intervention: mean: 292.7 standard_deviation: 39 group_size: 30 comparator: mean: 318.5 standard_deviation: 26.7 group_size: 32
---
Comparator: Gelatin sponge Outcome: Second 24 h drainage volume GroupA:
---
",True
97,10168,4173437,Crystalloid solution needed,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. No numerical values associated with this outcome.,FALSE,854,745,TEST,637,[],intervention: mean: 1.296 standard_deviation: 0.401 group_size: 49 comparator: mean: 1.262 standard_deviation: 0.112 group_size: 40,False
179,10756,5086025,BMI,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,32.81,5.31,32.93,4.85,-0.0232,0.0769,,,,,,TRUE,29049,17627,TEST,13068,"[739, 1755, 1654, 1640, 1675, 738, 1666, 1032, 3194]","intervention: mean:3473standard_deviation:529group_size:147comparator: mean:3645standard_deviation:620group_size:147
---
intervention:Group: 44Comparator:Group: 35outcome:BMI
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
1. What is the table of between-group comparison (Intervention compared to Control) for mean change from baseline with corresponding standard deviations at Y1?
---
The BMI of the intervention and the comparator was available, and only post-intervention data was included. Note that there were 37 participants in the study, two in the ""intervention"" group and 35 in the ""comparator"" group.
---
intervention:mean: xstandard_deviation: xgroup_size: xcomparator:mean: xstandard_deviation: xgroup_size: x
---
intervention: mean: 0.39 standard_deviation: 1.71 group_size: 7 comparator: mean: 0.31 standard_deviation: 1.36 group_size: 4
---
intervention: mean: 0.00 standard_deviation: 0.02 group_size: 58comparator: mean: 0.00 standard_deviation: 0.09 group_size: 65
---
intervention: mean: 38.125 standard_deviation: 8.627 group_size: 41control: mean: 32.8432 standard_deviation: 8.568 group_size: 30
---
",True
330,5377,5559992,Anxiety,Buprenophine 64 mg,Buprenophine 96 mg,continuous,,4,,5,1.25,2.5,0,0,0.6784,0.4756,,,,,found in table,TRUE,1146,884,TEST,721,[],intervention: mean: 0.94 standard_deviation: 0.48 group_size: 4 comparator: mean: 0.43 standard_deviation: 0.48 group_size: 4,False
386,1118,3577738,website use in terms of time on the website,website with social presence elements.,website without social presence elements.,continuous,,,,,151,117.4,150.8,107.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,[1637],"{ 
---
",True
324,4727,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1650, 1319, 1031]","intervention: mean:0.111standard_deviation:0.015group_size:190
---
This is a table of means and standard deviations for the outcome item of language enhanced attention and focus MI training condition group (MI-LEAF) and control group MI.
---
intervention: { mean: 10.25, standard_deviation: 1.61, group_size: 32 }
---
",True
114,9523,4319071,Fruit intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.17,1.71,2,1.67,0.1005,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[975, 2176, 811, 1363, 1589, 1399, 1753, 1361]","intervention:
---
intervention: mean: 1.92 standard_deviation: 1.36 group_size: 338 comparator: mean: 1.81 standard_deviation: 1.27 group_size: 263
---
intervention: [mean: 1.97, standard_deviation: 2.10, group_size: 766]
---
{
---
intervention: 
    mean: 0.28 
    standard_deviation: 0.07 
---
intervention: - mean: 3.300x - standard_deviation: 11.50x - group_size: 265x comparator: - mean: 4.770x - standard_deviation: 18.10x - group_size: 263
---
intervention: mean: 1.5 standard_deviation: 2.2 group_size: 803 comparator: mean: 1.1 standard_deviation: 1.8 group_size: 803
---
Based on the given trial article, what is the table of mean outcome (at pre-intervention and post-intervention) and standard deviation for Intervention, Comparator, and Outcome? Here, the outcome table includes the outcomes for pre/post intervention and standard deviation. Intervention: Intervention + targeting environmental-level
---
",True
205,5500,5380326,Interleukin 2,Vitamin D supplementation,Control,continuous,,40,,40,4.49,13.34,28.69,103.03,-0.2276,0.0503,,,,,,TRUE,10658,5810,TEST,4260,"[618, 1669, 1370, 1494]","intervention: mean:0mean_stddev:46.20standard_deviation:3.72group_size:19
---
intervention: mean: 1205.336810130 standard_deviation: 643.0145774247396 group_size: 16 comparator: mean: 1201.8966501244
---
outcome: interleukin 2
Intervention: vitamin D supplementation Comparator: control 
---
intervention: mean: 25.05 standard_deviation: 2.233 group_size: 33 comparator: mean: 24.399 standard_deviation: 2.8133 group_size: 33
---
",True
246,10305,5571493,Glycemic level,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,0.74,0.05,0.83,0.05,-1.7238,0.2743,,,,,,TRUE,1507,1019,TEST,928,[],intervention:,False
245,10307,5571493,Glycemic level,Saline + Quinine infusion,Dw 5% + Quinine infusion,continuous,,10,,10,0.74,0.05,0.82,0.05,-1.5322,0.2587,,,,,,TRUE,1507,1019,TEST,928,[],intervention: mean:83.228standard_deviation:4.999group_size:10comparator: mean:91.712standard_deviation:7.380group_size:10,False
359,8711,5971365,Symbol Digit Modalities Test (SDMT) score at week 96,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,720,,682,4.1,12.4,2.9,12.7,0.0956,0.0029,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1626, 724]","daclizumabbeta: mean: 41.1standard_deviation: 12.7group_size: 919intramuscularinterferonbeta-1a:mean: 41.1standard_deviation: 12.7group_size: 922
---
intervention: { mean: 38.35 standard_deviation: 11.51 group_size: 140 } comparator: { mean: 37.41 standard_deviation: 12.17 group_size: 139 }
---
",True
489,6383,3786549,Baseline characteristics: weight,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,56.16,8.1,57.82,8.24,-0.201397,0.045685,,,,,,TRUE,9725,6231,TEST,4323,"[1678, 1676, 1258]","intervention: mean: 56.16 standard_deviation: 8.1 group_size: 85*comparator: mean: 57.82 standard_deviation: 8.24 group_size: 85*
---
intervention: mean: 1.01 standard_deviation: 0.53 group_size: N = 20 comparator: mean: 0.48 standard_deviation: 0.27 group_size: N = 19
---
mean (standard_deviation, group_size):
---
",True
445,4098,4140238,ocular itching for visit 3B at 7 min,bepotastine besilate ophthalmic solution (BBOS) 1.5%,placebo,continuous,,70,,70,1.2,,2.1,,cannot calculate,cannot calculate,,,,,"Original outcome name is ""ocular itching"". However, due to many different visits and data from timepoints. We specified this in the outcome. Visit 3B was the first study they conducted and 7 min is the last timepoint. No SD information was given",FALSE,12685,6812,TEST,5052,"[1671, 1063, 1324, 1651]","intervention: mean: 0mmintervention: standard_deviation: 1.68intervention: group_size: 78-195comparator: mean: 3.68comparator: standard_deviation: 1.94comparator: group_size: 78-19
---
Not done: The provided JSON file (file: SDB_table.json) requires further conversion into YAML format. The resulting YAML data file (file: SDB_table.yaml) has been corrected for syntax errors and inconsistencies and will be published under your reference/publication. Please confirm that the resulting Y
---
intervention: mean: 1.8 standard_deviation: 0.6 group_size: 70 comparator: mean: 1.8 standard_deviation: 0.7 group_size: 70
---
intervention: mean: 5.5 standard_deviation: 13.8 group_size: 70 comparator: mean: 3.2 standard_deviation: 7.7 group_size: 70
---
",True
556,9828,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Control,continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1672, 1417]","intervention: mean: −20.2 standard_deviation: 21.0 group_size: 24 comparator: mean: 17.5 standard_deviation: 10.2 group_size: 29
---
Control: Fibromyalgia Impact Questionaire-Revised scores (0-100) 0.680.97S129.4211.48S14 (FIQ)42.507.52S1312.321.0
---
",True
688,13763,2836833,systolic or diastolic blood pressure,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1595, 1207, 1243, 1126, 1526]","intervention: 500_mg_calcium: mean: 500_mg_calciumgroup_size: 1500_mg_calcium: mean: 1500_mg_calciumgroup_size: 340comparator: 500_
---
intervention: mean: 51.02 standard_deviation:10.33 group_size:41comparator: mean:50.47 standard_deviation:10.23 group_size:37
---
intervention: mean: 1500 standard_deviation: 0 group_size: 57 Comparator: mean: 500 standard_deviation: 0 group_size: 78
---
Both values were extracted from this table row, as they apply to the ""maldigest"" group. The group size was extracted from the same table row as well.
---
intervention: mean: 121.50000 standard_deviation: 23.35000 group_size: 6962comparator: mean: 114.75000 standard_deviation: 23.50000 group_size:
---
",True
459,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],comparator: mean: 11.33 standard_deviation: 2.32 group_size: 17intervention: mean: 16.67 standard_deviation: 1.75 group_size: 16,False
208,2913,5459456,inflexion-extension for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,6.3,1.1,6.5,0.9,-0.1881,0.2511,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention: {
""ACVC-HA"": {
""mean"": 3.20, ""standard_deviation"": 1.75, ""group_size"": 6
---
intervention: mean: 4.0 standard_deviation: 0.3 group_size: 10 comparator: mean: 3.9 standard_deviation: 0.3 group_size: 10
---
{% set intervention = ""ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC"" %}
{% set comparator = ""Control"" %}
---
intervention:
---
intervention: mean:NANA21 standard_deviation:NANA9.1 group_size:21 comparator: mean:NA8.9 standard_deviation:NA4.2 group_size:8
---
",True
289,6103,4215531,MCCB performance : Processing Speed,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,44.6,12.2,48.2,12.3,-0.2877,0.1064,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1672, 1641, 963]","intervention:mean: xstandard_deviation: xgroup_size: xcomparator:mean: xstandard_deviation: xgroup_size: x
---
{ ""intervention"": { ""group_size"": ""19"", ""mean"": ""4.75"", ""standard_deviation"": ""1.89"" }, ""comparitor"": { ""group_size"": ""20"", ""mean"": ""7.65"", ""standard_deviation"": ""2.5
---
intervention: mean: 44.5 standard_deviation: 10.7 group_size: 19 comparator: mean: 42.3 standard_deviation: 10.6 group_size: 19
---
",True
567,8560,5541727,Tibial bone expansion,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-0.7,1.5,1,1.1,-1.1693949,0.29779588,,,,,"Values are from ""total tibial plateau"" for 24 months",TRUE,6118,5345,TEST,4032,"[867, 1610, 1671, 76]","intervention:
---
intervention:
---
intervention: mean: 0.5 standard_deviation: 4.0 group_size: 52 comparator: mean: 4.2 standard_deviation: 3.4 group_size: 52
---
The total size of each group for Intervention is 20 and Comparator is 22.intervention: mean: 38.6195 standard_deviation: 40.77522 group_size: 20comparator: mean: 26.393667
---
",True
112,9525,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,167.61,83.71,158.67,78.33,0.1101,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[975, 2176, 811, 1363, 1589, 1399, 1753, 1361]","intervention: mean: 159.121 standard_deviation: 69.24 group_size: 1014, 1395 comparator: mean: 154.223 standard_deviation: 56.295 group_size: 12
---
intervention:mean:159.12standard_deviation:69.24group_size:434 + 459 + 456comparator:mean:157.73standard_deviation:64.54group_size:456 + 459
---
The YAML response is:
---
intervention: mean: 0.82 standard_deviation: 0.32 group_size: 389171 comparator: mean: 0.67 standard_deviation: 0.25 group_size: 383171
---
intervention:mean:11.30standard_deviation:11.51group_size:597comparator:mean:12.20standard_deviation:7.07group_size:918
---
control: mean: 0.53 standard_deviation: 2.21 group_size: 804plus: mean: 1.04 standard_deviation: 0.04 group_size: 808basic: mean: 1.05 standard_deviation: 0
---
This is a valid YAML format for the requested tabular information of the article in the data extraction form. However, it is important to note that the reported data were not confirmed for being accurate as there was no source file or link provided within the article's supplementary material. Therefore, it should not be used to derive any conclusions
---
The outcome data is presented is the form of table. The time frame for the information is from baseline to 24 months. The table of mean outcome value and standard deviation for all time points (baseline(0 month), T1(12 month) and T2(24 month)) with subgroups of total sample and risk
---
",True
215,2913,5459456,lateral bending for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2.2,0.4,2,0.3,0.5347,0.2589,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","control: ACVC: ACVC-HA: { 'mean': 'X', 'standard_deviation': 'Y', 'group_size': 'Z' }:
---
intervention: mean: 2.2222222222222standard_deviation: 0.444444444444444group_size: 22comparator: mean: 2.222222222222
---
intervention: mean:26.9standard_deviation:6.7group_size:14comparator: mean:28.8standard_deviation:4.4group_size:12
---
{% set intervention_group_size, 6% set comparator_group_size, 6% set outcome_group_size, 6%}intervention: {% set mean, 10.5% set standard_deviation, 1.5% set group_size, 6%}comparator
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
",True
33,5575,3003523,Health-related quality of life improvement - Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,This outcome is measured by Short-Form 36-Items (SF-36).,TRUE,12247,10091,TEST,7520,"[1675, 455, 3308, 1649, 1104]","The following is the solution for the YAML format for Table 1: { ""intervention"": { ""mean"": 64.1, ""standard_deviation"": 18.3, ""group_size"": 390 }, ""comparator"": { ""mean"": 67.2, ""standard_
---
intervention: mean: 5.6 standard_deviation: 21.0 group_size: 187
---
intervention: mean: ""38.1"" standard_deviation: ""9.5"" group_size: ""393"" comparator: mean: ""38.6"" standard_deviation: ""8.8"" group_size: ""390""
---
certolizumab:mean:40.4standard_deviation:16.5group_size:1135
---
intervention: mean: 1.8 standard_deviation: 0.7 group_size: 361 control: mean: 1.8 standard_deviation: 0.6 group_size: 43
---
",True
432,3261,3475525,Scores on sugar quiz,MTL group,No label group,continuous,,98,,99,90,20.7,47.2,19.6,2.11539588,0.03166271,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention:
---
intervention:
mean: 79.609700980701985598618004667796065
---
Mean difference in absolute amount of sugar in grams19.20.86.80.8
---
intervention: mean: 28.75 standard_deviation: 2.83 group_size: 30comparator: mean: 16.00 standard_deviation: 3.00 group_size: 30
---
",True
353,4496,5874317,Squat jump,Bilateral training,Unilateral training,continuous,,9,,9,0.37,0.04,0.34,0.04,0.7142,0.2364,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[716, 3252, 976]","intervention: mean: -0.27 standard_deviation: 0.68 group_size: 9 comparator: mean: -0.44 standard_deviation: 0.61 group_size: 9
---
NUMBER=0.37NUMBER=0.25NUMBER=9
---
intervention: mean:18.53512standard_deviation:6.93557group_size:10comparator:mean:10.95329standard_deviation:5.00842group_size:10
---
",True
560,9834,3496170,Learned irrelevance index,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"[1671, 44]","intervention: mean: 0.31625 standard_deviation: 0.09348285 group_size: N=15 comparator: mean: N=1.08791 standard_deviation: 0.26225326 group_size:
---
intervention:
mean: 2.096
---
",True
75,3743,3546023,The percentage of B cells,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,11.97,4,13.72,4.53,-0.404,0.0704,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","{intervention: '200 mg/day palmvitee nonsmokers', comparator: 'baseline', outcome: 'The percentage of B cells'}
---
intervention: mean: -3.25 std_dev: 0.74 group_size: 56 comparator: mean: -1.49 std_dev: 0.32 group_size: 56
---
intervention:
---
intervention: mean: 4.240 standard_deviation: 0.193 group_size: 106 comparator: mean: 4.170 standard_deviation: 0.258 group_size: 92
---
intervention: mean1: 65.77 standard_deviation1: 3.55 group_size1: NUMBER: (The percentage of B cells, baseline for intervention:palmvitee for nonsmokers) comparator: mean1: NUMBER standard_deviation1: NUMBER
---
The YAML format should only include the fields ""mean"" and ""standard_deviation"" for each outcome. Example:
---
intervention: mean: 11.8862 standard_deviation: 3.8748 group_size: 46comparator: mean: 7.4362 standard_deviation: 2.9657 group_size: 46
---
intervention: mean: 2.2500000012920982 standard_deviation: 0.6163588220399753 group_size: 27 comparator: mean: 1.35169077
---
intervention:
---
intervention: mean: 15 group_size: 61 comparator: mean: 15.5 group_size: 64
---
",True
414,3262,3475525,Taste perception,MTL group,choices group,continuous,,98,,98,5.6,1.4,5.3,1.5,0.20597307,0.02051639,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 4.09 standard_deviation: 0.786 group_size: 189 comparator: mean: 4.12 standard_deviation: 0.851 group_size: 205 outcome: mean: NANA standard_deviation: N
---
intervention: mean: -0.301 standard_deviation: 0.833 group_size: 45 comparator: mean: -0.396 standard_deviation: 0.975 group_size: 44
---
intervention:
---
intervention: mean: 2.8125 standard_deviation: 2.319978525 group_size: 33 comparator: mean: 5.31053190720818 standard_deviation: 3.67024
---
",True
71,3043,3321528,handgrip strength,Intensive Care Unit acquired weakness (ICU-AW),without an ICU-AW diagnosis,continuous,,,,,6.6,4.4,23.4,8.9,cannot calculate,cannot calculate,,,,,Does not have group size information in article.,FALSE,6725,3999,TEST,2880,"[1398, 1531]","intervention: 'Intensive Care Unit Acquired Weakness' comparator: 'without an ICU-AW diagnosis'
---
intervention:mean:134standard_deviation:43.5group_size:20comparator:mean:108.2standard_deviation:48.4group_size:28
---
",True
580,10217,3504298,Anxious symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"[1656, 1393]","intervention:xstandard_deviation:xgroup_size:xcomparator:xstandard_deviation:xgroup_size:xoutcome:xmean:xstandard_deviation:xgroup_size:x
---
The YAML output for Table 2 is shown below:
---
",True
658,13177,5773985,duration of surgical procedure,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,32.2,15.5,33.68,18.91,-0.0842565,0.08007099,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,"[1592, 407]","intervention: mean: 3.00 standard_deviation: 1.08 group_size: 50 comparator: mean: 2.92 standard_deviation: 1.03 group_size: 50
---
intervention: mean: 39 mean: 0.5 standard_deviation: 1 standard_deviation: 0.5 group_size: 39 group_size: 39
---
",True
523,6741,5325897,First test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,10.24,0.77,9.73,0.77,0.64440958,0.1402544,,,,,,TRUE,4260,2410,TEST,1703,"[1361, 506]","{%assign intervention = ""Evaluation with feedback"", comparator = ""Evaluation without feedback"", outcome = ""First test results""%} intervention: mean: 10.67standard_deviation: 0.61group_size: 30comparator:mean: 10.35standard_dev
---
intervention: mean: 8.848 standard_deviation: 2.753 group_size: 17 comparator: mean: 6.967 standard_deviation: 3.398 group_size: 8
---
",True
561,9835,3496170,P3a amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"[1671, 44]","intervention: mean: 0 mean_standard_deviation: 5.52 group_size: 15 comparator: mean: 1032.5 mean_standard_deviation: 83.4 group_size: 15
---
Comparator
---
",True
25,3244,2972614,Motion range - Shoulder extension,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42.66,3.4,42.95,3.98,-0.0781,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"[838, 1256]","group_size: 30group_size: 22intervention: 1mean: 67.1standard_deviation: 6.9comparator: 1mean: 63.9standard_deviation: 9.2
---
intervention: mean: 0.31 mean_standard_deviation_unit: 1 40 standard_deviation: 4.28 standard_deviation_mean_unit: 1 40 group_size: 29 28 comparator: mean: 0.31 mean_standard
---
",True
291,6103,4215531,MCCB performance : Visual Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,49.4,12.8,46.5,9.8,0.2491,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1672, 1641, 963]","intervention: mean: -1.448 standard_deviation: 0.218 group_size: 16 comparator: mean: 02.393 standard_deviation: 0.218 group_size: 52
---
intervention: mean: 53.900 standard_deviation: 6.140 group_size: 15 comparator: mean: 57.620 standard_deviation: 7.740 group_size: 17
---
intervention: mean: 39.5 standard_deviation: 10.6 group_size: 19* comparator: mean: 33.5 standard_deviation: 11.1 group_size: 19*
---
",True
505,6485,5419060,Phlebotomy questionnaire score: CDC C,Phlebotomy training programme,Control,continuous,,23,,23,97,3.85,60,5.25,7.89939403,0.76522202,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1537, 528, 1598, 748]","intervention: mean: 0.08 standard_deviation: 0.08 group_size: 60comparator: mean: 0.16 standard_deviation: 0.09 group_size: 328
---
intervention: mean: 15.00 standard_deviation: 4.00 group_size: 24
---
intervention:mean:9.45standard_deviation:2.253group_size:31comparator:mean:2.286standard_deviation:1.927group_size:31
---
{ ""intervention"": { ""mean"": 73.112918, ""standard_deviation"": 7.226419, ""group_size"": 174 }, ""comparator"": { ""mean"": 56.605503, ""standard_deviation
---
",True
199,7736,5380284,Rates of POI,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
mean: 0.863461823",False
532,7829,4230312,improvement of disorder,quetiapine 300 mg/day,placebo,continuous,,283,,204,-15.58,10.43,-11.61,10.12,-0.3847888,0.00858754,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,"[1608, 1576, 1434]","intervention: mean: 15.58 standard_deviation: 6.2 group_size: 283 comparator: mean: 11.61 standard_deviation: 7.41 group_size:204
---
intervention: mean: 15.18 standard_deviation: 0.67 group_size: 103 comparator: mean: 11.58 standard_deviation: 0.75 group_size: 108
---
intervention:
---
",True
113,9526,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,167.61,83.71,173.28,81.63,-0.0685,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[975, 2176, 811, 1363, 1589, 1399, 1753, 1361]","intervention:
mean: 159.12
---
Here is the requested information in YAML format: intervention: mean: 159.12 standard_deviation: 69.24 group_size: 1022comparator: mean: 157.73 standard_deviation: 64.54 group_size: 
---
intervention:mean: 0.32standard_deviation: 0.81group_size: 902comparator:mean: 0.26standard_deviation: 0.47group_size:766
---
intervention: mean: 173.28 standard_deviation: 3.81 group_size: 95 comparator: mean: 163.24 standard_deviation: 3.22 group_size: 89
---
{% set int_1=intervention+targeting environmental+level factors %}intervention/1:mean:0.286104168standard_deviation:0.086897056group_size:int_1+1comparator/0:mean:0.
---
intervention: mean: 1.78 standard_deviation: 0.08 group_size: 764 comparator: mean: 1.32 standard_deviation: 0.05 group_size: 743
---
intervention: mean: 0.7805871104201513172 standard_deviation: 0.48184744558947775 group_size: 19924000+29831
---
intervention:
---
",True
367,224,1475568,Minnesota living with heart failure (MLHF) questionnaire baseline scores,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,"[1439, 1156]","intervention: mean: 63.89 standard_deviation: 16.12 group_size: 59 comparator: mean: 67.73 standard_deviation: 43.33 group_size: 64
---
intervention:
mean: x.x
standard_deviation: x.x
---
",True
416,3262,3475525,intent of purchase,MTL group,No label group,continuous,,98,,99,3.8,1.4,4.1,1.5,-0.2059408,0.02041274,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean:0.716385 standard_deviation:0.117958 group_size:48 comparator: mean:0.633967 standard_deviation:0.0602426 group_size:46
---
{
""intervention"": {
""mean"": ""94.25"",
---
- intervention: mean: 4.80 standard_deviation: 1.60 group_size: 148 comparator: mean: 4.21 standard_deviation: 2.00 group_size: 96
---
intervention: mean: 0.23 standard_deviation: 0.18 group_size: 89 comparator: mean: 0.35 standard_deviation: 0.22 group_size: 84
---
",True
357,4711,5884950,chemokines CXCL9,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,"[752, 1661, 1538, 1630, 267]","*intervention:  extensively hydrolyzed whey -based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).intervention:mean: 2
---
Table values taken from Table
---
intervention:mean:29median:29mode:32standard_deviation:11.9standard_error:0.621914850687056503comparator:mean:40.75median:40.60mode:46
---
intervention: mean: 72.7715 standard_deviation: 27.1349 group_size: 41comparator: mean: 53.3619 standard_deviation: 30.14448 group_size: 41
---
ComparatorinterventionCXCL9Mean0.37241.45763.35781Standard deviation0.049100.177200.17711Group size1021
---
",True
681,13506,5777419,reduction of plaque,probiotic,placebo,continuous,,16,,15,28.1,14.6,27.4,13,0.0492187,0.12920574,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[1099, 1320, 1023]","intervention: mean: 3.35 standard_deviation: 0.64 group_size: 28 comparator: mean: 3.35 standard_deviation: 0.63 group_size: 28
---
probiotic: mean: 0.4 standard_deviation: 1 group_size: 2371
---
probiotic: 0.16, 0.18, 0.23, 0.22, 0.19, 0.16, 0.23, 0.32, 0.32, 0.25, 0.19,
---
",True
525,6742,5325897,Final test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,18.53,0.22,18.99,0.22,-2.0343126,0.20230713,,,,,,TRUE,4260,2410,TEST,1703,"[1361, 506]","intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
intervention: { ""mean"": 18.93, ""standard_deviation"": 0.96, ""group_size"": 13 }
---
",True
277,6422,3654355,Baseline Height,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,173.2,8.6,172.3,10.4,0.0971,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: Standardized Mean DifferenceIntervention: Intensive lifestyle intervention (ILI) groupComparator: Waiting list controlDifferences from baseline outcome and standard deviation for Intensive lifestyle intervention (ILI) group and waiting list control 10–14 weeks after the start of intervention:
---
intervention: mean: 173.2 standard_deviation: 8.6 group_size: 71
 comparator: mean: 172.3 standard_deviation: 10.4 group_size: 33
---
intervention: {: mean: 171.0, : standard_deviation: 8.6, : group_size: 71}
---
intervention: meanx, standard_deviationx, group_size418outcome: heightstandard_deviationx, group_sizexcomparator: meanx, standard_deviationx, group_size839
---
intervention:
 mean: 163.66666666666667
---
",True
176,10753,5086025,Psychological flexibility,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,18.23,8.14,22.46,8.67,-0.4954,0.0793,,,,,Actually psychological inflexibility in the article,TRUE,29049,17627,TEST,13068,"[739, 1755, 1654, 1640, 1675, 738, 1666, 1032, 3194]","Sure, here is the table with the extracted data represented in YAML format: {INTERVENTION:[{""mean"":8.43,""standard_deviation"":5.04,""group_size"":44},{""mean"":8.57,""standard_deviation"":5.24,""group_size
---
The YAML format is a standard text-based format for serializing and transporting data structures. It is a human-readable alternative to the binary JSON (JavaScript Object Notation) format.
---
intervention:
---
{% set outcome = 'Psychological flexibility' %} {% set comparator = 'Control' %} {% set intervention = 'Intuitive Eating and Acceptance and Commitment Therapy' %} {% set intervention_group_size = 40 %} {% set comparator_group_size
---
{  ""intervention"": {  ""mean"": 36.975,  ""standard_deviation"": 7.315,  ""group_size"": 40 },  ""comparator"": {  ""mean"": 30.505,  ""standard_deviation"": 7
---
intervention: mean: 9.991standard_deviation: 3.573intervention: group_size: 1comparator: mean: 9.484standard_deviation: 3.377comparator: group_size: 1
---
{
---
intervention:mean: -1.34, -1.64standard_deviation: -2.34, 1.11group_size: 111comparator:mean: -0.99, -1.30standard_deviation: -2.55, 0.1
---
intervention: mean: 4.20 standard_deviation: 3.81 group_size: 102 comparator: mean: 3.53 standard_deviation: 3.81 group_size: 102
---
",True
606,11583,115849,Discontinuation due to lack of efficacy,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention:
---
intervention: mean: 0.11 standard_deviation: 3.78 group_size: 50 comparator: mean: <1 standard_deviation: 2.68 group_size: 49
---
""intervention"": { ""mean"": 0.00, ""standard_deviation"": 6.23, ""group_size"": 172 }, ""comparator"": { ""mean"": 0.00, ""standard_deviation"": 19.55, ""group_size"": 2
---
",True
684,13506,5777419,reduction of plaque,antibiotic,placebo,continuous,,16,,15,31.8,14.8,27.4,13,0.30695109,0.13068633,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[1099, 1320, 1023]","intervention: mean: 0.14 standard_deviation: 0.06 group_size: 16 comparator: mean: 0.13 standard_deviation: 0.07 group_size: 16
---
The YAML code for the information from the given trial article for the comparison between the ""antibiotic"" and ""placebo"" for the outcome of ""reduction of plaque"" (given in standard deviation units) is:
---
intervention:mean:7.59standard_deviation:10.5group_size:15comparator:mean:9.55standard_deviation:12.17group_size:16
---
",True
578,8564,2952311,Muscle hardness,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1591],"intervention:{ mean:52.667 standard_deviation:9.443 group_size:11 comparator: { mean:52.3 standard_deviation:5.18 group_size:11 out come :X
---
",True
534,7794,3508963,Pain relief,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,1.13,1.15,2.23,1.57,-0.7968282,0.01798945,,,,,Values from 30 minutes.,TRUE,3561,2387,TEST,1552,"[1557, 216]","intervention: mean: 1.5 group_size: 120 comparator: mean: 0.1 group_size: 120
---
{ interventi{n: ""intravenous lidocaine"" group_size: 118 mean: ""1.37"" standard_deviation: ""1.13"" comparator: ""intravenous morphine"" group_size: 111 mean: ""1.86"" standard_
---
",True
151,11147,4996097,"n"" consonant improvement",Septoplasty,Control,continuous,,33,,30,11897,,13229,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,"[1428, 1251, 776]","intervention:
mean: NUMBER
---
200:
---
intervention: mean: 3.00 standard_deviation: 5.00 group_size: 34
---
",True
393,1120,3577738,effectiveness,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[1637],"intervention: mean: 4.9 standard_deviation: 1.26 group_size: 482 comparator: mean: 4.4 standard_deviation: 1.49 group_size: 482
---
",True
117,2983,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,No cooling,continuous,,9,,13,,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"[1626, 879]","intervention: mean: ""63.2"" standard_deviation: ""26.5"" group_size: ""19""comparator: mean: ""15.4"" standard_deviation: ""11.9"" group_size: ""13""
---
The ""standard deviations"" are not included in the figure legend. To solve this, we need to extract standard deviations from the figures. However, it is sometimes difficult/impossible to extract the standard deviation information from figures. In such cases, statistical methods or data visualization techniques such as a boxplot or scatter plots
---
",True
116,2982,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,Mild-cooling,continuous,,9,,10,,,70,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"[1626, 879]","intervention: mean: 63.2 standard_deviation: 13.3.group_size: 19 comparator: mean: 15.4 standard_deviation: 15.5 group_size: 14
---
intervention: mean: 2.5084606 standard_deviation: 1.0921973 group_size: 13 comparator: mean: 1.2287667 standard_deviation: 1.3577060 group_size:
---
",True
424,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,19.3,10.3,8.2,5.7,1.33530568,0.12603411,,,,,,TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","intervention: { mean: x standard_deviation: x group_size: 48 } comparator: { mean: x standard_deviation: x group_size: 55 }
---
intervention: mean: 3.83 standard_deviation: 1.19 group_size: 5 comparator: mean: 0.95 standard_deviation: 0.32 group_size: 11
---
intervention: mean: 9.50 standard_deviation: 8.32 group_size: 4
comparator: mean: 5.28 standard_deviation: 5.46 group_size: 4
---
intervention: mean: 2.1 standard_deviation: 0.7 group_size: 30 comparator: mean: 2.7 standard_deviation: 0.8 group_size: 34
---
intervention: mean: 13.8 standard_deviation: 3 group_size: 30 comparator: mean: 19.5 standard_deviation: 3.4 group_size: 34
---
",True
605,11583,115849,ACR20 responder criteria,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: {: mean: 0.48, standard_deviation: 0.28, group_size: 88}competitor: {: mean: 0.29, standard_deviation: 0.29, group_size: 45}
---
The data presented in the table are based on information given in the article. As mentioned in the methods, we extracted the data from the clinical trial article. The information presented in the YAML table is based on what is presented in the table in the article. The data extraction process and post-processing is described in the methods section. The
---
intervention:
---
",True
398,2241,4678179,Median overall survival (OS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,6.9,4.09,6.1,5.57,0.1625371,0.03786046,,,,,"Median is given with CI. Since the outcome explicitly says ""median"", including median values. Back calculated SD using CI.",TRUE,9517,6474,TEST,5204,"[715, 1652, 1614, 1177]","intervention: mean: 6.9 standard_deviation: 4.1115 group_size: 106 comparator: mean: 6.1112 standard_deviation: 4.1106 group_size: 106
---
intervention: group_size: NUMBERmean: 0.973898815326183standard_deviation: 0.166666666666667comparator: group_size: NUMBERmean: 0.973
---
intervention:
---
intervention: mean: 2.4 standard_deviation: 1.2 group_size: 298
---
",True
90,5540,3912320,"Correct response rate for 4,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],intervention: mean: 0.2734standard_deviation: 0.267730.12group_size: 19comparator: mean: 0.4586standard_deviation: 0.206960.9group_size: 10,False
599,11583,115849,investigator global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention:
mean: 2.71 3.18 2.89 2.85 2.6 2.95 2.78 2.9 2.9 2.82 2.62 2.88 3.04 2.
---
naproxen 500 mg twice daily:
mean: XXXX standard_deviation: XXXX group_size: XXXX placebo: mean: XXXX standard_deviation: XXXX group_size: XXXX
---
intervention: mean: 2.1 standard_deviation: 1.1 group_size: 46 comparator: mean: 2.9 standard_deviation: 1.1 group_size: 46
---
",True
207,5501,5380326,Tumor necrosis factor alpha,Vitamin D supplementation,Control,continuous,,40,,40,752.94,1890.16,548.33,1210.9,0.1277,0.0501,,,,,,TRUE,10658,5810,TEST,4260,"[618, 1669, 1370, 1494]","intervention:mean: NUMBERstandard_deviation: NUMBERgroup_size: NUMBER1494.2261026.777
---
intervention: mean: 52.2 standard_deviation: 5.7 group_size: 40 comparator: mean: 52.6 standard_deviation: 5.7 group_size: 40 outcome: Tumor necrosis factor alpha
---
intervention: { ""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": ""x"" }
---
# This is the data structure that is required in a YAML format for the model: # intervention group contains: # standard_deviation: 29.41.5213 group_size: 31 # comparator group contains: # standard_deviation: 29.4 1.52
---
",True
70,3041,3321528,ankle dorsiflexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1398, 1531]","intervention: {mean: 4.9, standard_deviation: 8.7, group_size: 28}control: {mean: 1.2, standard_deviation: 3.2, group_size: 31}
---
intervention: mean: 4.0 standard_deviation: 1.0 group_size: 28 comparator: mean: 3.0 standard_deviation: 1.0 group_size: 28
---
",True
206,5499,5380326,Dipeptidyl peptidase-4,Vitamin D supplementation,Control,continuous,,40,,40,6032.37,1359.15,6408.33,1822.17,-0.2316,0.0503,,,,,Table and text has conflicting numbers. Values are from Table.,TRUE,10658,5810,TEST,4260,"[618, 1669, 1370, 1494]","intervention:meanstandard_deviationgroup_sizeintervention:
---
intervention: mean: 770.27 standard_deviation: 642.02 group_size: 40comparator: mean: 665.61 standard_deviation: 665.61 group_size: 40
---
intervention:mean: 6137.29standard_deviation: 250.50group_size: 40comparator:mean: 6408.33standard_deviation: 288.11group_size: 40
---
intervention: mean: 24.399 standard_deviation: 1.6775 group_size: 49 comparator: mean: 271.04 standard_deviation: 98.172 group_size: 49 outcome: dipeptidyl pept
---
",True
275,6420,3654355,Fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-15.7,5.3,-0.4,5,-2.9163,0.0853,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: mean: ""83.56614"" standard_deviation: ""11.3196546"" group_size: ""139"" comparator: mean: ""77.36475"" standard_deviation: ""7.6498131
---
intervention:
---
intervention:
---
intervention: mean: 4.40; standard_deviation: 4.40; group_size: 282comparator: mean: NUMBER; standard_deviation: NUMBER; group_size: 280
---
intervention: 
mean: 15.903 16.883 22.5 15.13 19.18 23.46 22.3 standard_deviation: 8.445 8.638 57.1
---
",True
585,10216,3504298,Depressive symptoms,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,"[1656, 1393]","intervention:
mean: 1.245556666666667
---
intervention: mean: -4.88 standard_deviation: 7.26 group_size: 19 comparator: mean: -10.22 standard_deviation: 6.34 group_size: 19
---
",True
470,4800,5515881,center of pressure (CoP) sway velocity,demanding balance training program,relaxation group,continuous,,,,,0.63,0.11,0.67,0.18,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1670, 1268]","intervention:
---
intervention:
mean: x
---
",True
24,3244,2972614,Motion range - Shoulder flexion,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,168,22.65,174.31,14.98,-0.314,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"[838, 1256]","intervention: mean: 167.17746888097605 standard_deviation: 12.124187320118334 group_size: 22 comparator: mean: 148.318181
---
intervention: mean: 156.000 standard_deviation: 30.769 group_size: 37 comparator: mean: 167.500 standard_deviation: 21.141 group_size: 37
---
",True
401,2723,5268424,score on the general dimension scale of negative affects (referred to as NA from here onward),view a video featuring individuals that live in extreme poverty,control,continuous,,55,,50,21.036,6.327,17.68,5.859,0.5453569,0.03959808,,,,,,TRUE,12258,6615,TEST,4148,"[1235, 937, 1631, 648]","intervention: group_size: 239 comparator: group_size: 202 mean: 15.43 standard_deviation: 2.4 comparing_to: 19.28 na: intervention: mean: 16.2 standard_deviation: 4.19
---
intervention: mean: -0.7200 standard_deviation: 2.0500 group_size: 7 comparator: mean: -0.2900 standard_deviation: 2.5200 group_size: 9
---
Mean: 21.036
---
{ ""intervention"": { ""mean"": 4.12, ""standard_deviation"": 0.856, ""group_size"": 101 }, ""comparator"": { ""mean"": 4.16, ""standard_deviation"": 0.935, ""group_size"":
---
",True
283,6422,3654355,baseline visceral fat area,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,255.7,64.7,245.6,66.3,0.1538,0.0445,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: mean: 10.1 standard_deviation: 1.9 group_size: 128 comparator: mean: 10.8 standard_deviation: 1.8 group_size: 129
---
intervention:
---
intervention:
mean: −6.7
---
intervention:xstandard_deviation:xgroup_size:xxxcomparator:mean: 180 (SD, 103)standard_deviation: xgroup_size: x
---
intervention:
mean: 0.71
---
",True
6,11451,1574360,The amount of saturated fat in the foods purchased,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.77,1.37,0.04,0.32,0.7273,0.0086,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,[],intervention: mean: -0.66 standard_deviation: 0.35 group_size: 251 comparator: mean: standard_deviation: group_size: 246,False
423,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,22.3,13.2,14,5.6,0.8274306,0.06809386,,,,,,TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","* Intervention: short-bore MR scanner
---
intervention: { ""group_size"": 55, ""mean"": 31.7, ""standard_deviation"": 21.6, ""comparator"": { ""group_size"": 48, ""mean"": 19.8, ""standard_deviation"": 8.5 } }
---
intervention:
mean: 0.004996946218282405639800076443007448002869115470846
---
intervention: mean: 1.7832 standard_deviation: 0.6218 group_size: number = 30 comparator: mean: 2.5413 standard_deviation: 0.7083 group_size: number = 34
---
- intervention:
mean:18.1standard_deviation:11.5group_size:18
---
",True
428,3261,3475525,Scores on the saturated fat quiz,MTL group,No label group,continuous,,98,,99,90.7,20.4,33.6,16.3,3.08231109,0.0444184,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 73.30Standard_deviation: 6.90Group_size: 97comparator: mean: 72.50Standard_deviation: 13.20Group_size: 96
---
intervention: mean: 44.3 standard_deviation: 22.5 group_size: 98 comparator: mean: 35.7 standard_deviation: 12.6 group_size: 99
---
Consumer Understanding of Front of Package Nutrition Labels: Food and Beverage Ratingsa: No Label group, Control Group, Choices group, MTL group, MTL+Caloric Intake group, TL+SNL group,
---
intervention: mean:94.2 standard_deviation:4.1 group_size:278 comparator: mean:87.4 standard_deviation:4.4 group_size:278
---
",True
149,11146,4996097,"a"" vowel improvement",Septoplasty,Control,continuous,,33,,30,138,,154,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,"[1428, 1251, 776]","intervention: mean: 25 standard_deviation: 01 group_size: 33comparator: mean: 27 standard_deviation: 01 group_size: 30
---
The given article only has statistical information as P-values. P-values are difficult to be converted to the test statistic used in ANOVA or ANCOVA. In order to perform an accurate analysis we require original data (e.g., tables with values per subject and per group).
---
intervention:
mean: -0.762
---
",True
314,9841,4928400,Operative time,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,74.1,12.2,78,6.4,-0.3985,0.0973,,,,,found in table,TRUE,4037,2288,TEST,1670,[1630],"intervention:
---
",True
644,12880,5830087,progression-free survival,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,"[966, 1275, 1632, 1659, 157, 1914, 831, 989]","intervention: mean: 3.5872 standard_deviation: 1.9552 group_size: 119 comparator: mean: 4.3782 standard_deviation: 2.007 group_size: 92
---
The YAML format would be the following: intervention: mean: NUMBER; standard_deviation: NUMBER; group_size: NUMBERcomparator:
---
{intervention: [ {mean: 11.6 standard_deviation: 2.5 group_size: 50} ]] comparator: [ {mean: 9.6 standard_deviation: 2.5 group_size: 23} ]}
---
intervention:
---
intervention: mean: N number
---
intervention:
group: intervention or control group name here.
---
> intervention: mean: 179.95 standard_deviation: 164.99 group_size: 65 comparator: mean: 199.35 standard_deviation: 126.88 group_size: 66
---
intervention:
---
",True
670,13297,4987981,IL-6 and TNF-α levels,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","intervention: mean: 300.52 standard_deviation: 230.58 group_size: 35 comparator: mean: 449.19 standard_deviation: 272.75 group_size: 35
---
intervention: mean: 97.6 standard_deviation: 20.8 group_size: 23 comparator: mean: 99.0 standard_deviation: 36.0 group_size: 23
---
{
""intervention"": {
""mean"": 11.2,
---
intervention: mean: -0.6 standard_deviation: 3.1 group_size: 23 comparator: mean: -0.4 standard_deviation: 1.7 group_size: 23 outcome: IL-6 mean: -2.5 standard_deviation: 17.2
---
intervention: mean: 5.60 standard_deviation: 4.10 group_size: 44
---
",True
673,13314,4550271,treatment according to guidelines,provider,control,continuous,,14,,12,36.4,32,22.6,23,0.47332022,0.15907021,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[946, 1631, 54, 2187, 1659, 153, 2173, 1311]","This is in ""RCT (Randomized Controlled Trial) Protocol"" format. Note that this is different from the ""Clinical Trial Protocol"" format, because we require two different protocols for data and methods extraction each for intervention and comparator arms of the trial. We need two different protocols because the trial authors in
---
intervention: mean: 0.48 standard_deviation: 0.21 group_size: 1446 comparator: mean: 0.42 standard_deviation: 0.20 group_size: 808
---
intervention: mean: 40.5 standard_deviation: 10.1 group_size: 1182 comparator: mean: 41.3 standard_deviation: 9.5 group_size: 665
---
intervention:
---
provider: mean: 61.9% (of fever cases) standard_deviation: 34.0% group_size: 6 control: mean: 61.9% standard_deviation: 34.0% group_size: 6
---
intervention: mean:0.84 standard_deviation:0.15 group_size:558 comparator: mean:0.68 standard_deviation:0.20 group_size:560
---
*Providers*: mean: 6.8; standard_deviation: 3.2; group_size: 12. YAML: [/home/documents/temp/ClinicalTrialsCitation-1.pdf]: page: 10 ""The treatment guidelines, designed for lay community health workers
---
provider:
---
",True
267,12440,2596788,GERD-knowledge,education,control,continuous,,102,,109,,,,,cannot calculate,cannot calculate,,,,,no standard deviations given or mean differences,FALSE,5143,3554,TEST,2520,"[1622, 909]","intervention:
---
intervention_comparator_outcome: [ { { ""intervention"": { ""mean"": ""9.1"", ""standard_deviation"": ""1.4"", ""group_size"": 129 }, ""comparator"": { ""mean"": ""7.1"", ""standard_deviation"": ""1.7"", ""
---
",True
103,1886,4188762,heart rate,remifentanil,ketamine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[1441],"intervention:mean: 1.81standard_deviation: 0.58group_size: 28
---
",True
411,3260,3475525,Correct selection of the healthier product,choices group,TL+SNL group,continuous,,98,,95,72.5,13.2,65.8,7.3,0.62309408,0.02173622,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 67.8 standard_deviation: 10.3 group_size: 96 comparator: mean: 65.8 standard_deviation: 7.3 group_size: 99
---
intervention:
number: 98; unit: groups; size: 98; mean: 77%; standard_deviation: 0.3; group_size: 98
---
intervention: group_size: 95 comparator: group_size: 90 92.3 standard_deviation: 15.5 mean: CORRECT SELECTION OF THE HEALTHIER PRODUCT intervention: group_size: 94 comparator: group_size: 89
---
{% set ""intervention_mean"" = 9.27 %} {% set ""intervention_sd"" = ""2.2"" %} {% set ""comparator_mean"" = 9.87 %} {% set ""comparator_sd"" = ""1.9"" %}
---
",True
162,7712,5056957,BMI reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,21.86,6.22,22.06,5.68,-0.0333,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1657, 626, 2074, 1039]","intervention: mean: −2.550625 standard_deviation: 45.30987551926 group_size: xx = <100> y = <100>
---
intervention: mean435.5185 standard_deviation55.5967 group_size1953 comparator: mean443.7333 standard_deviation60.3231 group_size1882 Outcome: BMI reduction [kg/m2
---
intervention: mean: 0.0 mean_group_size: 593 standard_deviation: 0.171 group_size: 593comparator: mean: 0.167 mean_group_size: 459 standard_deviation: 0.258 group
---
intervention: mean: 0.0463 standard_deviation: 0.0342 group_size: 645comparator: mean: 0.3827 standard_deviation: 0.2273 group_size: 505
---
",True
408,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,No label group,continuous,,90,,99,73.3,6.9,67.8,10.3,0.61923041,0.02222653,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 73.3 standard_deviation: 6.9 group_size: 89
---
intervention:mean:89.94standard_deviation:8.93
---
intervention: mean: 0.55 standard_deviation: 0.57 group_size: 98 comparator: mean: 0.654 standard_deviation: 0.7 group_size: 99
---
intervention: mean: 0.89 std_deviation: 0.04 group_size: 62 comparator: mean: 0.08 std_deviation: 0.02 group_size: 62
---
",True
529,6915,4411165,effects of cryostimulation on the ANS - heart rate,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-7.7,2.3,-5.02,1.07,-1.430817,0.25118093,,,,,"Changed from original outcome but adding ""- heart rate"" to make it more specific. Numbers are mean change.",TRUE,3146,2589,TEST,2336,"[1632, 485]","intervention: mean: -12.3 standard_deviation: 4.8 group_size: 10comparator: mean: -8.6 standard_deviation: 4.7 group_size: 10
---
For the first trial, the total population is an adult population. The subjects were 15–65 years old; hence, the mean body mass index was taken from this same bracket range of age. The group sizes for intervention and comparator are 12 each. The outcome is changes in heart rate from pre- to post-
---
",True
7,11452,1574360,the average cost of the food,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.63,0.4,0.62,0.36,0.0261,0.008,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,[],intervention: mean: 0.66 standard_deviation: 0.22 group_size: 227 comparator: mean: 0.98 standard_deviation: 0.05 group_size: 224 intervention_comparator_group_size: 451,False
594,11583,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean: 1.8 standard_deviation: 1.4 group_size: 87comparator: mean: 2.5 standard_deviation: 2.0 group_size: 83
---
intervention:mean: - x-xstandard_deviation: - xgroup_size: - xcomparator:mean: - x-xstandard_deviation: - xgroup_size: - x
---
intervention:
---
",True
147,1273,4880652,"systolic blood pressures at 5, 10, 15, and 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 3's graphics.,FALSE,1406,1149,TEST,966,[],intervention:,False
355,4498,5874317,Horizontal triple jump (non-dominant leg),Bilateral training,Unilateral training,continuous,,9,,9,5.71,0.71,5.7,0.45,0.016,0.2222,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[716, 3252, 976]","Bilateral training: mean: 42.3; standard_deviation: 7.5; group_size: 9Unilateral training: mean: 42.9; standard_deviation: 10.0; group_size: 9
---
intervention: group_size: n = 9comparator: group_size: n = 9outcome: horizontal triple jump (non-dominant leg)intervention: mean: 0.34 mean: 8.65 mean: 0.36 comparator: mean: 0.39 mean:
---
intervention:mean:0.18 (cm)standard_deviation:0.07 (cm)group_size:15comparator:mean:0.15 (cm)standard_deviation:0.04 (cm)group_size:14
---
",True
612,11584,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean: 1.15 standard_deviation: 0.75 group_size: 928comparator:mean: 1.69standard_deviation: 0.85group_size: 910
---
A YAML file is a plaintext file that is associated with the file extension.yaml or .yml. YAML stands for YAMA (JSON-like) files. Below is a sample YAML file for (1) etoricoxib 90 mg once daily, (2) naproxen 
---
intervention:
---
",True
698,5637,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Placebo group (P),continuous,,30,,30,137,61.3,62,37.2,1.45998637,0.08442967,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","intervention: mean: ""0"" standard_deviation: ""0"" group_size: ""0""comparator: meaningroupP: mean: ""28.3"" standard_deviation: ""2.5"" group_size: ""120""
---
intervention: mean: 7.7843 standard_deviation: 3.01374 group_size: 30 comparator: mean: 9.62 standard_deviation: 2.7462 group_size: 30
---
intervention: mean:2.782standard_deviation:0.787group_size:60comparator: mean:3.495standard_deviation:0.676group_size:60
---
intervention:mean: 2.8standard_deviation: 3.878group_size: 24comparator:mean: 2.107standard_deviation: 2.363group_size: 24
---
",True
648,13097,5976307,induction time,etomidate,propofol based on midazolam,continuous,,62,,62,2.46,0.993,2.21,1,0.24933056,0.03250873,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[1636],"Outcome: induction time
---
",True
584,10215,3504298,Depressive symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,"[1656, 1393]","intervention:
---
Depressive symptoms: {mean: 1.31, standard_deviation:2.41, group_size: 10.92}
---
",True
617,11602,1863515,absolute neutrophil count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-485,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"[1630, 1586]","intervention: mean: -0.43 standard_deviation: 0.13 group_size: 1,436comparator: mean: 1.77 standard_deviation: 0.74 group_size: 1,436
---
intervention: mean:−423standard_deviation:590group_size:754comparator: mean:82standard_deviation:625group_size:656
---
",True
110,9521,4319071,High-energy snack intake,Individual cognition and self-regulation processes intervention,Control,continuous,,459,,434,2.5,2.79,2.84,2.71,-0.1235,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[975, 2176, 811, 1363, 1589, 1399, 1753, 1361]","intervention:group_size: 456mean: 3.34standard_deviation: 2.98comparator:group_size: 434mean: 3.43standard_deviation: 3.16
---
intervention: mean: 3.51 standard_deviation: 3.24 group_size: 108 comparator: mean: 3.30 standard_deviation: 2.94 group_size: 108
---
intervention:mean: 13.1standard_deviation: 4.15group_size: 1338Comparator:mean: 12.7standard_deviation: 4.25group_size: 1325
---
intervention: mean: 3.50 standard_deviation: 0.25 group_size: 566 comparator: mean: 3.29 standard_deviation: 0.14 group_size: 569
---
intervention:
---
The YAML output is as follows:
---
intervention: {
""mean"": 0.86,
""standard_deviation"": 0.35,
---
intervention: mean: 0.00149908423959681standard_deviation: 0.3062234909874991group_size: 663comparator: mean: 0.001203
---
",True
12,12632,2667135,number of days with received courses of antibiotics,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,continuous,,103,,97,25.4,,13.5,,cannot calculate,cannot calculate,,,,,SD or CI is missing. Mean is given.,FALSE,11722,8106,TEST,5529,"[745, 1370, 1667, 1449, 915]","intervention: mean: 25.4 standard_deviation: 1.3 group_size: 103 comparator: mean: 13.5 standard_deviation: 0.9 group_size: 97
---
intervention: mean: x standard_deviation: x group_size: x comparator: mean: 13.5 standard_deviation: 9.49 group_size: x
---
intervention: mean: 13.0 standard_deviation: 6.4 group_size: 48 comparator: mean: 17.8 standard_deviation: 11.8 group_size: 43
---
intervention:
---
intervention:
---
",True
435,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.6,15.5,41.9,19.4,2.86225472,0.04310376,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 75.8 standard_deviation: 10.1 group_size: 90 comparator: mean:72.5 standard_deviation: 10.5 group_size: 120
---
intervention:
---
intervention: mean: 90.7 standard_deviation: 20.4 group_size: 92 comparator: mean: 92.3 standard_deviation: 15.1 group_size: 92
---
intervention:
---
",True
212,2913,5459456,lateral bending for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,9.2,0.9,9.6,1.1,-0.3762,0.2544,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention:
mean:37.75116.9264group_size:15comparator:mean:37.43677.35274group_size:8
---
intervention:
---
{Intervention:ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC, Comparator:Control, Outcome:lateral bending, Comparator2:ACVC, Outcome2:lateral bending, Mean:13
---
{intervention: 0.600/0.040/22comparator: 0.583/0.039/16}
---
intervention: mean: -0.4133294153764462 group_size: 12comparator: mean: -0.29152483925955050689178 group_size: 3
---
",True
422,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,18.1,11.6,9.3,5.5,0.97494517,0.11536073,,,,,,TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","{intervention: { mean: 39.25, standard_deviation: 8.56, group_size: 48 }, comparator: { mean: 20.74, standard_deviation: 6.30, group_size: 49 } }
---
intervention: { ""mean"": 12, ""standard_deviation"": 2, ""group_size"": 40 }
---
intervention: mean: 15.9 standard_deviation: 5.24 group_size: 5comparator: mean: 16.16 standard_deviation: 5.06 group_size: 16
---
intervention: mean:2.1 standard_deviation:1.1 group_size:30 comparator: mean:2.9 standard_deviation:0.7 group_size:34
---
intervention: mean: 18.1 standard_deviation: 11.6 group_size: 18 comparator: mean: 9.3 standard_deviation: 5.5 group_size: 22 :::NOTE:: This information is based on the numerical tabular data provided in the article
---
",True
387,1119,3577738,focused on the social presence elements in terms of frequency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[1637],"intervention:mean:40.34standard_deviation:0.00group_size:47 + 458comperator:mean:0.00standard_deviation:0.00group_size:98 + 482
---
",True
659,13178,5773985,the mean duration of postoperative analgesia,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,508.92,63.3,1840.84,819.51,-2.2556182,0.13087813,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"[1592, 407]","intervention: mean: ""4.15"" standard_deviation: ""0.52"" group_size: ""50"" comparator: mean: ""4.12"" standard_deviation: ""0.60"" group_size: ""50""
---
intervention: mean: 12 standard_deviation: 6.5 group_size: 20
---
",True
319,4723,5539943,reflections of sustain talk,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1650, 1319, 1031]","{intervention: mean: 3.340; standard_deviation: 2.69; group_size: 91comparator: mean: 2.90; standard_deviation: 2.58; group_size: 92}
---
intervention:mean:xstandard_deviation:xgroup_size:xcomparator:mean:xstandard_deviation:xgroup_size:x
---
intervention: group_size: 8 mean: 1.5435 standard_deviation: 0.5759 comparator: group_size: 8 mean: 0.9088 standard_deviation: 0.1552
---
",True
321,4725,5539943,"Frequency of client ""change talk"" (CT)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1650, 1319, 1031]","intervention: standard_deviation: 0.62 group_size: 45comparator: n/aoutcome:
---
intervention: mean: 25.45 standard_deviation: 10.83 group_size: 97comparator: mean: 31.86 standard_deviation: 20.7 group_size: 96
---
intervention: mean: 1.628 standard_deviation: 1.381 group_size: 46 comparator: mean: 0.413 standard_deviation: 0.518 group_size: 45
---
",True
73,3741,3546023,Urine cotinine levels,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.179,0.738,0.047,0.017,2.0036,0.1541,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: mean: 6.0718516 standard_deviation: 289.9552847866 group_size: 27 comparator: mean: 7.76796782060565 standard_deviation: 2
---
intervention: mean:10.601.69 group_size:58 comparator:mean:10.774.09 group_size:58 outcome: [ { ""baseline"":0.68,""followup"": 0.90,""followup_time"":""24 weeks""
---
intervention: mean: 24.735000 standard_deviation: 15.960000 group_size: 26 comparator: mean: 24.630000 standard_deviation: 18.510000 group_size:
---
intervention: mean: 33.128427 standard_deviation: 32.595845 group_size: 6 comparator: mean: 31.878268 standard_deviation: 31.034294 group_size: 
---
intervention:mean: 200.000standard_deviation: 0.015group_size: 60comparator:mean: 200.000standard_deviation: 0.015group_size: 60
---
intervention:mean:8.41328standard_deviation:4.02422group_size:67comparator:mean:8.46544standard_deviation:4.36211group_size:73
---
intervention: mean:6.770standard_deviation:7.400group_size:50comparator: mean:0.500standard_deviation:0.330group_size:50
---
intervention: mean: 2.000 standard_deviation: 0.600 group_size: 270comparator: mean: 2.000 standard_deviation: 0.564 group_size: 80
---
intervention:
---
{% assign ""intervention_group_size"" = ""24"" ""Comparator_group_size"" = ""11"" %}intervention {{ intervention_group_size }}comparator:{{Comparator_group_size}}
---
",True
457,4424,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],"intervention: {mean: 27.01, standard_deviation: 8.31, group_size: 10}comparator: {mean: 20.7, standard_deviation: 5.75, group_size: 20}",False
649,13097,5976307,total procedure time,etomidate,propofol based on midazolam,continuous,,62,,62,29.73,12.23,29.46,16.04,0.01881372,0.03225949,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[1636],"intervention: mean: 11.710 standard_deviation: 11.546 group_size: 124comparator: mean: 11.865 standard_deviation: 10.075 group_size: 124
---
",True
655,13175,5773985,mean volume of both the solutions used,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,4.15,0.52,4.12,0.6,0.05259525,0.08002766,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"[1592, 407]","intervention: { ""mean"": 4.15, ""standard_deviation"": 0.52, ""group_size"": 25 }
---
intervention: mean: 49.75 standard_deviation: 3.26 group_size: 36 comparator: mean: 49.17 standard_deviation: 3.73 group_size: 35
---
",True
611,11584,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean: 8.57 standard_deviation: 2.61 group_size: 353 comparator: mean: 8.63 standard_deviation: 2.52 group_size: 357
---
intervention: mean: -9.62 standard_deviation: 4.89 group_size: 353 
---
intervention:
---
",True
145,1272,4880652,heart rates,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 2's graphics.,FALSE,1406,1149,TEST,966,[],intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER,False
105,1885,4188762,mean blood pressure,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[1441],"intervention: mean: 36.73423422169 standard_deviation: 12.813376592167 group_size: 28 comparator: mean: 40.2350126592169 standard
---
",True
53,5307,3195393,Intermittent restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,5.1,0.07,0.7,0.02,9.6931,0.0498,,,,,Overall intermittent restraint rate for study site.,TRUE,15527,8380,TEST,5589,"[1670, 663, 1648, 1306, 708]","intervention:mean: NUMBERstandard_deviation: NUMBERgroup_size: NUMBERcomparator:mean: NUMBERstandard_deviation: NUMBERgroup_size: NUMBER
---
intervention:mean: 20.2standard_deviation: 20.3group_size: 148comparator:mean: 42.02standard_deviation: 0.02group_size: 148
---
intervention: std_deviation: 1.2293824745567244group_size: 11comparator: std_deviation: 0.4272199130510938group_size: 12
---
intervention:
mean: 0.37283615625122576
---
intervention: 0.40(1)±0.01(2)50(3)comparator: 0.60(1)±0.01(2)30(3)
---
",True
95,10163,4173437,Total blood loss,Tranexamic acid,Control,continuous,,30,,30,576,53,823,74,-3.7878,0.1862,,,,,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,[],intervention: mean: 123.45 standard_deviation: 10.2 group_size: 60 comparator: mean: 224.62 standard_deviation: 20.79 group_size: 60,False
403,2802,5781260,exercise-related loss of muscle strength,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 1227]","Placeholder for YAML output table:
---
Both placebo and lemon verbena groups show significant improvements in muscle strength and soreness in comparison to before intervention. However, the improvement in creatine kinase and plasma glutathione peroxidase was higher in the lemon verbena group.
---
",True
412,3262,3475525,Taste perception,MTL group,No label group,continuous,,98,,99,5.6,1.4,5.8,1.4,-0.1423069,0.02035649,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention:group_size: 101mean: 4.755standard_deviation: 1.932comparator:group_size: 99mean: 4.013standard_deviation: 2.072
---
intervention: mean: [0.471] standard_deviation: [0.498] group_size: [98] comparator: mean: [0.538] standard_deviation: [0.525] group_size: [98]
---
intervention: mean: 4.6 standard_deviation: 1.4 group_size: 98 comparator: mean: 4.1 standard_deviation: 1.4 group_size: 99
---
outcome:
---
",True
134,2449,4574984,Health-Related Quality of Life at 12 month - females,"intervention group, i.e. patient empowerment through information booklet and diary keeping - females","control group, which received standard care - females",continuous,,110,,95,61.07,30.21,63.27,24.79,-0.0788,0.0196,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,"[718, 1310, 1592, 928, 1664, 467]","intervention: mean: 69.4000 standard_deviation: 2.9100 group_size: 326comparator: mean: 69.6000 standard_deviation: 2.9000 group_size: 326
---
intervention: mean: 0.08 standard_deviation: 0.01 group_size: 326
---
intervention: mean:50.77769116699893standard_deviation:8.667304754381462group_size:120comparator: mean:50.416833256299
---
intervention:
mean: 69.27
standard_deviation: 8.73 (or, 0.1)
---
intervention: {""standard_deviation"":""SD"" ,""mean"":""Mean"" ,""group_size"":""n.""}
---
intervention:mean:0.48standard_deviation:24group_size:105
---
",True
575,8562,2952311,Verbal rating scale pain intensity,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1591],"intervention: mean: 1.400 standard_deviation: 1.030 group_size: 33
comparator: mean: 1.400 standard_deviation: 1.030 group_size: 33
---
",True
660,13179,5773985,number of analgesic tablets,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,1.64,0.99,0.8,1.08,0.7980815,0.08636934,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,"[1592, 407]","intervention: { ""mean"": ""5.08"", ""standard_deviation"": ""0.63"", ""group_size"": ""50"" }
---
intervention: mean: 29group_size: 94comparator: mean: 106standard_deviation: 27.9comparator: group_size: 22
---
",True
328,5375,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 64 mg,continuous,,5,,4,1,2.23,1.25,2.5,-0.0945,0.4505,,,,,found in table,TRUE,1146,884,TEST,721,[],intervention:,False
450,4005,4879328,weekly moderate physical activity sessions,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.19,1.82,-0.68,2.32,0.41353429,0.01877954,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[989, 1648, 1674, 1355, 1003]","intervention:mean:5.96standard_deviation:4.62group_size:114comparator:mean:5.22standard_deviation:3.44group_size:114
---
intervention: {mean: 97.76168,standard_deviation: 83.725614,group_size: 102}
---
intervention: {: mean: 4.3, : standard_deviation: 4.94, : group_size: 49}
---
intervention:mean:0.5standard_deviation:1standard_group_size:103comparator:mean:0.3standard_deviation:1standard_group_size:112
---
intervention: mean: 34.58 standard_deviation: 31.82 group_size: 104 comparator: mean: 21.84 standard_deviation: 35.98 group_size: 114
---
",True
352,4495,5874317,Change of direction improvement,Bilateral training,Unilateral training,continuous,,9,,9,5.46,0.2,5.67,0.16,-1.1042,0.2561,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[716, 3252, 976]","intervention: mean: 3.10 standard_deviation: 0.53 group_size: 9 comparator: mean: 3.13 standard_deviation: 0.68 group_size: 9
---
intervention: mean: 0.47 standard_deviation: 9.8 group_size: 10comparator: mean: 0.46 standard_deviation: 7.8 group_size: 7
---
intervention:mean: −0.019558368915501215standard_deviation: 0.5634620741016684group_size: 13comparator:mean: −0.406666
---
",True
451,4006,4879328,accelerometer-assessed moderate to vigorous physical activity (MVPA),"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,99,,108,7.41,66.12,-16.1,66.25,0.35389959,0.01966279,,,,,Values are from Accelerometer PA in Table 2. Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[989, 1648, 1674, 1355, 1003]","intervention:
---
intervention: mean:000Standard_deviation:000Group_size:000comparator: []means: [000]standard_deviation: [000]Group_size: [000]
---
intervention:
mean: 41.66104459271354138242
---
intervention: mean: x standard_deviation: x group_size: 104comparator: mean: x standard_deviation: x group_size: 114
---
intervention: { mean: -24.16 standard_deviation: 51.41 group_size: 100}
---
",True
218,2912,5459456,blood loss,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,56,19,51,20,0.2423,0.2518,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","In the YAML format, the table of mean outcome and standard deviation for this trial is:
intervention: ACVC-HA vs ACVC mean:55±18 standard_deviation:24.97 group_size:5 comparator: ACVC mean:56±19 standard_deviation
---
Only include if there is an interaction effect in the multivariate statistical model
---
intervention: {mean: 2.5, standard_deviation: 1.3, group_size: 14}comparator: {mean: 2.7, standard_deviation: 1.5, group_size: 27}
---
Comparator: anterior cervical corpectomy and fusion (ACCF) Outcome: blood loss Group: Group D, Group A Intervention: ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC Group: Group D, Group A
---
intervention: mean:0.3772standard_deviation:0.1561group_size:35comparator: mean:0.5436standard_deviation:0.4557group_size:35
---
",True
427,3404,3877023,The mean signal-to-noise (SNR) values,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,44,,49,17.97,6.58,11.28,4.35,1.20253898,0.05091017,,,,,,TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","intervention: mean:39.38standard_deviation:0.50group_size:8comparator: mean:38.5standard_deviation:0.50group_size:12
---
intervention: { ""group_size"": 48, ""mean"": 8.97, ""standard_deviation"": 2.55 }
---
intervention:
mean: 53.47857142857143
---
comparator: mean:17.97standard_deviation:6.58group_size:11intervention: mean:11.28standard_deviation:4.35group_size:14comparator: mean:11.28standard_deviation:4.35group
---
intervention: mean: 16.9 standard_deviation: 3.4 group_size: 30 (18 for comparison)
---
",True
671,13313,4550271,Community knowledge,provider,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,"[946, 1631, 54, 2187, 1659, 153, 2173, 1311]","{ : interventions: ""provider"": { : Comparator: ""control"", : Outcome: ""Community knowledge"" } : control: { : Comparator: ""control"", : Outcome: ""Community knowledge"" } : provider_school: { : Comparator: ""control"", : Outcome: ""Community knowledge"" }
---
{  ""intervention"": {""mean"": 44, ""standard_deviation"": 38, ""group_size"": 388},  ""comparator"": {""mean"": 38, ""standard_deviation"": 38, ""group_size"": 784}  }
---
intervention: mean: 92.0 standard_deviation: 12.0 group_size: 22888 comparator: mean: 91.0 standard_deviation: 11.9 group_size: 22888
---
provider: mean: 97.048 standard_deviation: 92.74335 group_size: 100control: mean: 55.723 standard_deviation: 53.606591 group_size: 488
---
::: type: table  title: Trial results description: Table to determine the effect of interventions on malaria testing data.  response: ""Intervention,Comparator,Outcome"" 1:""Provider,Control,Testing"" 2:""Provider school,Control,Testing"" 3:""Provider,Control,Prescribing""
---
intervention:
mean: 66.1488129714170677498230.3240655957142903comparator:90.6093223776434366
---
intervention:mean: 62.1standard_deviation: 32.24group_size: 15129comparator:mean: 72.92standard_deviation: 34.58group_size: 490
---
provider:mean:17.4920standard_deviation:7.3403group_size:536control:mean:9.5278standard_deviation:8.3439group_size:536
---
",True
210,2913,5459456,inflexion-extension for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.3,1.3,0.2,0.3708,0.2543,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention: mean: 8.53842974869725standard_deviation: 1.97404432993081group_size: 28comparator: mean: 57.81935678999
---
intervention: mean:6.5000standard_deviation:1.1111group_size:44comparator: mean:6.3000standard_deviation:1.1111group_size:37
---
intervention: {mean: -13.1°, standard_deviation: -2.2°, group_size: 12}
---
outcome: flexion_extension_C2-C4_Segment10.1371/journal.pone.0178775.t004 Motion Group A:
---
intervention: mean: 5.36 standard_deviation: 2.45 group_size: 29 comparator: mean: 3.26 standard_deviation: 1.65 group_size: 24
---
",True
692,5635,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Duloxetine (D),continuous,,30,,30,137,61.3,91.7,35.5,0.89262531,0.0733065,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","The required YAML table and the corresponding extracted information in the original article as a comment in the YAML file, are the following: ---intervention: mean: 10.2000709standard_deviation: 6.0000513group_size: 30comparator
---
duloxetine 60 and etoricoxib 120mg(group D/E) intervention { mean = 81.5; standard_deviation = 21.5; group_size = 30} duloxetine comparator { mean = 81.5; standard
---
All three authors have independently read and understood the instructions and checked the completed data extraction form against each other’s work. Any disagreements on the extracted data were resolved through consensus or consulting a fourth reviewer.
---
intervention: mean:19.320standard_deviation:9.212group_size:2349intervention: mean:15.346standard_deviation:5.974group_size:2369comparator: mean:14.295standard_
---
",True
630,12235,3510731,Median time in seconds (interquartile range) - Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,3.5,,3.6,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,[],intervention:,False
140,1275,4880652,SpO2 at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 5's graphics.,FALSE,1406,1149,TEST,966,[],"Yes, that is correct. The number in the square brackets [] indicates that there are multiple measurements taken that are listed one after the other. For VAS, the numbers indicate the timepoints after the surgery at which the measurements were taken. For HR, SBP, DBP, and SpO2, the number after the ""at",False
372,226,1475568,Knowledge about heart failure,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,"[1439, 1156]","""intervention: { ""mean"": 2.5, ""standard_deviation"": 0.5, ""group_size"": 48, ""pre_intervention"": 1.2}, { ""comparator"": { ""mean"": 2.3, ""standard_deviation"": 0.7, ""
---
intervention: mean:55.99 standard_deviation:7.39 group_size:59 comparator: mean:54.44 standard_deviation:4.96 group_size:59
---
",True
504,6485,5419060,Phlebotomy questionnaire score: CHC B,Phlebotomy training programme,Control,continuous,,23,,23,93,1.37,58,7.12,6.70952589,0.57627976,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1537, 528, 1598, 748]","intervention:
---
intervention:
mean: 28.1000000000000022222233333333333333333333333333333333333333
---
intervention: mean:29.5468standard_deviation:6.6576023group_size:18comparator:
---
intervention:mean: 60.78standard_deviation: 13.63group_size: 101comparator:mean: 53.27standard_deviation: 15.09group_size: 101
---
",True
326,5373,5559992,Anxiety,Buprenophine 64 mg,No treatment,continuous,,4,,4,1.25,2.5,26.5,14.7,-2.0802,0.7704,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],intervention: mean: 2.2 x standard_deviation: 0.6 group_size: 5 comparator: mean: 2.7 x standard_deviation: 0.0 group_size: 5,False
407,2806,5781260,Interleukin 6,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Numerical values are not given.,FALSE,4385,3505,TEST,2662,"[1670, 1227]","intervention: mean: 1.121 standard_deviation: 0.54 group_size: 20 comparator: mean: 1.143 standard_deviation: 0.48 group_size: 20
---
intervention:
---
",True
515,6552,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 2400 mg,Control,continuous,,,,,-52.7,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,"[1205, 1677, 1566, 907]","intervention:
mean: 28.700000
---
Mean: 39.1 SD: 12.5
---
intervention: {mean: 84.5, standard_deviation: 25.8, group_size: ""2400 mg"": 123}comparator: {mean: 22.9, standard_deviation: 25.5, group_size: ""placebo"": 
---
intervention: mean: 54 standard_deviation: 14.5 group_size: 202 comparator: mean: 12 standard_deviation: 13.5 group_size: 207
---
",True
555,9721,3648394,Flexibility,10-week yoga program,Control,continuous,,18,,19,31,8.7,26.4,10.4,0.46823146,0.11114985,,,,,Numerical values are from Week 11 data for sit and reach test.,TRUE,9556,6245,TEST,4261,"[1586, 970, 1651, 518]","comparator:
---
intervention: { ""mean"": 28.56, ""standard_deviation"": 10.02, ""group_size"": 21 }
---
This task of converting the given table in TEXT format into YAML format requires extracting information about the outcome mean, standard deviation, and group size from each intervention and control arm, and converting to the appropriate YAML format. I am able to do this successfully for the given information and create the YAML output. Here
---
intervention:
---
",True
559,9833,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Casein shake (Placebo),continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1672, 1417]","intervention:
---
intervention: mean: 20.53 standard_deviation: 5.57 group_size: 16comparator: mean: 17.56 standard_deviation: 8.21 group_size: 26
---
",True
442,8805,4467620,accuracy of the cognitive tasks,Exercise - Hot + Cooling conditions,At rest - Hot + Cooling conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"[1636, 1448]","Here. A "">"" symbol, as shown, is used for the ""acc"" value in the comparator group.
---
intervention: mean: 0.37 standard_deviation: 0.22 group_size: 8 comparator: mean: 0.37 standard_deviation: 0.22 group_size: 8
---
",True
184,4337,5122613,Improvement in faeces consistency,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,3.4,1,3.2,0.5,0.25,0.0611,,,,,,TRUE,6184,3742,TEST,2832,"[1633, 1102]","intervention:mean:2.65standard_deviation:2.31group_size:41+[/INTERVENTION]comparator:mean:2.99standard_deviation:3.01group_size:41
---
intervention: mean: 32.8 standard_deviation: 30.9 group_size: 17comparator: mean: 9.4 standard_deviation: 23.8 group_size: 17
---
",True
74,3742,3546023,serum α1-antitrypsin,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.75,0.39,1.45,0.24,0.867,0.0936,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: standard_deviation: 5.52 group_size: 56 comparator: standard_deviation: 3.16 group_size: 56
---
intervention: mean: 1.98 standard_deviation: 0.27 group_size: 34 comparator=<none_given>
---
intervention: mean: 7.01257 standard_deviation: 4.58588 group_size: 75 comparator: mean: NUMBER standard_deviation: NUMBER group_size: 77
---
intervention:
---
intervention: mean: 1.392 standard_deviation: 0.289 group_size: 12 comparator: mean: P<0.03 standard_deviation: P<0.035 group_size: 12
---
{intervention: 200 mg/day palmvitee smokers, comparator: 200 mg/day palmvitee smoke non smokers, mean: 0.030, standard_deviation: 0.008, group_size: 47}
---
{ ""intervention"": { ""mean"": 1.17, ""standard_deviation"": 0.55, ""group_size"": 115 }, ""comparison"": { ""mean"": 1.43, ""standard_deviation"": 2.86, ""group_size"": 1
---
The table of mean outcome and standard deviation in YAML (intervention, comparator, and serum α1-antitrypsin) is as follows: intervention: mean: 9.44 standard_deviation: 2.42 group {Intervention, Comparator} =: [41,,
---
outcome: serum alpha-1 antitrypsin
---
intervention:
---
",True
221,2914,5459456,Flexion-Extension stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.34,0.12,7.47,1.45,-6.5512,1.5912,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention: mean: 9280 standard_deviation: 33080 group_size: 29 comparator: mean: 9282 standard_deviation: 33136 group_size: 18
---
intervention: mean:4.10xstandard_derivation:0.64xgroup_size:8comparator: mean:3.6xstandard_derivation:0.6xgroup_size:8outcome: Flexion-Extension stiffness of C2-4
---
intervention: 
mean: 0.63 ✝ 0.30 ✝ 0.33 ✝ 7.20 ✝ 0.13 ✝ 0.05 ✝ 0.21 ✝ 
---
intervention: mean: 0.69 standard_deviation: 0.20 group_size: 10 comparator: mean: 0.35 standard_deviation: 0.12 group_size: 30
---
intervention:mean: 44.065standard_deviation: 44.065group_size: 29comparator:mean: 222.07standard_deviation: 28.2738group_size: 8
---
",True
329,5376,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 96 mg,continuous,,5,,5,1,2.23,0,0,0.5725,0.4164,,,,,found in table,TRUE,1146,884,TEST,721,[],intervention:mean: 5.2standard_deviation: 5.0group_size: 124comparator:mean: 5.9standard_deviation: 4.5group_size: 120,False
279,6422,3654355,baseline body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,128.9,19.4,127.1,21.6,0.0888,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1464, 1287, 1114, 2408, 1579]","intervention: mean: 114.457131 kilograms standard_deviation: 20.32297694692891 group_size: 71
---
intervention: mean: 128.9 standard_deviation: 19.4 group_size: 71 comparator: mean: 127.1 standard_deviation: 21.6 group_size: 33
---
intervention:mean: 62.20standard_deviation: 9.80group_size: 96comparator:mean: 62.26standard_deviation: 10.49group_size: 241
---
intervention: {:mean: 87.1, :standard_deviation: 13.0, :group_size: 6}[comparator: {:mean: 88.5, :standard_deviation: 13.0, :group_size: 6}]
---
intervention: mean: -1.523 standard_deviation: 60.169 group_size: 1 comparator: mean: -1.523 standard_deviation: 60.169 group_size: 4
---
",True
679,13506,5777419,attachment gain,probiotic,placebo,continuous,,16,,15,3.4,0.6,4.3,1.4,-0.8236508,0.14010861,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[1099, 1320, 1023]","intervention: mean:0.266666666666667standard_deviation:0.0847849888092274group_size:16comparator: mean:0.2583333333333
---
- Intervention: probiotic, mean: 4.1, standard_deviation: 1.4, group_size: 16#Comparison: placebo, mean: 3.9, standard_deviation: 1.4, group_size: 15Outcome: attachment gain
---
intervention: mean: 0.575771796379standard_deviation: 1.12276102204group_size: 192comparator: mean: 0.88888888889standard_deviation:
---
",True
201,7738,5380284,Pain scores 24 hours and 72 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:",False
69,3041,3321528,knee extension,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1398, 1531]","intervention: mean: 24.350 comparator: mean: 17.340 group_size: 28 group_size: 28
---
intervention: mean: 5 standard_deviation: 5 group_size: 16comparator: mean: 4 standard_deviation: 3 group_size: 24
---
",True
284,6301,3929816,Baseline characteristics and general anesthesia procedure,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,[],intervention: mean:12.13 standard_deviation:3.49 group_size:10comparator: mean:20.45 standard_deviation:5.3 group_size:10,False
531,7830,4230312,improvement of disorder,quetiapine 600 mg/day,placebo,continuous,,289,,204,-14.88,10.54,-11.61,10.12,-0.3148988,0.00846274,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,"[1608, 1576, 1434]","{intervention:mean:4.60;standard_deviation:0.62;group_size:289}{comparator:mean:2.77;standard_deviation:0.49;group_size:204}
---
improvement of disorder: ""0""
---
The YAML format is not specified since the YAML extract is the best output, so that the end-user can adapt it to the other applications if needed, hence having more flexibility (e.g., using a JSON form when the end-user demands is). We could change the YAML format to JSON upon user demands by
---
",True
664,13296,4987981,FPG,metformin,placebo,continuous,,21,,23,101.9,35.1,97.6,20.8,0.14806913,0.09134645,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","The YAML format should include the following fields for each Intervention and Comparator:
---
intervention: mean: 122 standard_deviation: 21 group_size: 26
---
intervention:mean: 222.50standard_deviation: 72.67group_size: 39comparator:mean: 240.44standard_deviation: 73.79group_size: 31
---
{ ""metformin"": { ""group_size"": 21, ""mean"": 15.2, ""standard_deviation"": 19.2} }
---
intervention: mean: x.23 standard_deviation: x.45 group_size: 32
---
",True
437,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,No label group,continuous,,90,,99,94.1,15.6,42.6,20.7,2.78020714,0.04166067,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 73.3 standard_deviation: 6.9 group_size: 96comparator: mean: 67.8 standard_deviation: 10.3 group_size: 97
---
intervention: group_size: 90 mean: 62.89 standard_deviation: 16.21 comparator: group_size: 98 mean: 66.01 standard_deviation: 11.57
---
intervention: mean: 31.5 standard_deviation: 9.7 group_size: 18 comparator: mean: 79.4 standard_deviation: 14.9 group_size: 18
---
intervention:mean:0.07152standard_deviation:0.04016group_size:279comparator:mean:0.06253standard_deviation:0.04118group_size:277
---
",True
533,8166,5800236,Months of sick leave,Nacadia® nature-based therapy,Cognitive behavioral therapy,continuous,,37,,35,,,,,cannot calculate,cannot calculate,,,,,Numerical values were not given for this outcome.,FALSE,4517,2571,TEST,1980,"[1537, 567]","{ ""intervention"": { ""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": ""x"" }, ""comparator"": { ""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": """" } }
---
intervention: mean: 8.40 standard_deviation: 2.60 group_size: 34 comparator: mean: 7.60 standard_deviation: 3.20 group_size: 30
---
",True
699,5638,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),etoricoxib (E),continuous,,30,,30,137,61.3,105.3,28.4,0.6549502,0.07024133,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","intervention: mean: 26.930 standard_deviation: 15.890 group_size: 38.0 comparator: mean: 24.270 standard_deviation: 14.970 group_size: 38.0
---
intervention: mean: 22.766 standard_deviation: 11.433 group_size: 87 comparator: mean: 26.166 standard_deviation: 11.533 group_size: 87
---
intervention: mean: 5.66 standard_deviation: 2.14 group_size: 30comparator: mean: 4 standard_deviation: 2.14 group_size: 30
---
intervention: mean: 6.28 standard_deviation: 2.11 group_size: 30 comparator: mean: 6.86 standard_deviation: 2.07 group_size: 30
---
",True
222,2914,5459456,Lateral bending stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.05,0.02,2.67,0.68,-5.1485,1.0784,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","intervention:
---
intervention: mean:4.7284227times_repeated: standard_deviation:3.421995022for:group_size:after_intervention:25after_comparator:30Intervention 3 (C4-5):Group A (Control)Group
---
intervention: mean: 3.2845 standard_deviation: 0.4821 group_size: 13 comparator: mean: 3.6271 standard_deviation: 0.9764 group_size: 13
---
intervention: mean: 0.452 standard_deviation: 2.478 group_size: 4 comparator: mean: 0.191 standard_deviation: 1.123 group_size: 8
---
intervention: mean: 49.5 standard_deviation: 3.1 group_size: 40 comparator: mean: 44.7 standard_deviation: 2.7 group_size: 24
---
",True
596,11583,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","Here's the YAML format for the information:comparator:mean: 3.205standard_deviation: 2.628group_size: 12intervention:mean: 5.044standard_deviation: 3.068group_size: 12
---
To extract the data from the table, I'm using the table1.csv file which contained the table data. The code below is used to extract the results for ACR20 responder criteria. Please note that the response value is the percentage of responders.
---
intervention: mean: 65.2 standard_deviation: 9 group_size: 386 comparator: mean: 55.8 standard_deviation: 9 group_size: 380
---
",True
383,949,3278655,maximum total point motion (MTPM),The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,0.98,3.91,0.79,2.27,0.0556,0.0926,,,,,Back calculated the SD values from CI. Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,"[1649, 1417]","intervention: {  ""mean"": 0.15, ""standard_deviation"": 0.42, ""group_size"": 28 } comparator: { ""mean"": 0.12, ""standard_deviation"": 0.37, ""group_size"": 27 }
---
intervention: { ""group_size"": { ""intervention"": 30, ""control"": 30 }, ""mean"": 22, ""standard_deviation"": ""0.9"" }
---
",True
591,11583,115849,Tender joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","- intervention: mean: 29 standard_deviation: 15 group_size: 374 comparator: mean: 29 standard_deviation: 15 group_size: 132
---
intervention:
---
intervention: mean: 17.72338298565132 standard_deviation: 8.48948126074421 group_size: 227 comparator: mean: 20.565720507
---
",True
694,5636,5712123,postoperative pain on movement,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,3.5,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","intervention:
---
intervention: mean: 5.6 group_size: 22 comparator: mean: 7.4 group_size: 22
---
intervention:
---
intervention: mean: 1.3 standard_deviation: 1.3 group_size: 30 comparator: mean: 12.3 standard_deviation: 3.7 group_size: 30
---
",True
619,11603,1863515,leucocyte count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,8818,,8362,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"[1630, 1586]","intervention: mean: 123 standard_deviation: 32 group_size: 667 comparator: mean. x standard_deviation: x group_size: 667
---
intervention: mean: 0 group_size: 695 comparator: mean: 0 group_size: 546
---
",True
425,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,24,12.9,11.7,6.3,1.22140465,0.07440001,,,,,,TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","intervention:
mean: \ 0.004 38 \ standard\_deviation: 0.062 0.010 \ group\_size: 29 comparator: mean: \ 0.003 26 standard\_deviation: 0.049 0.
---
intervention:
mean: 29.880000000000003
---
intervention:group_size: 70mean:65.62standard_deviation:66.94comparator:group_size: 70mean:234.47standard_deviation:168.91
---
intervention: mean: -0.2852 standard_deviation: -0.1628 group_size: 42 comparator: mean: -0.1369 standard_deviation: -0.1293 group_size: 21
---
No numerical information for the Outcome is available in the given trial.
---
",True
158,7710,5056957,Weight reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,55.91,15.64,56.48,14.76,-0.0373,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1657, 626, 2074, 1039]","intervention: mean: -5.9 group_size: 253 comparator: mean: -3.8 group_size: 232
---
intervention: mean: -7.150 standard_deviation: 14.169 group_size: 175 comparator: mean: -0.984 standard_deviation: 7.603 group_size: 174
---
intervention: mean: 34.60 standard_deviation: 11.53 group_size: 665 comparator: mean: 36.73 standard_deviation: 9.39 group_size: 586
---
intervention: { mean: 50.04; standard_ deviation: 11.16; group_size: 505}comparator: { mean: 50.08; standard_ deviation: 11.16; group_size: 645}
---
",True
593,11583,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: 90 mg once daily 2.70215579 comparator: placebo 1.165931974
---
intervention: 
---
intervention: mean: 0.7 group_size: 125 comparator: mean: 0.67 group_size: 133 standard_deviation: intervention: 0.8 comparator: 0.84
---
",True
463,4431,5726464,Lipid profile: HDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","intervention: mean:5.823standard_deviation:1.403group_size:100comparator: mean:5.565standard_deviation:2.099group_size:115
---
{intervention: {mean: 13.4, standard_deviation: 6.5, group_size: 62},comparator: {mean: 12.4, standard_deviation: 5.8, group_size: 66}}
---
The YAML format for the given trial article outcome will be: interventions: [ 'Vitamin D plus calcium supplementation' 'Control'] comparators: [ 'Control' 'Vitamin D plus calcium supplementation'] outcome: lipid profile: hdl-c: mean: NUMBER standard_deviation
---
",True
77,3746,3546023,The percentage of NK cells,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,19.03,7.82,24.72,8.78,-0.6721,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: mean: xxx standard_deviation: xxx group_size: xxxxcomparator: mean: xxx standard_deviation: xxx group_size: xxxx
---
intervention: mean: 0.91 standard_ deviation: 0.21 group_size: 50comparator: mean: 0.93 standard_ deviation: 0.19 group_size: 129response: mean: 1 standard_ deviation: 3 group_size
---
intervention: mean:45.68standard_deviation:48.96group_size:20comparator: mean:69.78standard_deviation:42.74group_size:29
---
intervention: mean: 0.38 standard_deviation: 0.17 group_size: 55 comparator: mean: 0.23 standard_deviation: 0.08 group_size: 57
---
intervention: mean: 1.2345 standard_deviation: 0.1234 group_size: 65comparator: mean: 5.08646 standard_deviation: 9.72362 group_size: 41
---
intervention: mean: 2.53 standard_deviation: 1.09 group_size: 11
---
Comparator:
---
intervention: mean: 19.2429876812 standard_deviation: 5.6180205115839 group_size: 56 comparator: mean: 19.3934210526351 standard_
---
intervention: mean: 0.570standard_deviation: 0.200group_size: 18comparator: mean: 0.810standard_deviation: 0.130group_size: 20
---
intervention:
---
",True
506,6485,5419060,Phlebotomy questionnaire score: CDC D,Phlebotomy training programme,Control,continuous,,23,,23,97,1.21,63,4.31,10.5566479,1.29829148,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1537, 528, 1598, 748]","intervention: mean:63.00 standard_deviation:1.01 group_size:4 comparator: mean:58.00 standard_deviation:0.58 group_size:3
---
intervention:mean:2.963standard_deviation: 1.802group_size:9group_size:9comparator:mean:1.49standard_deviation: 0.797group_size:20group_size:20
---
intervention: [ 4.23, 0.51, { ""group_size"": 340 }]
---
intervention: group_size:
---
",True
530,6917,4411165,Tskin of the head,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"[1632, 485]","intervention:mean: 0.28standard_deviation: 0.11group_size: 10comparator:mean: 0.14standard_deviation: 0.05outcome: Tsk(head)group_size: 10
---
intervention: mean: 35.5 standard_deviation: 1 standard_deviation group_size: 6 comparator: mean: 35.9 standard_deviation: 2.5 standard_deviation group_size: 6
---
",True
667,13296,4987981,total cholesterol,pioglitazone,placebo,continuous,,16,,23,207.2,42.3,184.4,37.5,0.5651889,0.11007363,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","intervention: mean: 106.07 standard_deviation: 31.73 group_size: 16 comparator: mean: 102.07 standard_deviation: 35.45 group_size: 21
---
intervention{mean:184.4standard_deviation:37.5group_size:21}comparator{mean:206.9standard_deviation:36.2group_size:21}
---
intervention: mean: pioglitazone standard_deviation: 59.4 group_size: 156 comparator: mean: placebo standard_deviation: 58.4 group_size: 159
---
intervention: mean: 20.5 standard_deviation: 17.4 group_size: 21 comparator: mean: 20.5 standard_deviation: 17.4 group_size: 21
---
The information extracted from the article are listed below:
---
",True
220,2912,5459456,time before eating,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.5,2.2,3.9,2.3,0.6791,0.2644,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","ACVC-HA: {mean: 3.9, standard_deviation: 2.3, group_size: 6}ACCF: {mean: 3.5, standard_deviation: 2.3, group_size: 11}
---
comparator:group_size: ""82""group_size_intervention: ""84""
---
intervention:
mean: NUMBER
---
Comparator:{ ""mean"": 9, ""standard_deviation"": 3 }
---
intervention: mean: 2.9000 standard_deviation: 5.1883 group_size: 248 comparator: mean: 3.8750 standard_deviation: 4.5562 group_size: 267
---
",True
524,6741,5325897,Second test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,17.73,0.46,12.13,0.47,11.7163546,2.42121609,,,,,,TRUE,4260,2410,TEST,1703,"[1361, 506]","intervention: mean: 10.58 standard_deviation: 0.52 group_size: 15 comparator: mean: 9.76 standard_deviation: 0.55 group_size: 15
---
intervention: mean: 17.73 standard_deviation: 1.09 group_size: 18 comparator: mean: 12.13 standard_deviation: 2.29 group_size: 18
---
",True
183,4341,5122613,Baseline characteristics and diet,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,10,4.6,11.5,4.6,-0.3222,0.0614,,,,,Mean daily fiber intake,TRUE,6184,3742,TEST,2832,"[1633, 1102]","intervention: mean: 28 group_size: 33 standard_deviation: 4.4 comparator: mean: 29 group_size: 33 standard_deviation: 4.4
---
intervention:
mean: 127.9
---
",True
301,5600,4355974,Days patient had to slow down,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"[1518, 1642, 573]","intervention:
---
intervention: mean: 5.0 standard_deviation: 2.0 group_size: 14 comparator: mean: 5.9 standard_deviation: 2.4 group_size: 14
---
intervention: mean:11.89 standard_deviation:7.26 group_size:125 comparator: mean:8.95 standard_deviation:5.19 standard_deviation:45
---
",True
311,7834,4541185,drop in heart rate,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,76.1,8.91,76.77,8.76,-0.0748,0.0667,,,,,found in table,TRUE,1359,1043,TEST,907,[],intervention: mean: -8.85 standard_deviation: 3.40 group_size: 30 comparator: mean: -7.28 standard_deviation: 3.75 group_size: 30,False
150,11145,4996097,Total nasal resistance,Septoplasty,Control,continuous,,33,,30,0.25,,0.27,,cannot calculate,cannot calculate,,,,,Used preoperative values. SD is not given.,FALSE,9291,4535,TEST,2976,"[1428, 1251, 776]","intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
Here's the YAML format table with all the requested information based on the extracted data from the given article:
---
intervention: mean: 1.1351306576 standard_deviation: 1.124069096082 group_size: 895comparator: mean: 1.3757924465 standard_deviation: 1
---
",True
308,7832,4541185,duration of analgesia,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,878.33,89.955,613.1,51.797,2.7597,0.1301,,,,,found in text,TRUE,1359,1043,TEST,907,[],intervention: mean: 878.33 standard_deviation: 89.955 group_size: 30comparator: mean: 613.10 standard_deviation: 51.797 group_size: 30,False
488,6383,3786549,Baseline characteristics: height,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,154.86,5.45,153.43,5.88,0.25003828,0.04580977,,,,,,TRUE,9725,6231,TEST,4323,"[1678, 1676, 1258]","intervention: mean: 62.34 standard_deviation: 6.07 group_size: 44 comparator: mean: 60.93 standard_deviation: 6.15 group_size: 44
---
-- test_group: group_size: 65 outcome: mean: 0.07270 standard_deviation: 0.08146-- control_group: group_size: 39 outcome: mean: 0.08991 standard_deviation: 0.0
---
intervention: 28.0 mean 1.6 standard_deviation 3.3 group_size 5 comparator: 28.0 mean 1.6 standard_deviation 3.3 group_size 5
---
",True
368,216,1475568,Heart failure-related quality of life at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,1,,5,,cannot calculate,cannot calculate,,,,,Only the mean change was found in text.,FALSE,4361,3649,TEST,2573,"[1439, 1156]","intervention: {mean: 54.35, standard_deviation: 13.84, group_size: 65}
---
intervention: mean: 45.60 standard_deviation: 27.65 group_size: 59 comparator: mean: 39.66 standard_deviation: 28.79 group_size: 64
---
",True
647,13025,4675066,The mean motor score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,93.9,10.8,92.4,9.7,0.14381908,0.07569371,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"[1501, 1640, 1216]","intervention: mean: 93.9standard_deviation: 10.8group_size: 29comparator: mean: 92.4standard_deviation: 9.7group_size: 30
---
intervention: mean: 107 standard_deviation: 11.8 group_size: 26comparator: mean: 102.4 standard_deviation: 9.9 group_size: 25
---
The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:
---
",True
638,12721,4132222,"higher prevalence of lesion scabbing, a sign of healing",application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,"[1617, 117]","intervention:mean:–standard_deviation:–group_size:–comparator:mean:–standard_deviation:–group_size:–
---
intervention: mean99.400 standard_deviation13.900 group_size19244 comparator: mean75.800 standard_deviation17.000 group_size20118
---
",True
100,930,4183415,Completed treatment,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,"[1557, 954, 1029, 882, 888, 842]","intervention: mean: NUMBER, standard_deviation: NUMBER, group_size: NUMBER
---
intervention:
---
intervention: mean: 14.941 standard_deviation: 7.212 group_size: NUMBER comparator: mean: 17.479 standard_deviation: 10.067 group_size: NUMBER
---
intervention: mean: 2.67 standard_deviation: 0.67 group_size: 50comparator: mean: 1.94 standard_deviation: 0.4 group_size: 59
---
interventions: {mean: 5.2; standard_deviation: 1.75; group_size: 37}comparators: {mean: 3.4; standard_deviation: 1.0; group_size: 40}
---
intervention: mean: 70.2 standard_deviation: 33.576282 group_size: 40 comparator: mean: 68.0 standard_deviation: 40.5185916 group_size: 37
---
",True
675,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider,control,continuous,,14,,12,56.1,31,64.2,28,-0.2644318,0.1561066,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[946, 1631, 54, 2187, 1659, 153, 2173, 1311]","intervention: mean: 34 percent standard_deviation: 26 percent group_size: 4946 control: mean: 30 percent standard_deviation: 27 percent group_size: 5311
---
intervention:
---
intervention: Mean: 0.28 Standard_deviation: 0.12 Group_size: 2490 comparator: Mean: 0.22 Standard_deviation: 0.11 Group_size: 2488
---
The YAML response is shown below:intervention:mean:0.73standard_deviation:0.139group_size:1094comparator:mean:0.648standard_deviation:0.2053group_size:988
---
intervention: mean: 61.90 standard_deviation: 34.00 group_size: 15 comparator: mean: 66.50 standard_deviation: 23.00 group_size: 21
---
intervention: mean: 0.1125 standard_deviation: 0.0893 group_size: 3297 comparator: mean: 0.1084 standard_deviation: 0.1107 group_size: 1248
---
intervention: mean: 0.4 group_size: 75 comparator: mean: 0.52 group_size: 103 
---
intervention:
---
",True
614,11584,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean: 58.7 standard_deviation: 19.3 group_size: 353 comparator: mean: 40.9 standard_deviation: 15.2 group_size: 357
---
intervention:mean: -3.02standard_deviation: 1.74group_size: 128comparator:mean: -3.02standard_deviation: 1.74group_size: 28
---
The YAML format should include the fields ""mean"", ""standard_deviation"", and ""group_size"" for only ""intervention"" and ""comparator"" but not ""outcome"". Example:
---
",True
247,10308,5571493,QT interval,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],"intervention:
mean: NUMBERSTANDARD_DEVIATIONGROUP_SIZE: 10comparator: mean: NUMBERSTANDARD_DEVIATIONGROUP_SIZE: 10outcome: [intervention, comparator]",False
590,11583,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention: mean: 0.88 standard_deviation: 0.12 group_size: 357 comparator: mean: 0.85 standard_deviation: 0.02 group_size: 357
---
investigator global assessment of disease activity:
---
intervention: mean: 3.23 standard_deviation: 0.75 group_size: 353 comparator: mean: 3.03 standard_deviation: 0.66 group_size: 357
---
",True
200,7737,5380284,Consumption of fentanyl,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"Gum-chewing group: {{""mean"": 922.914 ""standard_deviation"":237.599, ""group_size"":38}",False
519,6700,5154016,Second 24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,63.3,8.9,63.5,14.2,-0.0166581,0.06666898,,,,,,TRUE,3046,2156,TEST,1642,"[1448, 465]","intervention:hemostatic_sponge: mean:187.9standard_deviation:82.3group_size:30comparator:gelatin_sponge: mean:230.8standard_deviation:75.5group_size:30hemostatic_spon
---
intervention: mean: 54.06 standard_deviation: 5.57 group_size: 2 comparator: mean: 7.79 standard_deviation: 3.58 group_size: 2
---
",True
52,5306,3195393,Restraint frecuency,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,13.6,0.07,11.5,0.13,20.6573,0.2121,,,,,Added intermittent and continuous numbers from study site,TRUE,15527,8380,TEST,5589,"[1670, 663, 1648, 1306, 708]","intervention: mean: 4.113 standard_deviation: 1.193 group_size: 96comparator: mean: 6.142 standard_deviation: x group_size: x
---
intervention: mean: 2.00 standard_deviation: 0.00 group_size: 89 comparator: mean: 1.00 standard_deviation: 0.00 group_size: 89
---
intervention: mean: 0standard_deviation: 0group_size: 53comparator: mean: 0standard_deviation: 0group_size: 25
---
intervention: mean: 46.5 standard_deviation: 3.3 group_size: 398
---
intervention:
---
",True
76,3744,3546023,The percentage of B cells,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.06,3.81,14.4,4.03,-0.0856,0.0667,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: mean: 0.02 (group size: 7)comparator: mean: 0.02 (group size: 7)outcome: The percentage of cytotoxic capacity of NK cells
---
The YAML format for the given trial article is:intervention:mean:1.54standard_deviation:1.71group_size:13comparator:mean:1.89standard_deviation:2.53group_size:16
---
intervention: mean: x standard_deviation: x group_size: x,y
---
intervention:
---
intervention: mean: 0.1878647 standard_deviation: 0.1914656 group_size: 56comparator:mean: 0.1965504standard_deviation: 0.2058461group_size:
---
intervention:
---
intervention:
---
{
---
* { intervention: 200 mg/day palmvitee smokers comparator: 0 mg/day non-smokers outcome: The percentage of B cells group_size: 3 group_size: 11mean: 0.0200001standard_deviation: 0
---
The value should be in the following format:
---
",True
552,9725,3648394,Quality of life - PCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,2.7,46.9,4.8,0.1496389,0.10848973,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,"[1586, 970, 1651, 518]","Table 1: HRV measures and flexibility at baseline, post-intervention and follow-up measuresBaselinePost-interventionFollow-upYoga group (N = 18)Control (N = 19)Yoga group (N = 14)Control (N = 12)Yoga group (
---
yoga: pcs:mean: 43, standard_deviation: 10, group_size: 21, control: pcs:mean: 40, standard_deviation: 11, group_size: 20.
---
intervention:
---
intervention:
---
",True
170,2795,5079604,Cox proportional hazards of failure-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[739, 1755, 1654, 706]","intervention: mean: 0.28 standard_deviation: 0.11 group_size: 17 comparator: mean: 0.31 standard_deviation: 0.12 group_size: 16
---
intervention: mean: 1.0 standard_deviation: 0.0 group_size: 13 comparator: mea n: 1.0 standard_deviation: 0.0 group_size: 13
---
metformin: mean: 0.28 standard_deviation: 0.10 group_size: 22sitagliptin: mean: 0.31 standard_deviation: 0.10 group_size: 22
---
intervention: mean:1000x group_size:72x comparator: mean:500x comparator: standard_deviation:95.91x group_size:71x
---
",True
447,4003,4879328,effects for walking,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.55,2.29,0.31,3.84,-0.2681458,0.01855223,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[989, 1648, 1674, 1355, 1003]","The outcome ""body weight"" was missing in the given article for the comparators. Please provide the mean and standard deviation of this outcome for the comparator.
---
intervention:
---
intervention: mean: 13.4 standard_deviation: 13.76 group_size: 79 comparator: mean: 7 standard_deviation: 8.688 group_size: 79
---
Intervention: Get Healthy, Stay Healthy' (GHSH)Comparator: no continued contact
---
intervention: {mean: −0.69, standard_deviation: 2.80, group_size: 104}comparator: {mean: +0.29, standard_deviation: 3.22, group_size: 114}
---
",True
307,7831,4541185,duration of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,621.67,46.76,500.86,44.58,2.6102,0.1234,,,,,found in text,TRUE,1359,1043,TEST,907,[],intervention: mean: 113.96514884 standard_deviation: 87.6497825054 group_size: 29.0 comparator: mean: 88.9973265994 standard_deviation: ,False
469,4799,5515881,dynamic balance performance on the stability platform,demanding balance training program,relaxation group,continuous,,,,,7.54,2.57,6.29,1.84,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1670, 1268]","intervention: mean: 5.40 standard_deviation: 1.17 group_size: 40comparator: mean: 5.73 standard_deviation: 1.85 group_size: 40
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
",True
483,5712,3343759,Amsterdam-Nijmegen everyday language test (ANELT),very early speech and language therapy (SLT),control,continuous,,59,,55,,,,,cannot calculate,cannot calculate,,,,,"Median values are reported. Group size is based on ANELT by day 21, intent-to-treat.",FALSE,3838,2633,TEST,2065,"[1467, 589]","intervention: 28.3 17.7 123 comparator: 29.71717
---
intervention: mean: 1.3 standard_deviation: 1 group_size: 59
---
",True
249,10310,5571493,Hypoglycemia,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],intervention: mean: 74.00 standard_deviation: 5.00 group_size: 10 comparator: mean: 83.00 standard_deviation: 5.00 group_size: 10,False
434,3261,3475525,Scores on sugar quiz,MTL group,choices group,continuous,,98,,98,90,20.7,41.9,19.4,2.38845924,0.03496107,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 59 number of units group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER choices: mean: 79 number of units standard_deviation: NUMBER group_size: NUMBER
---
intervention: { mean: 35, standard_deviation: 17, group_size: 48 } comparator: { mean: 74, standard_deviation: 39, group_size: 48 }
---
intervention:mean: 55.5standard_deviation: 13.5group_size: 21183comparator:mean: 85.8standard_deviation: 19.0group_size: 21183
---
The YAML format for Intervention: MTL group, Comparator: Comparison, and Outcome: Scores on sugar quiz is:
---
",True
81,3740,3546023,tocotrienol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,675.16,150,63.6,5.67,5.6842,0.3475,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1535, 1635, 1613, 1258, 1416, 1999, 286, 1467, 1987, 120]","intervention: mean: 0.48685 standard_deviation: 1.83228 group_size: 19
---
intervention:
---
intervention: 200 mg/day palmvitee nonsmokers (group_size: 34)comparator: baseline (group_size: 34)outcome: tocotrienol_levels
---
intervention:
---
intervention: mean: 0.794 (= x) standard_deviation: 1.611 (= x) group_size: 21 (= x) comparator: mean: 0.553 (= x) standard_deviation: 0.531 (= x)
---
```yaml
intervention: 0.3181 mean:5.650 standard_deviation:2.994 group_size:20comparator:0.0000 mean:13.250 standard_deviation:1.889 group_size:15``
---
intervention: mean: [8, 9] standard_deviation: [5, 6] group_size: 10
---
intervention:mean: NUMBERstandard_deviation: NUMBERRgroup_size: NUMBERcomparator:mean: NUMBERstandard_deviation: NUMBERRgroup_size: NUMBER
---
intervention: mean: 3.1 standard_deviation: 1.4 group_size: 11 comparator: mean: 2.1 standard_deviation: 0.8 group_size: 36
---
intervention:
---
",True
317,9844,4928400,Hospital stay,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.2,1.2,2.1,1.1,1.7938,0.1338,,,,,,TRUE,4037,2288,TEST,1670,[1630],"hospital_stay:
---
",True
115,9524,4319071,Fruit intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,2.17,1.71,2.14,1.71,0.0175,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[975, 2176, 811, 1363, 1589, 1399, 1753, 1361]","intervention: [mean, standard_deviation, group_size]intervention+targeting environmental-level factors: 69.80, 1, 200comparator: basic intervention targeting cognition and self-regulation processes: 73.44, 1, 129[1
---
intervention: mean: 1.80 standard_deviation: 1.23 group_size: 1228 comparator: mean: 2.21 standard_deviation: 1.19 group_size: 539
---
intervention:mean:0.27standard_deviation:0.29group_size:902comparator:mean:0.23standard_deviation:0.29group_size:902
---
intervention:
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBERNumber: 0.49 standard_deviation: 1.09 group_size: 72
---
intervention, fruit, standard_deviation: 1.5498, group_size: 263, comparator, fruit, standard_deviation: 0.7110, group_size
---
intervention: mean: 1.025 standard_deviation: 0.318 group_size: 191 comparator: mean: 0.968 standard_deviation: 0.338 group_size: 382
---
intervention:
---
",True
426,3403,3877023,Scanning times,high-field horizontal open MR scanner,short-bore MR scanner,continuous,,49,,44,32,22,20,9,0.69457406,0.04572916,,,,,,TRUE,17694,9686,TEST,7100,"[1645, 1671, 769, 1569, 1667]","intervention:
mean: 32 minutes
---
intervention: mean: 31.7 standard_deviation: 21.6 group_size: 55 comparator: mean: 31.7 standard_deviation: 21.6 group_size: 55
---
comparison:
---
intervention:mean: NUMBERstandard_deviation : NUMBERgroup_size : NUMBERcomparator:mean: NUMBERstandard_deviation: NUMBERgroup_size: NUMBERResponse:comparatorGroup_size = 21interventionGroup_size = 30
---
intervention: mean: 60.271378425 standard_deviation: 36.885857405 group_size: 7 comparator: mean: 54.1798737556366 standard_deviation: 2
---
",True
374,227,1475568,Self-efficacy,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,"[1439, 1156]","intervention:
mean: 3.7064380285714285245
standard_deviation: 0.8435025493861897286128698296469693
---
Here is the requested YAML. As explained earlier, we produced the YAML from the “Baseline characteristics” table of the trial article. To retrieve the relevant data, we first extracted the control and intervention group baseline characteristics. Then, we identified the first data point of interest: HFQOL score which is 54.
---
",True
565,9839,3496170,N1 amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data is not given.,FALSE,2318,1990,TEST,1731,"[1671, 44]","biperiden: [mean: 0.64, standard_deviation: 0.07, group_size: 15]
---
intervention: mean: -11.5613 standard_deviation: 15.9318 group_size: 32comparator: mean: -9.08769 standard_deviation: 22.8774 group_size: 96
---
",True
51,5308,3195393,Continuous restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,8.5,0.07,10.8,0.13,-19.6737,0.1927,,,,,Overall continuous restraint rate for study site.,TRUE,15527,8380,TEST,5589,"[1670, 663, 1648, 1306, 708]","intervention: mean: 2.71 standard_deviation: 3.44 group_size: 170 comparator: mean: 3.26 standard_deviation: 1.69 group_size: 166
---
intervention: mean: 2.00 standard_deviation: 1.24 group_size: 97 comparator: mean: 7.94 standard_deviation: 1.24 group_size: 97
---
intervention: mean: 53 standard_deviation: 12.05 group_size: 126 comparator: mean: 76 standard_deviation: 10.55 group_size: 148
---
The following is the YAML format for the requested data. The group sizes are 642 for the Intervention group and 378 for the Control group. Both groups were for patients who had one or more episodes of physical or chemical restraint during the baseline period. The outcome “Continuous restraint” was measured after intervention
---
intervention:
---
",True
608,11584,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","# Table 1Efficacy Table 1 summarizes the results of the treatment comparisons for the primary and secondary efficacy endpoints. For all 4 primary endpoints, etoricoxib and naproxen were statistically superior to placebo. The percentage of patients who achieved ACR20 responder criteria response was
---
intervention:mean: -9.93standard_deviation: 12.96group_size: 357comparator:mean: -6.90standard_deviation: 24.79group_size: 353outcome:investigator global assessment of disease activity
---
intervention:
mean: 2.3666666666666667.019030792044426
---
",True
219,2912,5459456,recovery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.1,2,3.5,1.4,0.3286,0.2534,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","Sure, here's the answer table:
---
comparator: group_size: 20intervention: group_size: 18acvc_ha_cervical_disk_only: mean: 99.224188standard_deviation: 28.939031acvc_cervical_disk_only
---
intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
Intervention: ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC
---
{ ""intervention"": {""mean"": ""7.033"", ""standard_deviation"": ""0.555"", ""group_size"": ""47""}, ""comparator"": {""mean"": ""12.208"", ""standard_deviation"": ""1.119"", ""group_size"":
---
",True
461,4430,5726464,25(OH)D levels,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","mean: 26.4standard_deviation: 4.4group_size: 86mean: 28.4standard_deviation: 4.5group_size: 79
---
intervention: mean: 27.5 standard_deviation: 15.4 group_size: 70 comparator: mean: 0.17 standard_deviation: 1.72 group_size: 78
---
intervention: mean: – standard_deviation: 3.63 – group_size: 113 comparison: mean: – standard_deviation: 3.57 – group_size: 111
---
",True
294,6104,4215531,MCCB performance : Reasoning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.9,8.8,46.5,9.8,0.1472,0.1055,,,,,used post values and Treatment as Usual as Baseline,TRUE,7353,5561,TEST,4156,"[1672, 1641, 963]","intervention:mean:29.32standard_deviation:4.09group_size:20comparator:mean:28.66standard_deviation:5.12group_size:19
---
intervention: mean:NANA standard_deviation:NANA group_size:NAcomparator: mean:53.569standard_deviation:8.569group_size:18
---
intervention: mean: 44.6 standard_deviation: 12.2 group_size: 19 comparator:
---
",True
303,3879,4357072,reduction in burning sensation,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,1,2.1,5.3,6.1,-0.9171,0.1474,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],intervention: mean: 57.00 standard_deviation: 14.05 group_size: 15 comparator: mean: 49.00 standard_deviation: 16.18 group_size: 15 outcome: reduction in burning sensation,False
98,931,4183415,completion of each dose at the correct time,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,33.1,21.6,32.6,18.4,0.0246,0.052,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,"[1557, 954, 1029, 882, 888, 842]","intervention: <NULL>
---
No YAML output is generated, because: 1. There is no YAML header given to the model; 2. Since there is only one intervention studied, ""intervention"" and ""comparison"" are equivalent and ""comparison"" is sufficient for the model. 3. No numerical information is provided, because it is
---
intervention: mean: 97.0 standard_deviation: 8.3 group_size: 451 comparator: mean: 83.0 standard_deviation: 26.7 group_size: 453
---
intervention: mean: 0.0 mean_standard_deviation: 0.1 group_size: 74 comparator: mean: 0.24 mean_standard_deviation: 0.23 group_size: 44
---
intervention: mean: 52.99 standard_deviation: 14.71 group_size: 3485 comparator: mean: 52.14 standard_deviation: 10.39 group_size: 3484
---
intervention:
mean: xx
---
",True
318,9845,4928400,Time for return to daily activities,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,13.3,1.7,9,1.6,2.5595,0.1734,,,,,,TRUE,4037,2288,TEST,1670,[1630],"intervention: mean: 13.3 std_deviation: 1.7 group_size: 23
---
",True
677,13505,5777419,the total cultivable microbiota,probiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,"[1099, 1320, 1023]","intervention: mean: 90.6Standard_deviation: 78.5Group_size: 31comparator: mean: 24.7Standard_deviation: 15.5Group_size: 30
---
probiotic: mean: 10.2 standard_deviation: 23.5 group_size: 16
---
intervention: mean:15431.019standard_deviation:200.001group_size:16comparator: mean:10240.154standard_deviation:18245.712group_size:16outcome: -mean
---
",True
687,13762,2836833,weight loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1595, 1207, 1243, 1126, 1526]","The number of participants for each trial arm (n) and the number for the missing participants (M) are provided in the “randomisation” subsection under the “Methods” section. The information is as follows:
---
The YAML responses for ""weight loss"" using data from Table 2 are shown below:
---
intervention: mean: 2.4 kg standard_deviation: 4.11 kg group_size: 17 comparator: mean: 2.5 kg standard_deviation: 3.61 kg group_size: 20
---
intervention: mean: 6.80 standard_deviation: 1.80 group_size : [18.0, 16.0] comparator: mean: 7.90 standard_deviation: 1.70 group_size : [18.0, 16.0
---
See YAML tab below.
---
",True
290,6103,4215531,MCCB performance : Attentional Vigilance,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,38.5,11.8,41.3,10.1,-0.2496,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1672, 1641, 963]","intervention: mean: 18 standard_deviation: 5.042 group_size: 58comparator: mean: 18.6 standard_deviation: 5.23 group_size: 56 [/
---
Sure! Here are the responses: 
YAML: interventions:intervention1:
mean: 8.122standard_deviation: 3.284
---
intervention: mean: 39.5 standard_d: 10.6 group_size: 19 comparator: mean: 33.6 standard_d: 11.5 group_size: 19
---
",True
583,10218,3504298,Difference of cortisol on waking and the highest level of following samples,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"[1656, 1393]","intervention: mean: -0.1622 standard_deviation: 0.3303 group_size: 61 comparator: mean: 0.2181 standard_deviation: 0.5686 group_size: 60
---
intervention: { mean: -5.9 standard_deviation: -2.0 group_size: 26 }
---
",True
193,2094,5360580,Plasma PlsPE,1 mg/day of Pls purified from scallop,placebo,continuous,,138,,131,-0.59,1.11,-0.63,1.08,0.0364,0.0149,,,,,Data is from after 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"[1665, 1312, 844, 1155, 1247]","intervention: mean: 3.65 standard_deviation: 1.31 group_size: 166 comparator: mean: 3.93 standard_deviation: 1.28 group_size: 162
---
intervention: mean:0.00349032 standard_deviation:0.07968862 group_size:139comparator: mean:− 0.01629152 standard_deviation:0.07942458 group_
---
intervention: mean: 121.6854117000 standard_deviation: 25.480842981225 group_size: 54 comparator: mean: 117.6854117000 standard_dev
---
intervention: mean: 141.1 standard_deviation: 36.5 group_size: 2 comparator: mean: 139.2 standard_deviation: 30.9 group_size: 2
---
intervention: mean: 0.1625 standard_deviation: 0.18 group_size: 8 comparator: mean: 0.2796 standard_deviation: 0.25 group_size: 50
---
",True
146,1272,4880652,visual analogue scores,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,[],intervention:,False
661,13216,4458006,amplitude of whisking,facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1),"2 cm distally, at the main bifurcation (group 2)",continuous,,12,,12,17.2,,6.9,,cannot calculate,cannot calculate,,,,,No std given,FALSE,1302,1180,TEST,1009,[],intervention: mean: 4.4 standard_deviation: 0.18 group_size: 12 comparator: mean: 10.8 standard_deviation: 0.07 group_size: 12,False
292,6104,4215531,MCCB performance : Working Memory,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,48.2,9.2,50.8,12.1,-0.2368,0.106,,,,,used post values and Treatment as Usual as Baseline,TRUE,7351,5561,TEST,4156,"[1672, 1641, 963]","intervention: mean: 57 standard_deviation: 14.57 group_size: 57 comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER outcome: mean: 522.47 standard_deviation: 146.2
---
intervention: mean: 539.6 standard_deviation: 289.2 group_size: 12 comparator: mean: 637.9 standard_deviation: 280.9 group_size: 15
---
intervention: mean: 48.2 standard_deviation: 12.3 group_size: 42 comparator: mean: 42.8 standard_deviation:12.8 group_size: 42
---
",True
680,13506,5777419,reduction of PPD,probiotic,placebo,continuous,,16,,15,2.2,0.3,2.5,0.6,-0.6224049,0.13541486,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[1099, 1320, 1023]","intervention: mean: 5.0 standard_deviation: 2.0 group_size: 16comparator: mean: x standard_deviation: x group_size: 16
---
intervention: mean:0.9525 standard_deviation:0.44517 group_size:24 comparator: mean:0.47375 standard_deviation:0.427598 group_size:24
---
intervention:
---
",True
549,8464,3263860,PAID questionnaire fear of hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,,,,,cannot calculate,cannot calculate,,,,,Numerical values in Table which is a graphic,FALSE,3178,2587,TEST,2232,"[1614, 796]","## InterventionComparisonOutcomeTrial 2019-07-03 00:00:00InterventionComparatorOutcomeTrial 2016-03-23 00:00:00InterventionComparatorOutcomeTrial 2013-06
---
intervention: {}
---
",True
148,1274,4880652,Diastolic blood pressures at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 4's graphics.,FALSE,1406,1149,TEST,966,[],intervention:,False
607,11584,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","{% tabular ""intervention"", ""comparator"", ""outcome"", row=""1"" %}intervention: {group_size: 154, mean: 68.2, standard_deviation: 17.4}comparator: {group_size: 158, mean: 
---
intervention: mean: -0.04 standard_deviation: 0.15 group_size: 330 comparator: mean: 0.19 standard_deviation: 0.17 group_size: 353
---
intervention: mean: 53.0 standard_deviation: 14.7 group_size: 357 comparator: mean: 51.4 standard_deviation: 13.8 group_size: 353
---
",True
581,11584,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","{ % of ACR 20, mean, standard_deviation, group_size:
---
intervention: { ""mean"": 0.11, ""standard_deviation"": 0.08, ""group_size"": 990 }
---
intervention: mean: 0.190 standard_deviation: 0.094 group_size: 0 comparator: mean: 0.225 standard_deviation: 0.136 group_size: 0
---
",True
9,9684,2363753,Hospital stay,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],intervention: mean: NUMBER standard_deviation: NUMBER group_size: 40 comparator: mean: NUMBER standard_deviation: NUMBER group_size: 40,False
657,13176,5773985,objective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,7.4,1.93,7.28,1.59,0.06679907,0.08004462,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"[1592, 407]","intervention:mean: 3.00standard_deviation: 1.08group_size: 50comparator:mean: 2.92standard_deviation: 1.03group_size: 50
---
intervention:mean: 2.376329251893standard_deviation: 0.482438594824group_size: 46comparator:mean: 1.995457252737standard_deviation
---
",True
609,11584,115849,Tender joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1531, 1660, 1025]","intervention:
standard_deviation: 15.4
---
intervention: group_size: 345 comparator: group_size: 346
---
intervention: mean: 57.8 standard_deviation: 13.6 group_size: 449 comparator: mean: 52.1 standard_deviation: 16.4 group_size: 444
---
",True
241,8053,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),continuous,,12,,12,6,0.9,6.2,1.8,-0.1357,0.1671,,,,,,TRUE,6951,5679,TEST,4357,"[926, 1571, 1677, 482]","intervention: mean: 0.13 standard_deviation: 0.82 group_size: 12 comparator: mean: −0.03 standard_deviation: 0.81 group_size: 12
---
intervention: mean: 62.400 standard_deviation: 25.000 group_size: 12 comparator: mean: 68.600 standard_deviation: 22.100 group_size: 12
---
The table in this field, right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS), is presented in Table [1](#). As shown in the rows, for the first outcome (overall working memory), the average performance for sham stimulation
---
intervention: mean: 40.90 standard_deviation: 13.65 group_size: 12 comparator: mean: 36.38 standard_deviation: 13.27 group_size: 12
---
",True
453,4432,5726464,Glucose,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","treatment_arm:1- arm1- arm2- Outcome:25_oh_vitamin_D- mean:11.0- standard_deviation:3.6- group_size:79130--
---
intervention:
---
Mean,Standard_Deviation,Group_size 8,0.60,14 9,0.68,16
---
",True
365,12886,5976949,leptin/adiponectin ratio (LAR),"GDM2 (less tight glycaemic targets, <5.3 mmol/L and < 7.8 mmol/L)","GDM1 (tight glycaemic targets, fasting blood glucose_<_5.1_mmol/L and <7.0_mmol/L postprandial) postprandial,), control group- normal glucose tolerance",continuous,,21,,45,1.7,1.66,,,cannot calculate,cannot calculate,,,,,combined means and stds not given,FALSE,4402,2905,TEST,2274,"[1558, 1103]","intervention: mean: 6.41307standard_deviation: 0.766365group_size: 0comparator: mean: 4.59091standard_deviation: 1.079481group_size: 0outcome: lept
---
intervention: mean: 22.07 standard_deviation: 16.32 group_size: 21 comparator: mean: 12.71 standard_deviation: 4.27 group_size: 20
---
",True
196,2097,5360580,WMS-R (0 min),1 mg/day of Pls purified from scallop,placebo,continuous,,24,,24,1.29,3.14,1.08,1.55,0.0834,0.0834,,,,,Data is from 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"[1665, 1312, 844, 1155, 1247]","intervention: mean: 4.2 mean: 4.3 group_size: 166 comparator: mean: 4.3 mean: 4.4 group_size: 162
---
intervention: mean: 0.00 standard_deviation: 0.66 group_size: 145 comparator: mean: 0.33 standard_deviation: 0.60 group_size: 140
---
The YAML response for WMS-R (0 min) is:
---
{% assign output_yaml_1 = 1.04, output_yaml_2 = 30, output_yaml_3 = 30, output_yaml_4 =1.52, output_yaml_5 = 0.48, output_yaml_10 = 1.30
---
Comparator: 0.42051, standard_deviation: 0.34529, group_size: 59
---
",True
347,10234,5686687,Need for Ibuprofen,Resveratrol,Placebo,continuous,,22,,22,1200,848,5640,328,-6.7818,0.6136,,,,,found in table,TRUE,7451,3515,TEST,2366,"[1235, 1108]","Here is the resulting YAML for your extracted information:
---
intervention:mean:0mean_standard_deviation:500group_size:22comparator:mean:195mean_standard_deviation:3864group_size:22
---
",True
683,13506,5777419,reduction of PPD,antibiotic,placebo,continuous,,16,,15,2.3,0.3,2.5,0.6,-0.4149366,0.13194364,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[1099, 1320, 1023]","{ ""intervention"": {""mean"": ""2.80"", ""standard_deviation"": ""0.74"", ""group_size"": ""16""}, ""comparator"": {""mean"": ""3.60"", ""standard_deviation"": ""0.97"", ""group_size"": ""15""}, ""
---
outcome: reduction of PPD
---
intervention:
---
",True
551,9724,3648394,Push-up test,10-week yoga program,Control,continuous,,18,,19,21,11,20,13,0.08105953,0.10827593,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"[1586, 970, 1651, 518]","intervention: mean: 75standard_deviation: 10.4group_size: 18comparator: mean: 65standard_deviation: 6.4group_size: 19
---
There were 100 participants allocated to the intervention group and 50 allocated to the comparator group. The reported outcomes from this randomized controlled trial were measures of cardiovascular health (heart rate, resting heart rate) and anxiety (state and trait anxiety). Each outcome measure used different methods of calculating mean and standard deviation,
---
intervention: standard_deviation: 21.00
---
intervention:mean: 20.5standard_deviation: 8.9group_size: 30comparator:mean: 22.1standard_deviation: 7.4group_size: 30
---
",True
511,6550,4033571,Overall seizure median percent improvement,Extended-release oxcarbazepine 2400 mg,Control,continuous,,111,,117,-42.9,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,"[1205, 1677, 1566, 907]","intervention:mean: − 28.7standard_deviation: − 38.2group_size: 61comparator:mean: − 28.7standard_deviation: − 38.2group_size: 61200:mean: − 38.2standard
---
intervention: mean: ""-38.3"" standard_deviation: ""x"" group_size: ""24""comparator: mean: ""-28.7"" standard_deviation: ""x"" group_size: ""24""
---
intervention:mean: −26.400SD: 62.1291group_size: 126comparator:mean: −25.000SD: 45.2522group_size: 131
---
intervention: mean: 14 mean_standard_deviation: 29.74 group_size: 87 comparator: mean: 8 mean_standard_deviation: 30 group_size: 79
---
",True
558,9831,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Control,continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1672, 1417]","Intervention: Soy shake
---
intervention:mean: −2.06standard_deviation: 8.69group_size: 40comparator:mean: −1.92standard_deviation: 4.17group_size: 40
---
",True
175,10752,5086025,Intuitive eating total score,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,3.45,0.55,2.54,0.58,1.5858,0.1011,,,,,Actually comparing preintervention and postintervention,TRUE,29049,17627,TEST,13068,"[739, 1755, 1654, 1640, 1675, 738, 1666, 1032, 3194]","intervention:
mean: 34.400
---
intervention: [ { ""mean"": ""26.00"", ""standard_deviation"": ""2.69"", ""group\_size"": 83 }] comparator: [ { ""mean"": ""23.89"", ""standard_deviation"": ""3.70"", ""group_size"": 8
---
intuitive_eating_and_acceptance_and_commitment_therapy: mean: 0stnd_dev: 38.8group_size: 21control: mean: 3stnd_dev: 28.8group_size: 15
---
intervention:
---
intervention:mean: 18.9172standard_deviation: 5.675153group_size: 40comparator:mean: 12.210930standard_deviation: xgroup_size: 52
---
intervention:
---
The YAML format you mentioned is already in the PLOS One format, but it can also be represented in YAML format, which is in the form of key-value pairs where keys are often enclosed in square brackets and values are indented. The key ""intervention"" has three key-value pairs for ""
---
- Mean: 24.400382136256981Standard_deviation: 7.8384975524058808Group_size: 93970621027016
---
intervention: mean: 6.8898 standard_deviation: 10.6498 group_size: 22comparator: mean: x standard_deviation: x group_size: 8
---
",True
439,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,choices group,continuous,,90,,98,94.1,15.6,47.1,21.1,2.50703599,0.03803123,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 77.5 (7/480) standard_deviation: 13.2 (8/480) group_size: 166 comparator: mean: 71.2 (4/480) standard_deviation: 17.1 (3
---
intervention:
---
```yamlIntervention:MTL+caloricintake groupComparator:choicesgroupOutcome:ScoresandonionsquizIntervention: [mean, mean, 24.8896, standard_deviation, 18.7762, group_size, 90]Comparator: [
---
{intervention: {mean: x, standard_deviation: x, group_size: 39}, comparator: {mean: 8.0, standard_deviation: 2.3, group_size: 46}}
---
",True
28,3244,2972614,Motion range - Shoulder internal rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,49.33,9.62,49.77,4.49,-0.055,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"[838, 1256]","Here is the YAML format for the given data: Outcome: Motion range - Shoulder internal rotation. Intervention: 1 mean: '66.4 °(43.1)' standard_deviation: '26(22.5)' group_size: 33 comparator: 1 mean
---
""intervention"": { ""mean"": 49.33, ""standard_deviation"": 9.62, ""group_size"": 10 }, ""comparator"": { ""mean"": 49.77, ""standard_deviation"": 4.49, ""group_size"": 5
---
",True
460,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],intervention: mean: [NOT AVAILABLE] standard_deviation: [NOT AVAILABLE] group_size: NUMBER (80)comparator: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER (80),False
410,3260,3475525,Correct selection of the healthier product,choices group,No label group,continuous,,98,,99,72.5,13.2,67.8,10.3,0.3957062,0.02070251,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 72.50 standard_deviation: 13.20 group_size: 96 comparator: mean: 67.80 standard_deviation: 10.30 group_size: 96
---
intervention: μ:92.62σ:5.10group_size:98comparator: μ:71.49σ:19.65group_size:98outcome: Accurately matched healthier product to nutrition information panel
---
choices: {mean: NUMBER, standard_deviation: NUMBER, group_size: NUMBER}no_label: {mean: NUMBER, standard_deviation: NUMBER, group_size: NUMBER}
---
intervention: mean: 0.72 standard_deviation: 0.23 group_size: 432 comparator: mean: 0.37 standard_deviation: 0.31 group_size: 427
---
",True
203,5496,5380326,Vitamin D levels,Vitamin D supplementation,Control,continuous,,40,,40,45.93,15.37,21.87,5.31,2.0722,0.0768,,,,,,TRUE,10658,5810,TEST,4260,"[618, 1669, 1370, 1494]","intervention: mean:17.775standard_deviation:7.852group_size:80comparator: mean:12.675standard_deviation:7.852group_size:80-
---
intervention: mean:20.27standard_deviation:4.88group_size:40comparator: mean:20.88standard_deviation:5.40group_size:40
---
Comparator:ControlIntervention:Vitamin DOutcome:Vitamin DMean (SEM)Pre Mean (SEM)Post Mean (SEM)Pre group_sizePost group_size20.59 (0.76)20.88 (0.85)1536
---
intervention: mean: 16.03 standard_deviation: 2.24 group_size: 96comparator: mean: 3.94 standard_deviation: 45.26 group_size: 98
---
",True
195,2096,5360580,"WMS-R (30 min) In the patients aged 77 years or younger,",1 mg/day of Pls purified from scallop,placebo,continuous,,19,,21,1.84,3.87,0,0.96,0.6551,0.1056,,,,,Data is from 24 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"[1665, 1312, 844, 1155, 1247]","intervention: mean: 3.06626812058 standard_deviation: 3.082442782017 group_size: 145 comparator: mean: 2.612210593878 standard_deviation
---
{% set data = {""intervention"": {""mean"": ""1.36"", ""standard_deviation"": ""0.23"", ""group_size"": ""78"" }, ""comparator"": {""mean"": ""1.23"", ""standard_deviation"": ""0.22"", ""group_size"":
---
intervention: mean:0.0417standard_deviation:0.183group_size:44comparator: mean:0.0962standard_deviation:0.539group_size:51
---
intervention: mean: [1.04, 0.93, 1.52] standard_deviation: [0.76, 0.70, 0.48] group_size: [12, 24, 24] comparator: mean: [0.8
---
intervention:mean:2.91standard_deviation:0.69group_size:83comparator:mean:2.47standard_deviation:0.67group_size:84
---
",True
96,10165,4173437,Coagulation profile,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,[],intervention:[Tranexamic acid]mean: xstandard_deviation: xgroup_size: x39comparator:[Control]mean: xstandard_deviation: xgroup_size: x39Outcome:[Coagulation profile],False
30,5576,3003523,Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"[1675, 455, 3308, 1649, 1104]","Short-Form 36-Items improvement:
---
intervention: Certolizumab 200 mg
---
intervention: {:numerical_separator: "", ""} {:numerical: {""mean"": ""5.8"", ""standard_deviation"": ""0.5"", ""group_size"": ""393""}} {:numerical: {""mean"": ""6.4"", ""standard_deviation"": ""0.
---
intervention: { mean: -13.79 standard_deviation: 19.9 2 group_size: 117} comparator: { mean: -0.644385 standard_deviation: 9.798874 2 group_size: 10
---
intervention:
---
",True
31,5577,3003523,Short-Form 36-Items improvement,Certolizumab 400 mg,Control,continuous,,390,,199,38.9,8.9,31.5,7.4,0.8773,0.0082,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"[1675, 455, 3308, 1649, 1104]","intervention: {{- mean: ""64.1"" -}} {{- standard_deviation: ""18.3"" -}} {{- group_size: ""390"" -}}comparator: {{- mean: ""63.6"" -}} {{- standard_deviation: ""19.9""
---
{ ""intervention"": {""mean"":""4"", ""standard_deviation"":""1"", ""group_size"":""3799"" }, ""comparator"": {""mean"":""1"", ""standard_deviation"":""2"", ""group_size"":""3801"" }, ""outcome"":{""mean"": ""5.5"", ""
---
*intervention: [(mean, standard_deviation, group_size)]comparator: [(mean, standard_deviation, group_size)]
---
intervention:
---
A note on ""group size"" field in this record: the group_size for comparing intervention and comparator is ""x"". Please check the source table data. There is no mention about randomization in the text, so it was assumed that two groups were randomly assigned.
---
",True
349,10236,5686687,CA-125 levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,"[1235, 1108]","intervention:mean: 8.98standard_deviation: 3.42group_size: 25comparator:mean: 7.24standard_deviation: 4.19group_size: 24
---
intervention:
mean: null
standard_deviation: null
---
",True
454,4432,5726464,insulin,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1626, 1655, 420]","This is the result from extracting data from the provided trial article: insulin,mean,standard_deviation,group_sizeIntervention,Comparatorkcal08,18698,91Vitamin D plus calcium supplementation98,9148n/aStandard Deviation: 1
---
intervention:
---
intervention:mean: 1.056standard_deviation: 0.375group_size: 42comparator:mean: 1.033standard_deviation: 4.216group_size: 44
---
",True
91,5539,3912320,"Correct response rate for 2,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],intervention: mean: 0.3group_size: 17comparator: mean: 0.3group_size: 10,False
431,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.3,15.1,35.7,15.9,3.63162908,0.0563916,,,,,,TRUE,9086,4934,TEST,3542,"[521, 1669, 1628, 78]","intervention: mean: 73.3 standard_deviation: 6.9 group_size: 105comparator: mean: 72.5 standard_deviation: 13.2 group_size: 96
---
intervention: mean: 86.7 standard_deviation: 18.5 group_size: 98 comparator: mean:78.5 standard_deviation:15.5 group_size:98
---
intervention:
group_size: 98 # add commas to separate items when needed here and aftergroup_size: 98group_size: 90 # add commas to separate items when needed here and aftergroup_size: 95group_size: 99 # add commas to separate items when
---
intervention: [{""mean"":4.48},{""standard_deviation"":0.267},{""group_size"":-7-}]comparator: [12{""mean"":1.89},{""standard_deviation"":1.22},{""group_size"":-29-}]
---
",True
668,13296,4987981,triglycerides levels,metformin,placebo,continuous,,21,,23,194.3,63.1,181.8,61.3,0.19746629,0.09154041,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[709, 2023, 1027, 1675, 817]","intervention:mean: 1.84stdev: 0.92group\_size: 21comparator:mean: 2.1stdev: 1.3group\_size: 23
---
intervention:
---
Intervention: pioglitazone
---
intervention:
mean: 1.100000
---
intervention: mean: 0.09 standard_deviation: 0.04 group_size: 28 comparator: mean: 0.09 standard_deviation: 0.03 group_size: 30
---
",True
696,5639,5712123,morphine requirements,D group,P group,continuous,,30,,30,22.6,4.1,31.9,6.7,-1.6526241,0.08942639,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"[1642, 952, 1316, 498]","intervention: mean: NUMBER standard_deviation: NUMBER group_size: NUMBER
---
intervention: mean: 5 standard_deviation: 2 group_size: 200comparator: mean: 10 standard_deviation: 2 group_size: 200
---
{
""intervention"": {
""mean"": ""Naloxone"",
---
comparator: {group_size: ""30"", mean: ""109.13"", standard_deviation: ""39.91""}intervention: {group_size: ""30"", mean: ""78.50"", standard_deviation: ""34.15""}
---
",True
527,6918,4411165,systolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"[1632, 485]","intervention:
---
intervention: mean: 37.91872890421061standard_deviation: 8.979466970154985group_size: 26comparator: mean: 62.589747090
---
",True
101,1886,4188762,heart rate,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[1441],"intervention:
---
",True
570,8558,5541727,Symptom improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[867, 1610, 1671, 76]","intervention: allogeneic mesenchymal precursor cells + HA control: allogeneic HAmean standard_deviation group_sizeintervention: mean standard_deviation group_size7.50E+101.66E+11x3comparator: mean standard_deviation group_size6
---
intervention: mean: 4.389539185306315 standard_deviation: 0.8879535356826566 group_size: 11
---
intervention:mean: −18.91sd: 7.72group\_size: 22comparator:mean: −6.14sd: 12.92group\_size: 20
---
intervention: mean: 3.76 standard_deviation: 2.96 group_size: 194comparator: mean: 1.58 standard_deviation: 2.09 group_size: 173
---
",True
135,2450,4574984,Health-Related Quality of Life at 12 month - males,"intervention group, i.e. patient empowerment through information booklet and diary keeping - males","control group, which received standard care - males",continuous,,216,,231,72.49,23.66,71.71,27.1,0.0305,0.009,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,"[718, 1310, 1592, 928, 1664, 467]","intervention:
mean: xx.xxxxxxxxx
---
intervention: mean: 82.4 standard_deviation: 19.6 group_size: 231 comparator: mean: 75.2 standard_deviation: 18.1 group_size: 208
---
intervention: mean: 50.41 standard_deviation: 21.83 group_size: 114 comparator: mean: 50.41 standard_deviation: 21.83 group_size: 114
---
intervention: mean: 75.00 standard_deviation: 11.15 group_size: 222 comparator: mean: 77.24 standard_deviation: 8.33 group_size: 151
---
The table of mean and standard deviation for Health Related Quality of Life at 12 Month for intervention and control (males), with total group sizes is as following:
---
intervention: mean: -2.63 standard_deviation: 27 group_size: 116 comparator: mean: -6.16 standard_deviation: 25 group_size: 148
---
",True
198,7735,5380284,Surgery duration,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,Data is unavailable.,FALSE,1731,1429,TEST,1251,[],"intervention:
mean: 225.6",False
209,2913,5459456,inflexion-extension for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,4,0.3,4,0.6,1.9928,0.3741,,,,,,TRUE,13404,7477,TEST,5693,"[1479, 984, 1106, 1663, 563]","Here is the information requested by the reviewers:ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVCcomparer: controlIntervention:
---
comparator: mean: 3.9standard_deviation: 0.6group_size: 10intervention:mean: 4.0standard_deviation: 0.6group_size: 10standard_deviation: 0.3group_size: 8intervention:mean:
---
intervention: mean: 6.5standard_deviation: 0.8group_size: 98comparator: mean: 6.3standard_deviation: 0.9group_size: 96
---
intervention:
---
intervention:
mean: -0.139429192514305518110670174557comparator: 2.09496648298054050297347467
---
",True
239,8054,5534041,composite z-scores in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.11,0.81,-0.25,0.71,0.4563,0.171,,,,,,TRUE,6951,5679,TEST,4357,"[926, 1571, 1677, 482]","intervention:mean:−0.25standard_deviation:0.71group_size:13comparator:mean:0.25standard_deviation:0.81group_size:13
---
intervention: mean: 73.00 standard_deviation: 21.06 group_size: 11 comparator: mean: 68.91 standard_deviation: 18.97 group_size: 10
---
intervention: {mean: 0.09, standard_deviation: 0.81, group_size: 12}
---
intervention: mean: '0.32' standard_deviation: '0.52' group_size: '3' comparator: mean: '0.07' standard_deviation: '0.32' group_size: '3'
---
",True
572,8561,5541727,medial tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-1.4,4.2,-3.3,5.3,0.39232146,0.2621027,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,"[867, 1610, 1671, 76]","intervention: mean: −0.7; standard_deviation: 4.0; group_size: 11 group_size: 6 The first number in standard_deviation is not in a normalized scale.
---
intervention: mean: - 0.1267 standard_deviation: 0.2153 group_size: 11 comparator: mean: - 0.0758 standard_deviation: 0.1354 group_size: 7
---
intervention: mean: -1.4 standard_deviation: 4.2 group_size: 98 comparator: mean: -4.0 standard_deviation: 3.9 group_size: 98
---
intervention: mean: 0.00783519 standard_deviation: 0.101049 group_size: 513733 comparator: mean: 0.00791806 standard_deviation: 0.105773
---
",True
27,3244,2972614,Motion range - Shoulder adduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42,4.27,42.04,5.26,-0.0084,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"[838, 1256]","intervention: mean: 30.42 standard_deviation: 9.77 group_size: 30 comparator: mean: -0.04 standard_deviation: 2.01 group_size: 22
---
intervention:
---
",True
106,1885,4188762,mean blood pressure,remifentanil,"normal saline, lidocaine, or ketamine",continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[1441],"{
---
",True
490,6383,3786549,Baseline characteristics: deliveries,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,2.14,1.76,2.64,1.79,-0.2792152,0.04589751,,,,,,TRUE,9725,6231,TEST,4323,"[1678, 1676, 1258]","intervention: standard_deviation: 5.45 group_size: 96 mean: 2.14 comparator: standard_deviation: 2.72 group_size: 96 mean: 2.64
---
intervention: mean: 2.89 standard_deviation: 0.56 group_size: 31 comparator: mean: 2.86 standard_deviation: 0.59 group_size: 27
---
intervention:
mean: 0.00561729515638550440533996423673808503432254228638480866617779
---
",True
